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ABSTRACT
In this thesis we will consider two mathematical models on malaria transmission and patho-
genesis. The transmission model is a human-mosquito interaction model that describes the
development of malaria in a human population. It accounts for the various phases of the
disease in humans and mosquitoes, together with treatment of both sick and partially im-
mune humans. The partially immune humans (termed asymptomatic) have recovered from
the worst of the symptoms, but can still transmit the disease. We will present a mathematical
model consisting of a system of ordinary differential equations that describes the evolution of
humans and mosquitoes in a range of malarial states.
A new feature, in what turns out to be a key class, is the consideration of reinfected
asymptomatic humans. The analysis will include establishment of the basic reproduction
number, R0, and asymptotic analysis to draw out the major timescale of events in the process
of malaria becoming non-endemic to endemic in a region following introduction of a few
infected mosquitoes. We will study the model to ascertain possible time scale in which
intervention programmes may yield better results. We will also show through our analysis of
the model some evidence of disease control and possible eradication.
The model on malaria pathogenesis describes the evolution of the disease in the human
viii
host. We model the effect of immune response on the interaction between malaria parasites
and erythrocytes with a system of delay differential equations in which there is time lag
between the advent of malaria merozoites in the blood and the training of adaptive immune
cells. We will study the model to ascertain whether or not a single successful bite of an infected
mosquito would result in death in the absence of innate and adaptive immune response.
Stability analysis will be carried out on the parasite free state in both the immune and non
immune cases. We will also do numerical simulations on the model to track the development of
adaptive immunity and use asymptotic methods, assuming a small delay to study the evolution
of the disease in a naive individual following the injection of small amount of merozoites into
the blood stream. The effect of different levels of innate immune response to the pathogenesis
of the disease will be considered in the simulations to elicit a possible immune level that can
serve as a guide to producing a vaccine with high efficacy level.
ix
CHAPTER 1
INTRODUCTION
1.1. The biology of malaria
Malaria is one of the most fatal diseases in the world. The symptoms that characterised
malaria may have been observed as far back as the prehistoric period [89], through the classical
era but it was not until the European renaissance period that the name malaria was derived
from the Medieval Italian word, mal aria meaning “bad air”, thinking that the foul vapours
emanating from the stagnate water and swamps was the cause of fever, a major symptom of
the disease.
A brief historical overview of the disease shows that some descriptions of what seemed
to be the disease symptoms are given in the historical records of some early civilisations.
The Chinese record, Huangdi Neijing describes the disease as repeated fever paroxysm that
causes enlargement of the spleen with the potential of generating an epidemic. Ateminisinin
combination treatment, a front line drug adopted by the World Health Organisation for the
treatment of malaria came from a Chinese plant, Qing-hao. This was discovered about 2300
years ago when it was first used to treat acute intermittent fever episodes. An account of
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the disease is also given in the ancient Egyptian medical Papyri. For instance, the ancient
Hindus of India ascribe the disease to the bite of a certain insect. Ancient Greeks, including
Homer, Empedocles and Hippocrates also referred to the disease as having characteristics of
intermittent fever causing enlarged spleens seen in people living in marshy places. It is believed
by some researchers that malaria must have been responsible for the fall of the Roman Empire
following an archaeological discovery of the presence of malaria in the bones of a Roman child
who died 1500 years ago. The cause of malaria was not known from the down of history
until later part of the 19th century when Charles Laveran discovered the malaria parasite
in human blood in Africa. Few years later, Giovanni Grassi and Raimondo Filetti used the
word plasmodium to name the malaria parasite and in 1897, Ronald Ross demonstrated that
plasmodium parasite can be transmitted from infected human to mosquitoes.
The aim of this chapter is to provide the reader with some of the biological and historical
background of malaria in an attempt to create an insight to the problem that forms the basis of
this study. Malaria is an infectious disease with characteristic symptoms of recurrent episodes
of chills, fever, sweating, and anaemia mostly prevalent in tropical climatic regions caused by
the parasitic infection of red blood cells by a protozoan of the genus Plasmodium, which is
transmitted from human to human by the bite of an infected female anopheles mosquito [3],
which requires a blood meal to nurture its eggs. Plasmodium parasites that cause diseases
in humans are basically of four species namely, plasmodium falciparum, plasmodium vivax,
plasmodium ovale and plasmodium malariae. Falciparum malaria caused by plasmodium
falciparum is far more severe than other types of malaria, which is being described as the
most deadly of all types [48]. The parasite undergoes a series of changes as part of its complex
life cycle.
WHO revealed that malaria kills at least one million people annually in sub-Saharan Africa
2
[116] with the potential to significantly increase in response to climate change (due to the
role of temperature and rainfall in the population dynamics of its mosquito vector) [63, 122].
Since malaria increases morbidity and mortality, it continues to inflict major public health
and socio-economic burdens in developing countries, which in Africa, slows economic growth
by up to 1.3 percent each year [115].
Most researches conducted in malaria epidemiology border around disease transmission,
parasite interaction with the human host as well as the mosquito vector. These have resulted
in the generation and advancement of various intervention strategies aimed at control, elim-
ination and total eradication of the disease. Although Malaria elimination has already been
achieved in most of Europe, North America, Australia, North Africa and the Caribbean, and
parts of South America, Asia and Southern Africa [119], the disease still remains endemic
especially, in the tropical and sub tropical regions of the world. Tremendous contributions
are being made by the World Health Organisation with the aim of eradicating the disease
worldwide. This led to the initiation of the Roll-Back Malaria Programme saddled with
responsibilities bordering on two key areas of prevention and treatment. However, this eradi-
cation initiative has been met with some intervening factors reducing it to mere disease control
characterised by high mortality of children and pregnant women, the most vulnerable group.
The way to disease eradication appears to be far fetched since there is evidence of rapid
re-establishment of the disease in areas where it has been eliminated due to mosquitoes and
parasites that are resistant to chemicals to which they were previously susceptible [18, 121].
Other challenges include, use of adulterated drugs instead of the recommended ones, single
dosage medication or ‘quick treatment’ without complete clearance of parasites, the paradox
of partial immunity or asymptomatic parasite carriage. The issue of asymptomatic parasite
carriage is crucial in the the transmission and pathogenesis of malaria. Intermittent Preventive
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Treatment (ITP) is part of the public health programme instituted by the WHO with the aim
of treating and clearing existing malaria parasites and preventing new infections in children
and pregnant women. Due to ongoing debates on whether or not asymptomatic carriers
should be treated, an increased knowledge on the asymptomatic carriage of malaria parasites
is needed to assess the risk-benefit ratio of Intermittent Preventive Treatment [117].
Due to a research carried out on the prevalence of asymptomatic carriage of P. falciparum
in sub-saharan Africa, Ogutu et al. [85] maintains that a large proportion of P. falciparum
infections are asymptomatic or sub-clinical and microscopy-detected levels of asymptomatic
carriage as high as 39% on children under 10 years old have been reported. Based on this
they presented a hypothesis that “if a significant reduction of the malaria parasite pool could
be obtained through treatment of asymptomatic carriers, over a period of time, a reduction
in disease transmission could be obtained across the entire endemic population, even in ar-
eas of high transmission”. Without testing the hypothesis, the paper highlights some of the
implications including the benefits and challenges associated with the treatment of asymp-
tomatic carriers. Therefore, it becomes imperative to understand their role in perpetuating
an endemic malaria, for which mathematical modelling can play a key role.
In this thesis, we present a mathematical modelling framework to explicate the dangers of
partial immunity necessitated by ‘quick treatment’ through intake of single dosage of malaria
medicine leading to inappropriate clearance of parasites in mostly malaria endemic regions.
The discovery of malaria vaccine would be a sure way to disease eradication. Thus, concerted
efforts are required to create adequate understanding of the pathogenesis of the disease in
the human host. The blood stage parasite is the main cause of disease pathology and to
date, efforts to generate an effective blood stage vaccine have not been successful on the
ground that clinical immunity is slow to develop and short lived and one reason for this is the
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extensive antigenic diversity found in plasmodium parasite leading to a poor understanding
of protective host immune responses [25]. We also present a mathematical model to describe
the key processes involved in the interaction of blood stage parasites (merozoites), healthy
erythrocytes and the human immune system. In the remaining subsections we shall discuss
the structure of the thesis, the life history of the malaria parasite and intervention strategies.
1.1.1. The structure of the thesis
This thesis is made up of 6 chapters. In chapter 1 we present the introduction to our work
in which some relevant biological issues leading to the work are discussed. In chapter 2,
we present a review of some infectious disease models including mathematical models in
malaria epidemiology to prepare the background to the transmission model. We present the
derivation and analysis of the transmission model in chapter 3 and round up the chapter
with a brief discussion of the numerical simulations and asymptotic analysis. In chapter 4
we discuss the immune system in relation to malaria infection and a brief review of some
relevant mathematical models as this will create an enabling environment in the derivation
and analysis of the in-host model in chapter five. This is followed by an overall conclusion
and suggestions for future work in chapter 6.
1.2. Life cycle of malaria parasite
In this section we present the life cycle of the plasmodium parasite. Understanding the
various stages in which the parasite exists will provide some useful information to the reader
by creating an understanding of the modelling methodology that we have used in this thesis.
The malaria parasite has a complicated life cycle involving a mosquito and a human, which
can be identified in three phases namely the sporozoite phase, merozoite or erythrocytic phase
and gametocyte phase. The merozoite phase starts and ends within the human host whereas
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Figure 1.1: A figure describing the life cycle of P. falciparum, the most deadly of all Plasmodium species. Other species have
a similar life cycle. However, time of development from one stage to another varies. Following infection from a mosquito bite,
the parasite in the form of sporozoites evade the immune system and evade the liver where they undergo asexual reproduction.
A large number of Merozoites, which are products of the asexual reproduction are released into the blood steam. Each merozoite
invades a red blood cell and reproduces asexually. After approximately 48 hours the erythrocyte ruptures and quickly invades a
fresh erythrocyte to renew the cycle. Some merozoites differentiate into male and female gametes that are later picked up by a
feeding mosquito. Sexual reproduction occurs in the stomach of the mosquito and in addition to some form of asexual replication,
sporozoites are released to complete the cycle. This picture is reproduced, with kind permission, from Alan F. Cowman [25].
the parasite in the first and third stages need both the mosquito and human environments to
strive. The female anopheles mosquito requires blood meal to nurture its eggs and during the
process of blood feeding it injects the malaria parasite in form of sporozoites that preoccupy
its salivary glands into the body of its human host at the site of bite. These sporozoites are
conveyed via the circulatory system to the liver after evading innate immune cells, in which
they invade hepatic cells.
Each of these sporozoites penetrates a liver cell using it to reproduce asexually through
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a process often referred to as exoerythrocytic schizogony culminating in the production of
merozoites, which are released into the bloodstream. During the process of schizogony an
infected hepatic cell or red blood cell passes through four metamorphic stages namely young
ring, old ring, young trophozoite and old trophozoite to become a schizont. However, this pro-
cess may vary depending on the plasmodium species. For instance, for some malaria parasites
such as Plasmodium vivax and Plasmodium ovale, the development of certain trophozoites is
arrested at earlier stages to form some temporarily dormant cells termed hypnozoites, which
may reactivate after some weeks, months, or years being responsible for relapses of the disease
[27]. Once these merozoites are released into the blood stream, each starts another round of
asexual replication using a red blood cell and after approximately 48 hours, except Plasmod-
ium malariae that maintains a 72 hour cycle, each surviving merozoite from any of the other
three species produces a second generation of merozoites. Immediately after the erythrocyte
invasion, the Plasmodium falciparum parasite has the appearance of a ‘ring’ and after about
12 hours it gradually adopts a more solid appearance known as a ‘young trophozoite’, which
continues to grow after 24 hours to become a schizont or segmenta and after about 12 hours
later ruptures to release daughter parasites that infect other erythrocytes [45]. The pro-
duction of second and subsequent generations of merozoites increases the level of parasitemia
creating intermittent fever paroxysms and other disease symptoms due to inflammations from
continuous rupturing of infected erythrocytes. Plasmodium falciparum merozoites attack all
red blood cells, not just the young or old cells, as do other types and a patient with this type
of malaria can die within hours of the first symptoms [71]. Prolonged fever destroys so many
red blood cells causing blockage of the blood vessels in vital organs (especially the kidneys),
which in some cases culminates in the enlargement of the spleen [7]. When malaria infection
is left untreated for a long time, it can lead to many complications including severe anaemia.
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There may be brain damage, leading to coma and convulsions. The kidneys and liver may
also fail [35].
An infected red blood cell committed to a further generation of merozoites, passes through
a period of schizogony as illustrated in Figure 3.3, with permission from [25]. The period
starts from an immature ring stage, through trophozoite stage to a mature schizont, and
eventually bursts to release merozoites. As an alternative to continuous merozoite replication
cycles, some of these merozoites differentiate into sexual forms of the parasite called game-
tocyte. These gametocytes, made up of the male form (microgametocytes) and the female
form (macrogametocytes) are later picked up by a female anopheles mosquito during blood
feeding. Fertilization occurs in the stomach of the mosquito as a microgamete becomes flag-
ellated and penetrates a macrogamete to form a zygote. The zygote developed into a motile
form oockinete and penetrates the midgut wall of the mosquito for further development into
an asexual form, oocyst. After rounds of multiple replication the oocyst ruptures to release
sporozoites, which migrate to the salivary gland of the mosquito waiting to be injected into
the skin of the human host.
1.3. Intervention strategies and immunity to malaria
The global struggle to combat malaria is being led by the world Health Orgaisation (WHO).
It has been a joint effort by local, national and international governments including some
non governmental organisations. There is no vaccination yet for the disease but certain
measures are being taken to control it. These control measures are being taken under a
Global Partnership programme called Roll Back Malaria (RBM), targeted at reducing the
burden of the disease, in particular for the most vulnerable, namely children and pregnant
women. In order to throw more light on our research we will have a brief survey of the main
control strategies that have been so far adopted in the fight against the disease. The control
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measures include
• Intermitent preventive treatment (IPT) especially, for pregnant women during antinatal
and infants irrespective of disease symptoms.
• The use of Insecticide-treated bed nets (ITN)
• Prompt and effective management of the disease through testing, treating and track-
ing (T3) of every malaria case using antimalarial drug combination (eg. Ateminisinin
combination treatments).
• Reducing mosquito population through the destruction of breeding sites or killing of the
larva stage at breeding sites that cannot be destroyed.
• Use of indoor residual spaying (IRS) in killing infected mosquitoes resting indoors after
feeding and susceptible mosquitoes that may be hiding indoor waiting to feed on humans.
• Introduction of insecticide-treated livestock in treating castles in areas where mosquitoes
feed on domestic animals
• Introduction of genetically modified mosquitoes that would produce single sex young
ones. Although this has not been implemented but researches are ongoing in this area.
• Administration of transmission blocking drugs like gametocydal drugs to reduce the
transition of merozoites to gametocytes.
These control measures have not been able to produce the desired results as they are bound to
face some challenges. For instance one of the greatest challenges in the fight against malaria is
drug resistance which has been on the increase. Similarly, the benefits of intermittent preven-
tive treatment may not be certain since, the effects of repeated treatments on the development
of immunity are the major challenges of intermittent preventive treatment (IPT)[117]. The
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treatment policies are designed to reduce morbidity and mortality by ensuring that rapid and
complete cure of every malaria case is achieved so that fatal and severe disease situations
including cases of chronic anaemia are prevented. Another important objective of effective
treatment is to reduce the human reservoir of infection so that disease transmission can be
minimised.
The World Health Organisation aims at tackling malaria at the community level so as to
reduce the intensity of malaria transmission at the local level by protecting people against
infective mosquito bites reducing the density of mosquitoes as well as their life span. The
application of indoor and outdoor residual spraying, clearing of home surroundings, good
drainage systems, use of treated bed nets, among others are geared towards achieving these
objectives. For instance one of the greatest challenges in the fight against malaria is drug re-
sistance which has been on the increase. Mono-therapies have been identified as contributing
immensely to drug resistance and the recommended use of Ateminisinin combination treat-
ments is a measure to cub this form of drug resistance. This is an indication that single dose
treatments do not always result in complete parasite clearance. Thus, in addition to creating
drug resistance, mono therapy makes the patient temporarily asymptomatic.
Based on the problem we have described so far our objective is to derive a mathematical
model that can specifically characterise the dynamics of the disease in endemic regions with
special interest in its transmission and control. We will employ relevant techniques with the
aid of relevant data characterising intensive malaria transmission to analyse the model with
the aim of determining possibilities of elimination of the disease. In the next chapter we will
discuss some important infectious disease models and their relevance to malaria epidemiology.
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CHAPTER 2
MODELLING BACKGROUND
2.1. Infectious disease models
Since malaria is an infectious disease, its models may share in common some characteristic
features of other infectious disease models. Any investigation of such a model must take into
consideration the mode of infection or transmission, that is whether the disease is contagious
or vector transmitted. This however, would be one of the determining factors as to whether an
epidemic would prevail or the disease is habitually prevalent in the population. A particular
disease could be an epidemic, pandemic or endemic. Contagious diseases sometimes turn out
to be epidemic especially, when new cases in a particular human population within a particular
period exceed peoples expectations based on recent experience. Often, an epidemic can be
pandemic in that it spreads and affects a very high proportion of the population across a large
region within a continent or between continents. On the other hand, an infectious disease
is said to be endemic if it is persistently prevalent in a population. Most of the infectious
disease models reviewed focus on explicating the dynamics of the disease by investigating its
incidence and prevalence through some basic assumptions relating the affected population,
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the status and spread of the disease, and the mode of recovery. These models are the well
known compartmental models SI, SIS, SIR, SEIR and SEIRS, S=Susceptible, I=Infectious,
E=incubating, R=Recovered [17, 50, 68]. However, Hethcote [50], discusses two additional
models, MSEIR and MSEIRS where M represents child immunity transferred by a mother
in form of antibodies through the placenta. Hence a newborn may have temporary passive
immunity to an infection and after the antibodies disappear from the body the infant moves
to the S class.
The SI model describes a simple epidemic in which a susceptible population is exposed to
infection. The basic foundation of this model can be found in the following assumptions.
• The disease is contagious and can only be transmitted from human to human.
• The rate that susceptible people and infected people interact is proportional to both
the number of susceptible people and the number of infected people with the rate of
proportionality expressed by a contagion parameter.
• A susceptible who gets infected becomes infectious immediately and remains so indefi-
nitely without recovery.
• The duration of the epidemic is relatively short, therefore, the population is always
constant and closed meaning that there are no births and deaths.
The SI model constructed on the basis of the foregoing assumptions is a coupled system of two
ordinary differential equations. The rate of change of the susceptible population with respect
to time would be decreasing and that of the infective would be increasing at a rate proportional
to the contagion parameter or precisely, the infectious contact rate. The implication of this
is that, if a susceptible population is exposed to an infectious disease with some proportion
of the population being infected then the disease would spread exponentially to engulf the
12
entire population. The SI epidemic model does not describe an epidemic realistically since an
infective may die or recover and if in some diseases there is no immunity, then the recovered
becomes susceptible again. The SIS model describes a disease scenario where infected people
have the tendency of recovering from the disease without gaining immunity. Thus, infected
people become susceptible again immediately after recovery. It might be appropriate for some
sexually transmitted diseases like gonorrhoea because after recovery, the host is once again
susceptible to infection [17]. The SIR model describes an infectious disease in which some
infected people recover from the disease and after acquiring immunity cannot be susceptible
again. This model unlike the SI and SIS models may have some practical implications. For
instance it may be suitable for the transmission of a flu epidemic since once a person has had
a particular strain of flu, his immune system prevents him from being reinfected with that
strain. The classical SIR model is of the form
dS
dt
= −βSI,
dI
dt
= βSI − αI,
dR
dt
= αI,
where β is the contagion parameter and α, the recovery rate assumed to be proportional
to the number of infected people. The system is nonlinear and cannot be solved explicitly,
although implicit solutions can be found. In addition to determining equilibrium and stability
of the model, we can obtain by analytical means the final state of the epidemic. We note
that this form of the SIR model does not involve demography but inclusion of some host
demographic factors like birth and death may alter its dynamics by permitting the disease
to persist in the population in a long term. Despite its limitations as entrenched in the
assumptions characterising the SIR model, it is the basis for more involved deterministic
models in epidemiology. The SEIR model is an improvement on the SIR in most disease case
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where incubation is relevant. It involves recovery and immunity without the possibility of
contacting the disease again but differ slightly from the SIR model in that the later, once
being infected, passes through an incubation period E before showing disease symptoms.
The SEIRS models describe the dynamics of endemic diseases where individuals who contact
the disease progress through a period of incubation before showing disease symptoms and
becoming infectious and after recovery from the disease may gain partial immunity and later
become susceptible after loss of immunity. Although, early transmission models in malaria
epidemiology seem to have taken the shape of the SIR model, the SEIRS model appears to
portray a better representation of the dynamics involved. Malaria transmission is a cyclic
relationship between an infectious human population and a susceptible mosquito population
on one hand and an infectious mosquito population and a susceptible human population in
the other hand. Various mathematical models have been constructed to help understand the
dynamics of malaria. We present a review of some of these models in the next section that
are closely related to the work in this thesis.
2.2. A survey of mathematical models in malaria epidemiology
2.2.1. Transmission models
Sir Ronald Ross was the first to construct a mathematical model for malaria [96]. He used
two equations, one representing the rate of change of infected humans with time and the
other that of infected mosquitoes. One important outcome of the analysis of his model is
that of threshold density of the Anopheles mosquito, which according to him, “to counter
malaria anywhere we need not banish Anopheles there entirely but we need only to reduce
their number below a certain figure”. Based on this, Kermack and McKendrick published a
classic paper in 1927 that discovered a threshold condition for the spread of a disease and
gave a means of predicting the ultimate size of an epidemic [17]. In 1957, MacDonald made
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further extensions on the work on the malaria model of Ross [65].
In a systematic historical review of mathematical models in epidemiology, Smith et al.
[103] avers that several mathematicians and scientists contributed to the Ross-Macdonald
model for a period of 70 years. The model plays a crucial role in the development of malaria
transmission model and was first written by Aron and May in 1982 as
dx
dt
= mabz(1− x)− rx, (2.2.1)
dz
dt
= ax(1− z)− gz, (2.2.2)
where x and z are fractions of infectious humans and adult females mosquitoes respectively.
The parameter a represents the number of bites a single female mosquito gives to humans and
b is the probability that a single bite transmits infection to the human. The average number
of female mosquitoes is represented by m. The mortality rates of humans and adult female
mosquitoes are gz and rx respectively. This model has been extensively discussed in Chitnis
[21]. Its assumptions are based on a simplified process-based description of the pathogen life
cycle [103], as represented by the biology in section 1.2. These are described by the following
four events.
• Mosquito transmits pathogen to susceptible human during blood feeding.
• Pathogen infects human and multiplies to a high density.
• Susceptible mosquito ingests pathogen during blood feeding.
• Pathogen developes in the mosquito and migrates to the salivary gland ready to be
injected into a susceptible human.
Further work done on the Ross-Macdonald model by Bailey in 1982, led to the general theory
that describes malaria transmission in form of the classical SIR-SI model and since then
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considerable modifications have been made in the quest for a model that will better describe
the mosquito-human interaction process and pathogen transmission.
A more sophisticated model that incorporates acquired immunity in malaria was con-
structed by Dietz et al. [30], which gave a more realistic description of malaria epidemiology
at the Garki area in Nigeria, given entomological input and provided conditional inputs and
comparative forecasts for several specific intervention.
Many malaria models involving immunity have been reviewed in [20, 22, 81]. The models
proposed by Anderson and May [5] and Aron and May [9] use the assumption that acquired
immunity does not depend on duration of exposure. While the models of Aron [7, 8] and
Bailey [12] are based on the assumption that immunity is boosted by additional infections.
A more comprehensive mathematical model typical of a characteristic endemic malaria is the
one proposed by Ngwa and Shu [82]. A malaria model with periodic mosquito birth and
death rates was proposed in [29]. The paper considers a novel situation where the birth and
death rates of mosquitoes and human death rate are periodic. Although the model does
not include incubating classes of both human and mosquitoes but they established a basic
reproduction number such that the disease will only prevail if this number was greater than
unity, otherwise the disease will die out. Another model involving the effects of seasonality
and immigrations of infected humans was proposed in [76]. The results show that the strength
of seasonality increases the number of infections and it is not possible to achieve a disease
free equilibrium in the presence of infective immigrants, signifying that the disease cannot
be completely eradicated if there is constant inflow of infected immigrants. Most prominent
in the models discussed so far is the concept of the basic reproduction number. The basic
reproduction number of an infectious disease is a very important concept in epidemiology.
This important quantity provides the key to transmission dynamics, indicating the ease by
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which major epidemics may be prevented and prospects for the eradication of an infection
[95]. The symbol R0 is often used to represent it. If a single infectious case is introduced
in a population of susceptibles and assuming the population evolves in a continuum sense,
it is expected to generate a chain of subsequent infections for the disease to fully register
itself (endemic) or die out eventually. The expected number of secondary cases that would
arise from the introduction of a single primary case into a fully susceptible population is
referred to as the basic reproduction number of the disease. R0 is a threshold parameter
which determines whether or not an infectious disease will be endemic, such that
• if R0 < 1 each successive infection generation is smaller than its predecessor, and the
infection cannot persist
• if R0 > 1 successive infection generations are larger than their predecessors, and the
number of cases in the population will initially increase, not necessarily indefinitely, but
the disease remains endemic.
The method of analytical solutions to these models have always been that of defining
a domain where the model is mathematically and epidemiologically well-posed, proving the
existence and stability of a disease-free equilibrium point, defining the basic reproduction
number and describing the existence and stability of the endemic equilibrium points.
2.2.2. Summary from the survey
We have presented a review of some of the known models found to be relevant to our work.
To the best of our knowledge, none of the transition models considers the assumption that
immune humans being bitten by infectious mosquitoes may be constantly incubating and there
is the possibility of some immune humans falling sick immediately after loss of immunity. We
incorporate into our model some of the features found in the SEIRS model of Ngwa and
17
Shu [82]. In the next chapter we will present and analyse the proposed model of malaria
transmission.
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CHAPTER 3
TRANSMISSION MODEL
In this chapter we derive and study an epidemiological model of malaria. This model extends
that of Ngwa and Shu [82] to take into account the various phases of the disease in humans
and mosquitoes. The partially immune humans (termed asymptomatic) have recovered from
the worst of the symptoms, but can still transmit the disease. A new feature, in what turns
out to be a key class, is the consideration of re-infected asymptomatic humans leading to an
additional incubating class. We first derive the model, then we undertake stability analysis to
establish a basic reproduction number and finally employ a time scale analysis to gain insight
into how an epidemic evolves from a small outbreak from a disease free population. The
modelling is relevant for a 0.5 year timescale in which the population is not expected to change
too much in the absence of malaria. The modelling also takes into account a routine treatment
administered to symptomatic individuals. In addition, we consider a putative treatment for
post symptomatic humans, to limit the capacity for asymptomatic human carriers of the
disease.
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3.1. Derivation of the model
A population of humans in a region is susceptible to malaria infection if the environmental
conditions in that region favour the breeding of the anopheles mosquitos. We recall from
Section 1.2, that once an infectious female anopheles mosquito injects malaria parasites into
a human at the site of bite, these parasites undergo some developmental stages within the
host. These stages partition the host into a waiting state to disease manifestation, or disease
state or non-disease state in the presence of parasites. In order to set the necessary framework
for the proposed model, we divide the human population into compartments of susceptible,
latent, latent asymptomatic, symptomatic and asymptomatic carriers, and that of mosquitoes
into susceptible, latent and infectious compartments. State variables in the model are given
in Table 3.1 and the movement between compartments is summarised in Figure 3.1, the
individual pathways to be discussed below.
State variable Description
N Total human population
C Susceptible human population
L Incubating human population
LA Number of latent asymptomatic infectious humans
S Number of symptomatic infectious humans
A Number of asymptomatic infectious humans
M Total mosquito (female anopheles) population
X Number of susceptible mosquitoes
Y Number of incubating (latent) mosquitoes
Z Number of infectious mosquitoes
Table 3.1: The state variables in the model .
The total population of humans and (female) mosquitoes are simply the sum of their
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respective state variables, i.e.
N = C + L+ LA + S + A,
M = X + Y + Z.
We use C to represent the set of susceptible humans who initially do not have malaria
parasites but have natural nonspecific immunity, whilst L represents the collection of humans
who have received infectious bites and are within the liver and early erythrocyte stage infection
(humans will remain in this state, untreated, for about 15 days). The S class involves those in
the erythrocyte stage that have developed both disease symptoms and gametocytes. Unlike
those in the L class, symptomatic infectious humans require treatment as those in the L class
do not know they are infected. Individuals reach a partially immune or asymptomatic status
A when they no longer have symptoms of the disease that would warrant clinical attention but
are still infectious to mosquitoes, which may be caused by improper treatment or reinfection
(individuals in this class can remain so for a mean time of around 165 days, provided they
  Births
Susceptible humans
    
Latent humans Symptomatic infectious
                  S
Asymptomatic infectious
                     A
Latent Asymptomatic
    Infectious   contacts
   Infectious
   contacts
Infectious
contacts
Plasmodium     carriagerelated deaths Natural deaths Natural deaths
                   LA
LC
   Infectious mosquitoes    Latent mosquitoes Susceptible mosquitoes
                    Z                   Y                      X
        humans humans
                humans
Natural deaths        Births
Natural deaths Disease deathsNatural deathsNatural deaths
Treatment
  Treatment
Figure 3.1: Schematic representation of mosquito human interraction model. The rectangle indicates the state variables, the
ovals are actions within humans and mosquitoes and the hexagon indicates action between species.
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are not infected again). We use LA for individuals in the A class being bitten by infectious
mosquitoes. Since they carry both gametocytes and asexual parasites, loss of immunity may
cause their immediate transition into the S class instead of the C class. A mosquito is said to
be in the Y class as soon as it ingests gametocytes from an infectious human until the time
(about 12 days) before sporozoites migrate to the salivary gland when the mosquito becomes
infectious and proceed to the Z class. The LA, S and A classes are infectious to X while the
Z class infects C and A.
What is most fascinating about an infectious disease model is its suitability for disease
control, or ideally the eradication of infection. The practical use of such models must rely
heavily on the realism put into the model. As usual, this does not mean inclusion of all
possible effects, but rather the incorporation in the model mechanisms, in as simple a way as
possible, that appear to be the major components [77]. The model explains the dynamics of
both human and mosquito populations as they progress from susceptible noninfectious states
to infectious states. Malaria is transmitted when a susceptible human is bitten by an infected
Anopheline mosquito. The rate at which a susceptible person becomes infected is a function
of contact rate with infective mosquitoes and level of host susceptibility [90]. We assume
that mosquito biting vectors are equally susceptible and human infectiousness to mosquitoes
is determined solely by the gametocyte density or the density of infection in the human host
[55].
Susceptible humans get infected at rate βheZ
C
N
where eZ is the rate at which infected
mosquitoes bite (constant e being the biting rate per human per unit time), C
N
is the prob-
ability that the human bitten is susceptible and βh is the number of human infections per
bite. Likewise the rate of reinfection of an asymptomatic individual is βheZ
A
N
. The rate
at which uninfected mosquitoes obtain the plasmodium parasite from human carriers is
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e (βsS + βaA+ βaLA)
X
N
, noting that humans in class L are in the incubating stage of in-
fection and are not infectious to mosquitoes. Susceptible mosquitoes are recruited into the
mosquito population through a constant birth rate λm. Assuming that each mosquito has the
same biting behaviour, there will be a total of eM bites by mosquitoes on humans. But only
C
N
of these bites will be made on susceptible humans. The probability that a bite is made by
an infectious mosquito is Z
M
. It is important to note here that the parameter βh assumes that
not all bites by an infectious mosquito on a susceptible human can lead to infection. The
parameter βh ∈ [0, 1] is the proportion of bites by an infectious mosquito that passes on the
infection, where βh = 1 means all bites transmits the disease. However, βh = 0.086 in data,
so there is only a 10% chance of an infected mosquito to pass on its infection. The cross
infection rate βhe
Z
N
between the human and mosquito populations depends on the average
number of mosquito bites per unit time and the transmission probability normalised by the
human population [15, 120]. We also assume that the recruitment of humans into the suscep-
tible population occurs at a constant per capita birth rate λh and apart from asymptomatic
individuals no human in the latent and symptomatic infectious classes would be affected by a
bite from an infectious mosquito. This assumption becomes necessary since we are primarily
concerned about how infectious bites from mosquitoes can lead to the disease. Those in the
L class are already in the process of transition into the S class who are entitled to treatment.
Incubating humans become infectious after a mean latency time 1
ηh
.
All human classes “die naturally” at per capita rate µh while some individuals in the S
class die at an additional rate αhS from the disease. The survivors receive treatment and
either recover with complete clearance of parasites to join the susceptible class at a rate
rsS (individuals undergo a 14-day treatment), or only recover from symptoms (after a 3-day
monotherapy) without parasite clearance to join the A class at a rate raS.
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The post symptomatic class, A still carry merozoites and produce gametocytes, so can
infect biting mosquitoes. A human can be in this state for several weeks or months and hence
play an important part in sustaining an epidemic, noting that symptomatic individuals are
in this state for 3-14 days [19, 34, 38]. It seems that if there exists some treatment to target
post infected humans, then the pool of people who infect mosquitoes will be reduced. We
then consider in our model a putative treatment which removes individuals from the A and
LA class down to C and L respectively. The effect of the treatment parameter, φθh (φ are
being treated) in R0 will be an important part of the analysis.
Susceptible mosquitoes get infected through infectious contacts with infectious humans at
a rate e (βsS + βaA+ βaLA)
X
N
and proceed to the incubating compartment. Although there
are some conflicting findings on whether or not the plasmodium parasite reduces the life span
of infectious mosquitoes, direct laboratory results of [40, 52, 58, 59] suggest that the malaria
parasite reduces mosquito survival. Since mosquitoes do not recover from infection it follows
that the infectiousness of mosquitoes end in their death [15, 82]. We assume that mosquitoes
in the incubating class die naturally at a rate µmY and the rest get infectious at a rate ηmY
to join the infectious compartment which they remain until their death either naturally, or
through the carriage of infectious parasites in their body [76] at a rate αmZ.
Using the above assumptions, then the system of equations for the human classes are
dC
dt
= λhN + rsS + laA− βhe Z
N
C − µhC + φθhA, (3.1.1)
dL
dt
= βhe
Z
N
C − ηhL− µhL+ φθhLA, (3.1.2)
dLA
dt
= βhe
Z
N
A− ηhLA − µhLA − φθhLA, (3.1.3)
dS
dt
= ηhL+ ηhLA − αhS − rsS − raS − µhS, (3.1.4)
dA
dt
= raS − βhe Z
N
A− laA− µhA− φθhA, (3.1.5)
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and for the mosquito classes are
dX
dt
= λmM − βse S
N
X − βaeA
N
X − βaeLA
N
X − µmX, (3.1.6)
dY
dt
= βse
S
N
X + βae
A
N
X + βae
LA
N
X − ηmY − µmY , (3.1.7)
dZ
dt
= ηmY − αmZ − µmZ, (3.1.8)
and the total populations are
dN
dt
= λhN − αhS − µhN, (3.1.9)
dM
dt
= λmM − αmZ − µmM, (3.1.10)
where (3.1.9) is derived from adding (3.1.1)−(3.1.5) and (3.1.10) is the sum of (3.1.6)−(3.1.8).
To close this system we need a set of initial conditions for each of the state variables. A
suitable set depends on the context of the study. In section 3.7 we will consider the evolution
of the disease in a disease free human population with a small number of infected mosquitoes.
Nevertheless, we impose
t = 0, N = N0, M = M0
as initial population values for humans and mosquitoes.
3.2. Parameter values
All the model parameters are listed in Table 3.2 together with values taken from various
sources. We note that these parameters are from P. falciparum malaria, the most deadly par-
asite, predominant in Sub-saharan Africa. Some of the data are experimentally measured and
some are values assumed in models. However, we have made some assumptions on parameters
that do not seem to have well defined values. In [21, 82] for instance, βa was considered to be
of lower value than βs as they arbitrarily assume in their model that the probability of trans-
mission of infection from recovered or partially immune humans to susceptible mosquitoes is
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one tenth the probability of transmission from infectious humans to susceptible mosquitoes.
But in this model we obtain the values of βa and βs based on the experimental findings of
[44] which reveals that asymptomatic humans are rather far more infectious than those in the
disease class. Although the mechanism of immunity to malaria is not well understood, Ngwa
and Shu [82] avers that a smaller proportion of humans recover from malaria without gaining
immunity.
3.3. Nondimensionalisation
Since the variables N and M are the sum of the relevant compartment values, it is convenient
to re-express the compartment values as population fractions using
Cˆ =
C
N
, Lˆ =
L
N
, LˆA =
LA
N
, Sˆ =
S
N
, Aˆ =
A
N
, Xˆ =
X
M
, Yˆ =
Y
M
, Zˆ =
Z
M
,
so that
Cˆ + Lˆ+ LˆA + Sˆ + Aˆ = 1, (3.3.1)
Xˆ + Yˆ + Zˆ = 1. (3.3.2)
The time derivatives for the variables will become, using variable C as an example
dNCˆ
dt
= N
dCˆ
dt
+ Cˆ
dN
dt
= N
dCˆ
dt
+ (λh − αhSˆ − µh)NCˆ,
There are a number of time scales in the system, mosquito life cycle (weeks), incubation and
symptom (weeks), population turnover (tens of years), asymptomatic clearance (∼ 6 months),
and the most suitable choice for the scaling depends on the context. We are focusing on an
endemic area and year time scale, in which the total population change is negligible in the
absence of the disease, hence we scale time with the asymptomatic susceptible transmission
parameter la, and write
t =
tˆ
lˆa
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so that tˆ = 1 is about 165 days. Recalling that M0 and N0 are the initial populations of
humans and mosquitoes respectively, we write
N = N0Nˆ ,M = M0Mˆ
and define the following dimensionless parameters:
β =
βheM0
laN0
, b =
βse
la
, d =
βae
la
, η =
ηh
la
, µ =
µh
la
, λ =
λh
la
, α =
αh
la
,
γ =
rs
la
, ρ =
ra
la
, θ =
φθh
la
, f =
ηm
la
, q =
λm
la
, g =
µm
la
, h =
αm
la
,
and by substituting these new parameters into (3.1.1)−(3.1.10) and dropping the hats for
clarity we get
dC
dt
= λ+ γS + A− βZCM
N
− λC + αCS + θA, (3.3.3)
dL
dt
= βZC
M
N
− ηL− λL+ αLS + θLA, (3.3.4)
dLA
dt
= βZA
M
N
− ηLA − λLA + αLAS − θLA, (3.3.5)
dS
dt
= ηL+ ηLA − (α + γ + ρ+ λ)S + αS2, (3.3.6)
dA
dt
= ρS − A− βZAM
N
− λA+ αAS − θA, (3.3.7)
dX
dt
= q (1−X)− bSX − dAX − dLAX + hXZ, (3.3.8)
dY
dt
= bSX + dAX + dLAX − (f + q)Y + hY Z, (3.3.9)
dZ
dt
= fY − (h+ q)Z + hZ2, (3.3.10)
dN
dt
= −αSN + (λ− µ)N, (3.3.11)
dM
dt
= −hZM + (q − g)M. (3.3.12)
In solving the problem we can use (3.3.1) and (3.3.2) to reduce the number of ODEs. We
solve the system together with (3.3.1) and (3.3.2).
28
Dimensional form Nondimensional parameter Value Value in terms of 
βheM0
laN0
β 62.43 O( 1
2
)
ηh
la
η 11.1 1

µh
la
µ 0.0056 O(2)
λh
la
λ 0.017 O(2)
αh
la
α 0.01 O(2)
rs
la
γ 11.5 O(1

)
ra
la
ρ 54.45 O( 1
2
)
βse
la
b 7.2 O(1

)
βae
la
d 38.2 O(1

)
ηm
la
f 14 O(1

)
λm
la
q 21.45 O(1

)
µm
la
g 20.62 O(1

)
αm
la
h 1.45 O(1)
φθh
la
θ
Table 3.3: List of dimensionless parameters and their definitions in terms of
the original parameters, the dimensional values. In the final column we express
the size of the parameter in terms of the small parameter  = η−1 ≈ 0.09, this
being relevant for section 3.7.
The dimensionless parameter values are shown in Table 3.3 and the parameters in relation
to the small parameter  (= η−1) are also included. We note from the rescalings that the
population of humans, N0, and mosquitoes, M0, need not be presented but only
M0
N0
. We
do not have data for malaria vectors/human populations, but we assume that the initial
female mosquito population M0 is ten times that of humans N0 due to the claim that in an
endemic area of dengue fever the ratio of female Aedes aegypti (the main vector of the virus)
population to human population is 10 : 1 [10]. Though the main vector in our case is the
female Anopheles mosquito, we expect that in an endemic malaria region, the distribution of
female An. gambiae mosquito will be well compared with that of Aedes aegypti. But the
rescalings are such that
M0
N0
only affects the parameter β. By definition,  is the ratio of ηh and
la (i.e. the proportion of time for the latency period compared to the mean asymptomatic state
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timescale) and  1, means that asymptomatic humans remain infectious for a longer time
compared to the latency period of humans. Analysing the model using  as a small parameter
provides a convenient basis for the application of asymptotic methods in understanding the
effect of partial immunity on the spread of malaria.
3.4. Establishing the basic reproduction number of the transition model
The application of approaches like the traditional or intuitive method used in [5, 82] or the
next generation matrix method used in [21, 20] may be used in the determination of the
basic reproduction number, R0. Here we use the next generation operator approach, which
approximates the number of secondary infections due to one infected individual and express
R0 in the traditional form as suggested by van den Driessche and Watmough [31]. As usual
we consider a small perturbation of the disease free state (C = 1, X = 1, L = LA = S = A =
X = Y = Z = 0) and assume that growth and decay is much faster than population change,
i.e. M = N = 1, we consider the linearised system expressed in the form
R′ = FR− V R, (3.4.1)
where, R′ =
dR
dt
and
F =

0 0 0 0 0 β
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 d b d 0 0
0 0 0 0 0 0

, V =

a1 −θ 0 0 0 0
0 a0 0 0 0 0
−η −η a2 0 0 0
0 0 −ρ a3 0 0
0 0 0 0 a4 0
0 0 0 0 −f a5

, R =

L
LA
S
A
Y
Z

;
here, FR represents the emergence of new infections, V R the transition of these infections
between compartments and R the “reservoir of infection”. The constants a′is are expressed
in terms of the model parameters as follows:
a1 = η + λ, a0 = η + λ+ θ, a2 = α + γ + ρ+ λ, (3.4.2)
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a3 = 1 + λ+ θ, a4 = f + q, a5 = h+ q.
This method assumes that there is a non-negative matrix G = FV −1 that guarantees a unique,
positive and real eigenvalue strictly greater than all others. Computing the inverse of V yields
G =
1
b0

0 0 0 0 βb11 βb12
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
f1 f2 f3 f4 0 0
0 0 0 0 0 0

(3.4.3)
where,
b0 = a0a1a2a3a4a5, b11 = fa0a1a2a3, b12 = a0a1a2a3a4, f1 = bb2 + db3, f2 = db4 + bb5 + db6,
f3 = bb7 + db8, f4 = db9, b2 = ηa0a3a4a5, b3 = ηρa0a4a5, b4 = a1a2a3a4a5, b5 = ηa1a3a4a5,
b6 = ηρa1a4a5, b7 = a0a1a3a4a5, b8 = ρa0a1a4a5, b9 = a0a1a2a4a5.
The characteristic equation of (3.4.3) in terms of the eigenvalue, σ, shows that four of the
eigenvalues vanish leaving the expression
σ2 =
β (bb2 + db3) b11
b20
, (3.4.4)
which expressed in terms of the model parameters gives
σ2 =
βηf (b (1 + λ+ θ) + ρd)
(η + λ) (α + γ + ρ+ λ) (1 + λ+ θ) (f + q) (h+ q)
. (3.4.5)
Although the next generation matrix demands that R0 = σ is the basic reproduction number,
in practice σ2 is often taken as R0 (indeed this was the assumption used in the original work
applying this method). We note from the numerator of (3.4) that the basic reproduction
number is proportional to the square of mosquito biting rate (e2) as expected.
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3.5. Steady state solution and model analysis
Consider the domain
Γ ∈ R10 = {C,L, LA, S, A,X, Y, Z,N,M : C ≥ 0, L ≥ 0, LA ≥ 0, S ≥ 0, A ≥ 0,
X ≥ 0, Y ≥ 0, Z ≥ 0, N > 0,M ≥ 0, C + L+ LA + S + A = 1, X + Y + Z = 1},
(3.5.1)
and suppose at t = 0 all variables are non-negative, then C(0) + L(0) + LA(0) + S(0) +
A(0) = 1 and X(0) + Y (0) + Z(0) = 1. If C = 0, and all other variables are in Γ, then
dC
dt
≥ 0. This is also the case for all other variables in (3.3.3)−(3.3.10). If N = 0, then
dN
dt
= 0 and M = 0 implies
dM
dt
= 0. But if N > 0 and M > 0, assuming λ > µ
and q > g i.e. λh > µh and λm > µm, then with appropriate initial conditions,
dN
dt
> 0
and
dM
dt
> 0 for all values of t > 0. We note that the right-hand side of (3.3.3)−(3.3.12)
is continuous with continuous partial derivatives, so solutions exist and are unique. The
model is therefore mathematically and epidemiologically well posed with solutions in Γ for all
t ∈ [0,∞). The disease free state (C,L, LA, S, A,X, Y, Z) = (1, 0, 0, 0, 0, 1, 0, 0) is locally and
globally asymptotically stable when R0 < 1 and unstable for R0 > 1, where
R0 =
βηf{b (1 + λ+ θ) + ρd}
(η + λ) (α + γ + ρ+ λ) (1 + λ+ θ) (f + q) (h+ q)
, (3.5.2)
is the expected number of secondary infection cases that would arise from the introduction of
a single primary case into a fully susceptible population. We note that R0 = 1 is a bifurcation
surface in which the system changes its stability status, but we will only show proof of
stability for the disease free state. Since R0  1 using Table 3.3 and the infectiousness of
asymptomatic humans to mosquitoes is significantly large, a good target for treatment is to
reduce the infectivity of asymptomatic humans (reduce d) and that of symptomatic humans
(reduce b) by increasing the treatment parameters θ and γ. An important task is to determine
an amount of treatment that can bring R0 to a safe level. For instance, for R0 to be brought
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down to unity, we will expect, θ to be
θc =
(η + λ)(α + γ + ρ+ λ)(f + q)(h+ q)(1 + λ)− βηf{b(1 + λ) + ρd}
βηfb− (η + λ)(α + γ + ρ+ λ)(f + q)(h+ q) , (3.5.3)
in terms of the parameters.
3.6. Stability analysis of the transition model
Here we derive sufficient conditions for global stability of the disease free state from all initial
conditions ∈ Γ. The Jacobian matrix obtained by linearising system (3.3.3)−(3.3.10) about
the disease free equilibrium point, (C,L, LA, S, A,X, Y, Z) = (1, 0, 0, 0, 0, 1, 0, 0) is
Jdf =

−λ 0 0 a6 1 + θ 0 0 −β
0 −a1 θ 0 0 0 0 β
0 0 −a0 0 0 0 0 0
0 η η −a2 0 0 0 0
0 0 0 ρ −a3 0 0 0
0 0 −d −b −d −q 0 h
0 0 d b d 0 −a4 0
0 0 0 0 0 0 f −a5

(3.6.1)
with the a′is as defined above and a6 = α + γ. Its characteristic polynomial equation with
eigenvalues (κ) is
(κ+ λ)(κ+ a0)(κ+ q)(κ
5 +H1κ
4 +H2κ
3 +H3κ
2 +H4κ+H5) = 0, (3.6.2)
where
H1 = a1 + a2 + a3 + a4 + a5
H2 = a2a5 + a3a4 + a4a5 + a1a2 + a1a3 + a1a4 + a3a5 + a2a3 + a2a4 + a1a5,
H3 = a1a2a3 + a1a2a4 + a2a3a4 + a2a3a5 + a2a4a5 + a3a4a5 + a1a4a5 + a1a2a5 + a1a3a4 + a1a3a5,
H4 = a1a2a4a5 + a1a3a4a5 + a2a3a4a5 + a1a2a3a4 + a1a2a3a5 − βηfb,
H5 = a1a2a3a4a5 − βηf(ba3 + ρd).
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We note the linear factorisation = (3.6.2) clearly yields negative real eigenvalues, however,
from the quintic equation, no such deduction can immediately be made.
Lemma 3.6.1. The disease-free equilibrium is locally asymptotically stable if R0 < 1 and
unstable if R0 > 1.
Proof. From the definition of ai in (3.4.2), R0 is given by
R0 =
βηf(ba3 + ρd)
a1a2a3a4a5
.
If R0 < 1, then
a1a2a3a4a5 > βηf(ba3 + ρd).
The the coefficients of the quintic polynomial of (3.6.2) are all positive and non zero; so by
the Descartes’ rule of signs there are no positive real eigenvalues, this means there are 1, 3
or 5 negative real eigenvalues with the remaining being complex conjugate pairs. We need to
show that Routh Hurwitz stability conditions for a fifth order polynomial as stated in [2] and
given in this case by
H1H2H3 > H
2
3 +H
2
1H4,
(H1H4 −H5)
(
H1H2H3 −H23 −H21H4
)
> H5 (H1H2 −H3)2 +H1H25
are both satisfied. By letting F = H1H2H3 −H23 −H21H4 we express the above conditions as
F > 0 implies Q > 0 where,
Q = (H1H4 −H5)F −H5 (H1H2 −H3)2 −H1H25 .
We need to express Q as a finite sum of positive terms involving the model parameters. Using
Maple to undertake the tedious algebra, we are able to show that F and Q1 are sums of
positive terms and
Q = Q1 +
{
(a23D1 + a1D2 +D3 +D4 +D5 +D6)(C1 + E2) + (3.6.3)
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a21(D7 +D8) + a1D9 +D10)
}
(C1 − E2) +
{
a23E2 + C2(b4 + E1)
}
(b4 − E1).(3.6.4)
Expressions for the constants, C ′is, D
′
is, E
′
is and b4 are given in Appendix A.1. The Maple
input file used in obtaining the results is not included in the Appendix due to its size but can
be made available on request.
Since b4 > E1 and C1 > E2, it follows that Q > 0. Thus, the disease-free equilibrium
is locally and asymptotically stable if R0 < 1. The coefficients H1, H2, H3 are positive and
we observe that if R0 > 1, a1a2a3a4a5 < βηfρd + βηfba3 wherein H5 is negative. Therefore
the sequence of coefficients, 1, H1, H2, H3, H4, H5 has only one sign change irrespective of
the sign of H4. By using Descartes’ rule of sign there must exist at least one positive real
eigenvalue, we conclude that the disease free state is unstable if R0 > 1.
When R0 = 1, a1a2a3a4a5 = βηfρd + βηfba3 and 3.6.2 has one zero eigenvalue, which
shows that R0 = 1 is a bifurcation surface in (β, η, f, ρ, d, b, λ, θ, γ, α, q, h) parameter space.
Lemma 3.6.2. The disease-free equilibrium is globally asymptotically stable in Γ if
ηβ
η + λ
≤ (h+ q), fb
f + q
≤ γ + λ and fd
f + q
≤ λ(η + θ + λ)
η + λ
.
Proof. Consider the function φ : {(C,LA, S, A,X, Y, Z) ∈ Γ : C,X > 0} → R, where
φ =
η
η + λ
(1− C) + λ
η + λ
(LA + S + A) +
f
f + q
(1−X) + q
f + q
Z. (3.6.5)
We note that φ ≥ 0 and is continuously differentiable on the interior of Γ. We shall show that
the disease free equilibrium is a global minimum of φ on Γ if (3.6.7) holds. The derivative of
φ computed along solutions of the system is
dφ
dt
=
( ηβ
η + λ
− q)Z + { fb
f + q
− (γ + λ)
}
S +
{ fd
f + q
− (1 + θ + λ)
}
A
+
{ fd
f + q
− λ(η + θ + λ)
η + λ
}
LA − ηβ
η + λ
(
LA + S + A
)
ZS
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−α(C + λ
η + λ
L
)− 1
f + q
{
fbS + fd
(
A+ LA + qhZ
)}
Y S
− 1
f + q
(
fbS + fdA+ fdLA + qhX
)
Z. (3.6.6)
We can see clearly that
dφ
dt
≤ 0 whenever
ηβ
η + λ
≤ (h+ q), fb
f + q
≤ γ + λ, fd
f + q
≤ λ(η + θ + λ)
η + λ
. (3.6.7)
In fact, for (LA, S, A, Y, Z) = (0, 0, 0, 0, 0),
dφ
dt
≤ 0 and (LA, S, A, Y, Z) is the largest positively
invariance subset in the interior of Γ and by LaSalle’s invariant principle [60], (LA, S, A, Y, Z)→
(0, 0, 0, 0, 0) as t→∞, while (C,X)→ (1, 1) on the boundary of Γ. Some calculations given
in Appendix A.2, using the inequalities in (3.6.7) show that the basic reproduction number
is less than unity. The disease free state is globally stable if (3.6.7) are true, noting (3.6.7)
⇒ R0 < 1.
3.7. Time scale analysis
In this section we present the time scale analysis of the model. Asymptotic analysis on the
M and N equations show that M changes on the time scale t = O(), while N changes on
t = O( 1
2
). Thus we assume M
N
to be constant over the time scale of our analysis. By letting
θ = 0, we present the time scale analysis of the dimensionless system
2
dC
dt
= 4λˆ+ γˆS + 2A− βˆZC − 4λˆC + 4αˆCS, (3.7.1)
2
dL
dt
= βˆZC − ηˆL− 4λˆL+ 4αˆLS, (3.7.2)
2
dLA
dt
= βˆZA− ηˆLA − 4λˆLA + 4αˆLAS, (3.7.3)
2
dS
dt
= ηˆL+ ηˆLA −
(
ρˆ+ γˆ + 4αˆ + 4λˆ
)
S + 4αˆS2, (3.7.4)
2
dA
dt
= ρˆS −
(
2 + 4λˆ
)
A− βˆZA+ 4αˆAS, (3.7.5)

dX
dt
= qˆ (1−X)− bˆSX − dˆAX − dˆLAX + hˆXZ, (3.7.6)

dY
dt
= bˆSX + dˆAX + dˆLAX −
(
fˆ + qˆ
)
Y + hˆY Z, (3.7.7)
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
dZ
dt
= fˆY −
(
hˆ+ qˆ
)
Z + hˆZ2, (3.7.8)
subject to
C(0) = 1, L(0) = 0, LA(0) = 0, S(0) = 0, A(0) = 0,
Y (0) = y0, X(0) = 1− y0, Z(0) = 0.
The definitions of the parameters with hats are given as
β =
1
2
βˆ, η =
1

ηˆ, µ = 2µˆ, λ = 2λˆ, α = 2αˆ, γ =
1

γˆ, ρ =
1
2
ρˆ, (3.7.9)
b =
1

bˆ, d =
1

dˆ, f =
1

fˆ , g =
1

gˆ, h = hˆ. q =
1

qˆ,
where we have assumed for simplicity all parameters to be equal (not proportional) to the
powers of  as indicated in Table 3.3. We will carry out the analysis in the limit,  → 0,
y0 → 0 and y0  . We note R0 ∼ 1

in this limit so endemic outbreak is guaranteed. The
time scale analysis reveals the endemic equilibrium for the human population as
C ∼ 2
γˆηˆ
(
qˆ + dˆ
)(
qˆ + fˆ
)
ρˆβˆfˆ dˆ
,
LA ∼ 1,
S ∼  ηˆ
ρˆ
,
A ∼ 
ηˆ
(
qˆ + dˆ
)(
qˆ + fˆ
)
βˆfˆ dˆ
,
L ∼  γˆ
ρˆ
,
and for mosquitoes
X ∼ qˆ
qˆ + dˆ
,
Y ∼ dˆqˆ(
qˆ + dˆ
)(
qˆ + fˆ
) ,
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Z ∼ fˆ dˆ(
qˆ + dˆ
)(
qˆ + fˆ
) .
Details of the analysis are presented below in which there is evolution from an introduction
of infected mosquitoes (population fraction y(0) = y0) to an uninfected area.
The left-hand side of equations (3.7.1)−(3.7.8) seem to provide an initial guess of two
time scales (i.e t = O(2) and t = O()) but quite interestingly it happens to be a multi-scale
problem. The method we use is that of formal asymptotics, namely singular perturbation
methods whose application to problems in mathematical biology and classical mechanics is
well established. The report does not include all the technical details involved as we are only
interested in the leading-order behaviour of the system. There are a number of timescales but
the six main timescales as predicted by the model are
t = O(2), ≈ 1-3 days: A small amount of infected mosquitoes introduced into the system
become infectious after passing through the incubation period. Susceptible humans bit-
ten by these mosquitoes get infected. The early infection registers itself in the human
compartments. However the effect of this early infection remains unnoticeable ( O(y0))
in the latent asymptomatic class. The amount of susceptible mosquitoes increases lin-
early due to natural birth.
t = O(
4
3 ), ≈ 7-8 days: In this time scale susceptible mosquitoes get infected by biting
asymptomatic infectious humans. The amount of mosquitoes converting to the infec-
tious class is also balanced by the amount of mosquitoes becoming infected by biting
people in the asymptomatic infectious class. This behaviour is expected because indi-
viduals with clinical malaria have low level of gametocytes. Thus the early infection of
susceptible mosquitoes is likely to come through contact with asymptomatic infectious
humans since they have high gametocyte density. Infected humans are still “negligible”,
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O(1/3y0).
t = O(
5
4 ), ≈ 9-10 days: As more mosquitoes get infected through contact with asymp-
tomatic infectious humans, the amount of susceptible mosquitoes reaches its maximum
and starts decreasing. Whereas the feedback from infectious humans offsets the linear
growth effect of the initial small amount of infected mosquitoes introduced, eventually
causing the amount of latent mosquitoes to grow exponentially. Human infected =
O(−1/2y0).
t = 
5
4 ln(1/2/y0)/K0 + O(
5
4 ), K0 = (βˆηˆfˆ dˆ)
1
4 , ≈ 2 weeks: Asymptomatic humans be-
come infected with new asexual parasites due to contact with infectious mosquitoes.
The amount of sick people converting to asymptomatic status is being balanced by the
amount of asymptomatic humans converting to the latent asymptomatic class due to a
boost in their partial immunity level. Thus , more mosquitoes become infected and the
overall flow of infection culminates in a fast transition of susceptible humans into the
latent class.
t = O(), ≈ 2-3 weeks: Disease has become noticeable with infected humans = O(1). La-
tent asymptomatic humans are still infectious to mosquitoes as C, S and A adjust to
their equilibrium values. L decays exponentially.
t =  ln(1/)/ηˆ + O(), ≈ 2 months: In this time scale all the human compartments equi-
libriate, notably C = O(2), and latent individuals are becoming symptomatic and
converting to LA rapidly. While the mosquito compartments adjust to assume their
equilibrium state.
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3.7.1. t = O(2)
Using “ˆ” to denote the variables in this time scale we write
t = 2tˆ,
and with appropriate balancing of terms in each of the equations exploring the idea that out
of a small amount y0 of infected mosquitoes introduced into the population only a smaller
proportion y0 becomes infectious, we seek leading order solution of the form,
C ∼ 1 + y0Cˆ1, L ∼ y0Lˆ0, LA ∼ 3y20LˆA0 , S ∼ 2y0Sˆ0,
A ∼ 2y0Aˆ0, X ∼ 1− y0 + y0Xˆ1, Y ∼ y0 + y0Yˆ1, Z ∼ y0Zˆ0.
On substitution of these rescalings into (3.7.1)-(3.7.8), we obtain the leading order system
dCˆ1
dtˆ
= −βˆZˆ0, dLˆ0
dtˆ
= βˆZˆ0,
dLˆA0
dtˆ
= βˆAˆ0Zˆ0, (3.7.10)
dSˆ0
dtˆ
= ηˆLˆ0 − ρˆSˆ0, dAˆ0
dtˆ
= ρˆS0,
dXˆ1
dtˆ
= qˆ, (3.7.11)
dYˆ1
dtˆ
= −
(
fˆ + qˆ
)
,
dZˆ0
dtˆ
= fˆ , (3.7.12)
recalling y0   1, satisfying the initial conditions
Cˆ1(0) = 0, Lˆ0(0) = 0, LˆA0(0) = 0, Sˆ0(0) = 0,
Aˆ0(0) = 0, Yˆ1(0) = 0, Xˆ1(0) = 0, Zˆ0(0) = 0.
By doing direct integration we get the following leading order solutions
Cˆ1 ∼ −1
2
βˆfˆ tˆ2, Lˆ0 ∼ 1
2
βˆfˆ tˆ2, LˆA0 ∼
1
30
βˆ2ηˆfˆ 2tˆ5, Sˆ0 ∼ βˆηˆfˆ
2ρˆ
tˆ2,
Aˆ0 ∼ 1
6
βˆηˆfˆ tˆ3, Xˆ1 ∼ qˆtˆ, Yˆ1 ∼ (−fˆ − qˆ)tˆ, Zˆ0 ∼ fˆ tˆ.
We observe that susceptible humans (C) and latent mosquitoes (Y ) are decaying linearly in
time from their initial values due to latent mosquitoes converting to the infectious class and
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susceptible humans becoming infected as a consequence of infectious contact with mosquitoes
in the Z class. With Aˆ0 = O(t
3) there is a balance shift in (3.7.7), when Aˆ0 = O(
−2) i.e. at
a timescale t = O(−
2
3 ), as susceptible mosquitoes become infected by biting asymptomatic
humans. It is interesting to note that L and S equilibrate such that
S
L
∼ η
ρ
in this time scale
and remain so as we will see in all the following timescales.
3.7.2. t = O(4/3)
Denoting variables with over-bars in this time scale we write
t = 4/3t¯,
and obtain the variable rescalings
C ∼ 1 + −1/3y0C¯1, L ∼ −1/3y0L¯0, LA ∼ −1/3y20L¯A0 , S ∼ 2/3y0S¯0,
A ∼ y0A¯0, X ∼ 1− y0 + 1/3y0X¯1, Y ∼ y0 + 1/3y0Y¯1, Z ∼ 1/3y0Z¯0.
On substitution of these rescalings into (3.7.1)−(3.7.8), and considering the leading order
terms we found that all the other equations remain the same as (3.7.10)−(3.7.12) in the
previous time scale but the X and the Y equations both have an additional term, dˆA¯0, given
by
dX¯1
dt¯
= qˆ − dˆA¯0, dY¯1
dt¯
= dˆA¯0 −
(
fˆ + qˆ
)
,
marking the advent of feedback of infection from asymptomatic individuals to susceptible
mosquitoes due to the initial small amount of infected mosquitoes introduced into the to-
tally susceptible human population. This creates a balancing effect between the amount of
mosquitoes converting to the infectious class and the amount becoming infected by biting
people in the asymptomatic infectious class. We use the initial conditions
C¯1(0) = 0, L¯0(0) = 0, L¯A0(0) = 0, S¯0(0) = 0,
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A¯0(0) = 0, Y¯1(0) = 0, X¯1(0) = 0, Z¯0(0) = 0,
to obtain the following solutions.
C¯1 ∼ −1
2
βˆfˆ t¯2, L¯0 ∼ 1
2
βˆfˆ t¯2, LˆA0 ∼
1
30
βˆ2ηˆfˆ 2t¯5, S¯0 ∼ βˆηˆfˆ
2ρˆ
t¯2,
A¯0 ∼ 1
6
βˆηˆfˆ t¯3, X¯1 ∼ − 1
24
βˆηˆfˆ dˆt¯4, Y¯1 ∼ 1
24
βˆηˆfˆ dˆt¯4, Z¯0 ∼ fˆ t¯.
The only notable difference between these and the earlier time scale is in X and Y with an
accelerated rate of mosquito infection from asymptomatic infectious humans. The implication
of this is that the flow of the solution may change direction especially when the amount of
mosquitoes getting infected becomes more than the inflow of new born mosquitoes. This
happens at the point of breakdown
t¯ = O(−1/12),
where Y¯1 becomes O(y0). The dynamics of the system in the next time scale is a consequence
of the change in the order of Y¯1.
3.7.3. t = O(5/4)
We use “ ∼ ” to denote variables in this time scale where,
t = 5/4t˜,
and the appropriate rescalings of the variables are
C ∼ 1 + −1/2y0C˜1, L ∼ −1/2y0L˜0, LA ∼ −3/4y20L˜A0 , S ∼ 1/2y0S˜0,
A ∼ −1/4y0A˜0, X ∼ 1 + y0X˜1, Y ∼ y0Y˜1, Z ∼ 1/4y0Z˜0.
On substitution of these into (3.7.1)−(3.7.8) we find (at leading order) that the equations
representing the human compartments are unchanged, but due to the dominant contribution
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of asymptomatic infectious humans on the infection of mosquitoes, the rate of change of Y˜1
and X˜1 are proportional to the amount of asymptomatic humans with that of Z˜0 proportional
to Y˜1. The system in full is
dC˜1
dt˜
= −βˆZ˜0, dL˜0
dt˜
= βˆZ˜0,
dL˜A0
dt˜
= βˆA˜0Z˜0, ηˆL˜0 = ρˆS˜0,
dA˜0
dt˜
= ρˆS˜0,
dX˜1
dt˜
= −dˆA˜0, dY˜1
dt˜
= dˆA˜0,
dZ˜0
dt˜
= fˆ Y˜1.
Through successive differentiation of
dZ˜0
dt˜
we find that
d4Z˜0
dt˜4
= KZ˜0, and by matching with
the solution of section 3.7.2 as t¯→∞ we have as initial conditions
C˜1(0) = L˜0(0) = L˜A0(0) = S˜0(0) = A˜0(0) = Z˜0(0) = 0, X˜1(0) = −1,
Y˜1(0) = 1,
dZ˜0
dt˜
(0) = fˆ ,
d2Z˜0
dt˜2
(0) = 0,
d3Z˜0
dt˜3
(0) = 0, Z˜0(0) = 0,
where K = βˆηˆfˆ dˆ. The large time solution of the system given by
C˜1 ∼ − βˆfˆ
4K1/2
eK
1/4 t˜, L˜0 ∼ βˆfˆ
4K1/2
eK
1/4 t˜, LA0 ∼
βˆfˆ
32dˆK1/4
e2K
1/4 t˜, S˜0 ∼ βˆηˆfˆ
4ρˆK1/2
eK
1/4 t˜,
A˜0 ∼ βˆηˆfˆ
4K3/4
eK
1/4 t˜, X˜1 ∼ −1
4
eK
1/4 t˜, Y˜1 ∼ 1
4
eK
1/4 t˜, Z˜0 ∼ fˆ
4K1/4
eK
1/4 t˜,
shows that both the mosquito and human compartments are growing exponentially. For K0 =
K
1
4 , the approximations for this timescale become poor when C˜1 = O(e
K0 t˜) = O(1/2/y0), i.e.
t˜ = ln(1/2/y0)/K0 when asymptomatic humans become infected with new asexual parasites
due to contact with infectious mosquitoes.
3.7.4. t = 
5
4 ln(1/2/y0)/K0 + O(
5
4 )
In order to describe events captured on this time scale we translate in time from the former
time scale and write
t = 
5
4 ln(1/2/y0)/K0 + 
5
4 tˇ,
where “ˇ” is the symbol for variable representation. The initial small amount of infection has
been totally distributed and whose effect has developed into the beginnings of a full blown
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epidemic with C and L becoming O(1) and no dependence on y0, to leading order as we can
see in the following rescalings
C ∼ Cˇ0, L ∼ Lˇ0, LA ∼ 1/4LˇA0 , S ∼ Sˇ0, A ∼ 1/4Aˇ0,
X ∼ 1 + 1/2Xˇ1, Y ∼ 1/2Yˇ1, Z ∼ 3/4Zˇ0.
Following the usual substitution procedure we find that at leading order, some equations
remain the same as in the preceding time scale whereas the C, L, A, X and Y equations are
now being expressed as
dCˇ0
dtˇ
= −βˆCˇ0Zˇ0, dLˇ0
dtˇ
= βˆCˇZˇ0,
dLˇA0
dtˇ
= βˆZˇ0A0, (3.7.13)
S0 =
ηˆ
ρˆ
Lˇ0,
dAˇ0
dtˇ
= ρˆS0 − βˆZˇ0Aˇ0, dXˇ1
dtˇ
= −dˆAˇ0 − dˆLˇA0 , (3.7.14)
dYˇ1
dtˇ
= dˆAˇ0 + dˆLˇA0 ,
dZˇ0
dtˇ
= fˆ Yˇ1
where by matching with the long time solution of section 3.7.3
tˇ→ −∞,
Cˇ0 → 1−, Lˇ0 → 0+, LˇA0 → 0+, Sˇ0 → 0+, Aˇ0 → 0+, Xˇ1 → 0+, Yˇ1 → 0+, Zˇ0 → 0+,
the situation where asymptomatic humans become infected with new asexual parasites due
to their contact with infectious mosquitoes, which eventually reduces the size of A as asymp-
tomatic humans leave for the LA class. Consequently, more susceptible mosquitoes get infected
as latent asymptomatic humans transfer infection. In order to obtain a solution of the system,
we note
dCˇ0
dtˇ
+
dLˇ0
dtˇ
= 0,
d(LˇA0 + Aˇ0)
dtˇ
= ηˆLˇ0,
d3Zˇ0
dtˇ3
= ηˆfˆ dˆLˇ0.
The first equation yeilds, Cˇ0 + Lˇ0 = 1. Substituting this into the differential equation for Cˇ0,
leads to the fourth-order nonlinear ode, which is the main equation that drives the dynamics
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of the system on this time scale given by
d4Fˇ
dtˇ4
= −K
(
1− eFˇ
)
where, K is as defined above and Fˇ = ln(Cˇ0). This equation does not seem to have an
analytical solution but we can extract some key information by investigating its behaviour.
It is straightforward to show that F = 0(Cˇ0 = 1) is an unstable steady state. Considering
g(F ) = −K
(
1− eFˇ
)
, F = 0 ⇒ g = 0, F < 0 ⇒ g < 0 and F > 0 ⇒ g > 0. Thus, F = 0
is unstable. By matching we have F → 0− , or Cˇ0 → 1−, as tˇ → −∞ hence dFˇ
dtˇ
< 0 as tˇ
increases, i.e. a non-negligible amount of humans are becoming infected. For large, negative
Fˇ we have
d4Fˇ
dtˇ4
∼ −K,
as the homogenous ODE whose general solution is,
Fˇ = − 1
24
Ktˇ4 +
1
6
α1tˇ
3 +
1
2
α2tˇ
2 + α3tˇ+ α4,
as tˇ → +∞, where α1, α2, α3 and α4 are unresolved constants depending on solution as
tˇ→ −∞. The solutions for the susceptible and latent human compartments are
Cˇ0 ∼ B0 exp
(a1
6
tˇ3 +
a2
2
tˇ2 + a3tˇ
)
e−
K
24
tˇ4 , Lˇ0 ∼ 1−B0 exp
(a1
6
tˇ3 +
a2
2
tˇ2 + a3tˇ
)
e−
K
24
tˇ4 ,
indicating a very rapid exchange from the C to the L class describe how the force of infection
generated by infectious mosquitoes, Z drastically reduces the size of C and increases that of
L. As Cˇ0 → 0 and by applying dominant balancing of terms we obtain large time behaviour
of other variables as
LˆA0 ∼ ηˆtˇ, Sˇ0 ∼
ηˆ
ρˆ
, Aˇ0 ∼ 6ηˆ
k
tˇ−3, Xˇ1 ∼ −1
2
dˆηˆtˇ2, Yˇ1 ∼ 1
2
dˆηˆtˇ2, Zˇ0 ∼ k
6βˆ
tˇ3.
as tˇ→∞. Due to the rapid drop in the C class, there are series of minor transition timescales
in which C = O(1) falls to C = O(2), in several very small timescale stages. We shall omit
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the details and move on to the next major rebalance of the system, at tˇ = O(−
1
4 ), where the
infected mosquito classes become non-negligible and the latent classes dominate the human
population.
3.7.5. t = O()
We use the symbol “ ? ” to denote variables on this time scale. By expressing time as
t = t?,
we state the rescalings of the variables as follows:
C ∼ 2C?0 , L ∼ L?0, LA ∼ LA?0, S ∼ S?0 , A ∼ A?0, X ∼ X?0 , Y ∼ Y ?0 , Z ∼ Z?0 ,
noting that susceptible class is now O(2) and that most of human population are in the
latent classes. On substitution of these into the full system as usual, yields a situation where
some of the variables have assumed quasi-steady states, i.e. they are expressed in terms of
the other variables, especially,
C?0 =
γˆ
ρˆ
A?0, S
?
0 =
ηˆ
ρˆ
(L?0 + LA
?
0) , A
?
0 =
ρˆS?0
βˆZ?0
.
The remaining variables are described by the system
dL?0
dt?
= −ηL?0,
dLA
?
0
dt?
= ηL?0,
dX?0
dt?
= qˆ −
(
qˆ + dˆLA
?
0
)
X?0 ,
dY ?0
dt?
= dLA
?
0X
?
0 − (fˆ + qˆ)Y ?0 ,
dZ?0
dt?
= fˆY ?0 − qˆZ?0
subject to
L?0(0) = 1, LA
?
0(0) = 0, Y
?
0 (0) = 0, X
?
0 (0) = 1, Z
?
0(0) = 0.
The straightforward solutions are
L?0 ∼ e−ηt
?
, LA
?
0 ∼ 1− e−ηt
?
,
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and consequently, S?0 =
ηˆ
ρˆ
. We cannot solve for the other variables, but it is useful to note
that the leading behaviour as t? →∞, are the steady states
C?0 ∼ 2
γˆηˆ
(
qˆ + dˆ
)(
qˆ + fˆ
)
ρˆβˆfˆ dˆ
, A?0 ∼ 
ηˆ
(
qˆ + dˆ
)(
qˆ + fˆ
)
βˆfˆ dˆ
,
X?0 ∼
qˆ
qˆ + dˆ
, Y ?0 ∼
dˆqˆ(
qˆ + dˆ
)(
qˆ + fˆ
) , Z?0 ∼ fˆ dˆ(
qˆ + dˆ
)(
qˆ + fˆ
) .
We note that while other variables are in their steady states, the amount of latent humans
decays rapidly causing the amount of latent asymptomatic humans to grow due to massive
inflow of asymptomatic humans being infected with asexual parasites. Although not apparent
from the solutions we can show that approximation to L will no longer be O(1) when
t? =
1
ηˆ
ln (1/) +O(1)
which leads us to the final time scale.
3.7.6. t =  ln(1/)/ηˆ + O()
Variables on this time scale are described using “´” so that;
t =

ηˆ
ln(1/) + t´
and
C ∼ 2C´0, L ∼ L´0, LA ∼ 1, S ∼ S´0, A ∼ A´0, X ∼ X´0, Y ∼ Y´0, Z ∼ Z´0.
On substitution of these into (3.7.1)−(3.7.8) we find that the variables in their steady states
remain unchanged and LA ∼ 1. Only L´ is evolving at leading order according to,
dL´0
dt´
=
γˆηˆ
ρˆ
− ηˆL´0.
47
Figure 3.2 shows that the rapid drop of susceptible humans as shown in the fourth
timescale of the analysis follows immediately after a sharp increase in the number of in-
fectious mosquitoes. The fraction of Latent humans, L increases as C drops. The number
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Figure 3.2: Solutions of dimensionless system (3.7.1)-(3.7.8) using  = 0.001 and all other dimensionless parameters set to
unity. The top graph represents the various compartments in the human population and the bottom graph shows the fractions
of mosquito population. Note the time axes are the log10 values for time and that the human and mosquito fractions are also
been logged. The vertical dotted lines indicate different timescales, marking conspicuous events. The six timescales are t = 2,
t = O(
4
3 ), t = O(
5
4 ), t = 
5
4 ln(1/2/y0)/K +O(
5
4 ), t = O() and t =  ln(1/)/ηˆ +O(). We only present the fourth and the
sixth timescales for the human population whilst the third timescale is omitted from the mosquito classes.
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of latent asymptomatic humans had been of low order from the beginning of the analysis
and L had always dominated the infection classes. But immediately after the disease fully
established itself, we observe that in the fifth timescale, L is no longer O(1) as LA grows to
overtake L, which culminates in the final state of the disease showing about 90% of the human
population in the Latent asymptomatic class as predicted by the analysis. Different stages of
events in the mosquito population as predicted by the analysis are also well represented by
the simulations.
By matching with the previous timescale we have L´0 ∼ e−ηt´ as t´→ −∞, hence the solution
L´0 =
γˆ
ρˆ
− e−ηˆt´,
which decays to
γˆ
ρˆ
as t´→∞. Thus we reach the complete equilibrium state at leading order,
namely
C ∼ 2
γˆηˆ
(
qˆ + dˆ
)(
qˆ + fˆ
)
ρˆβˆfˆ dˆ
, L ∼  γˆ
ρˆ
, LA ∼ 1, S ∼  ηˆ
ρˆ
, A ∼ 
ηˆ
(
qˆ + dˆ
)(
qˆ + fˆ
)
βˆfˆ dˆ
,
X ∼ qˆ
qˆ + dˆ
, Y ∼ dˆqˆ(
qˆ + dˆ
)(
qˆ + fˆ
) , Z ∼ fˆ dˆ(
qˆ + dˆ
)(
qˆ + fˆ
) .
3.7.7. Conclusion from the analysis
Through our timescale analysis we have provided insight into the transmission of the disease
as shown by the numerical simulations. Six main time scales as predicted by the model are
used with appropriate rescalings to explicate the dynamics of the disease in relation to events
as they evolve from early incidence to endemic state. There are important concluding remarks
about the spread of the disease:
• Throughout the analysis, S has been proportional to L showing that the level of the
disease depends very much on non-immune individuals becoming infected. We also find
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that C remained at O(1) from the first timescale until the fourth time scale,
t = 
5
4 ln(1/2/y0)/K0 + O(
5
4 ),
when it suddenly dropped to O(2), which suggests that intervention programs may yield
better results if implemented before this time scale, preferably by the time t = O(
5
4 ),
during which the feedback from infectious humans offsets the linear growth effect of the
initial small amount of infected mosquitoes. This equates to about 2-3 weeks from the
initial infection.
• The contribution of asymptomatic infectious humans has a significant effect on the
dynamics of the disease. This becomes evident in the time scale t = O(4/3) and
influences the mode of infection throughout the period of analysis. This is due to our
choice of the values of the model parameters, which we have assumed that asymptomatic
humans are far more infectious than symptomatic humans. We recall that disease
symptoms are associated with the erythroctye cycle, a period characterised by incursion
and invasion of the red blood cells by asexual parasites.
• The noticeable build-up of latent asymptomatic humans at steady state is a clear char-
acteristic of the dynamics of malaria in an endemic region. This portends a dangerous
scenario and creates adverse effect on public policies aimed at control or eradication
of the disease. It appears adults get partial immunity at the expense of children and
women (who may likely loose immunity) during pregnancy. The condition   1, or
precisely la  ηh, on which our analysis is based, represents a situation where humans
spend a very long time in the asymptomatic class potentially, but they get infected
almost immediately harbouring infection without remarkable symptom of the disease
and from known results, this is reinforced through continuous infection as shown in our
50
analysis.
• In order to use our model to achieve effective control or eradication of the disease we will
perform some more simulations in the future to ascertain if it is worth considering an
option of reducing the time humans spend in the asymptomatic class through treatment
so that we can recommend and promote the simple slogan, check your ‘Malaria Infection
Status’ (MIS) and get treated. Another option is to ascertain whether or not prompt
treatment of sick people would guarantee a disease free state by considering γ as a
treatment parameter.
• The scenario in which the analysis is based has R0 > 1 so an endemic situation is guar-
anteed. It is intresting to note that the dominant human class is the LA class who are
both latent and infectious to mosquitoes. This class is absent in all other models to our
knowledge, yet, this model suggests, it is by far the most important class in sustaining
the disease. Throughout this analysis, S = O() which means that the amount of death
due to the disease is negligibly small, and, together with a negligible natural birth and
death rate, N ≈ 1 throughout this analysis. The scalings for mosquitoes suggest that
death by the disease is negligible compared to natural death, and hence dM
dt
∼ (qˆ−gˆ)M/
so that M will change in a t = O() timescale. In reality there will be limitation to
population growth, but is not expected that the main conclusion of the analysis are not
too affected by this.
3.8. Numerical Simulations
In section 3.6 we analysed the transition model by adducing sufficient conditions to show
that the diseases free state is locally and asymptotically stable if R0 < 1 and unstable for
R0 > 1. We also conducted a timescale analysis in section 3.7 to study the evolution of the
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disease based on R0 > 1 to demonstrate the existence of an endemic state. In this section we
will use numerical simulations to verify the results of our analysis. We will also demonstrate
numerically that the endemic state is globally and asymptotically stable if R0 > 1 using a set
of initial conditions described in Γ defined by (3.5.1).
Due to the findings in the asymptotic analysis, we assume that M
N
is constant throughout
the simulations. The numerical solution is obtained by using MATLAB’s ode45, a variable
order Runge-Kutta method with a relative tolerance of 10−7 and absolute tolerance of 10−6.
The parameters used for the simulations as defined in Table 3.3 are β = 62.43, η = 11.1
(i.e.  = 0.09), µ = 0.0056, λ = 0.017, α = 0.01, γ = 11.5, ρ = 54.45, θ = 0, b = 7.2,
d = 38.2, f = 14, g = 21.12, h = 1.45, q = 21.45. At time t = 0 we have the following
initial conditions in the proportions: C = 1, L = 0, LA = 0, S = 0, A = 0, X = 0.9999,
Y = y0 = 0.0001, Z = 0, N = 1, M = 1. This is a situation where the entire susceptible
human population is exposed to a small fraction of infected mosquitoes. The program was
run in MATLAB with different sets of initial conditions, a check was also conducted using
MAPLE’s ode45 in all cases and the qualitative form of the steady state solutions were the
same, although the system gets to a steady state faster as y0 increases. In Figure 3.3a,c, the
proportion of susceptible human population drops. This is more pronounced in Figure 3.3a,
in which we have used θ = 0 to represent non-treatment of asymptomatic humans leading
to more infection of susceptible humans. The latent human fraction peaks and later drops
to a steady state. There is a high proportion of latent asymptomatic humans showing that
asymptomatic state is being preserved in continuous infection. In Figure 3.3b, more than half
of the mosquito population are infected indicating high level of disease prevalence. However
a smaller proportion of mosquitoes become infected when θ = 20 as shown in Figure 3.3d.
In Figure 3.4a,b, the population of humans and mosquitoes are gradually increasing. Figure
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3.4c,d,e,f show the effect of different values of y0 on the various fractions of human population.
We investigate each of the human sub-populations as y0 varies from 0.00001 to 0.1 and the
results show that there is a unique steady state for each human compartment irrespective of
the value of y0 except that it takes a longer time to reach the steady state with a smaller y0.
We note that the delay increases linearly as y0 decreases exponentially as predicted by the
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Figure 3.3: Results showing the effect of the initial infected mosquito population on evolution of endemic infection where
t = 1, represents 165 days in real time. The initial conditions used are C = 1, L = 0, LA = 0, S = 0, A = 0, X = 0.9999,
Y = 0.0001, Z = 0, N = 1, M = 1 and the parameter values are given in Table 3.3. In Figure 3.3c,d, there is some level of post
disease treatment (θ = 20), whilst we have used θ = 0 in Figure 3.3a,b to explicate the dynamics of endemic malaria in which
asymptomatic humans are not treated
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analysis of section 3.7.4
The results demonstrate the typical behaviour of rapid infection of susceptible individuals
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Figure 3.4: Results showing the human and mosquito populations (Figure 3.4a,b) and the effect of introducing different
amount of infected mosquitoes on the various fractions of human population (Figure 3.4c,d,e,f). The values used for the simula-
tions are the same as those in (Figure 3.3c,d) except that for Figure 3.4a,b we used g = 21.02 and for (Figure 3.4c,d,e,f) we have
used the initial conditions, C = 1, L = 0, LA = 0, S = 0, A = 0, X = 1− y0, Y = y0, Z = 0, N = 1,M = 1 with different values of
y0 as shown in the graphs.
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Figure 3.5: Results showing the disease free state when R0 < 1 and the endemic state for R0 > 1 by varying the value of R0
from 0 to 5. The parameter values used to obtain these results are given in Table 3.3 except θ = 4.13. We used the parameter,
β to change R0 where R0 = 5 corresponds to β = 9.35.
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Figure 3.6: Basic reproduction number (R0) bifurcation diagram. The curve shows a transcrital bifurcation obtained by
drawing the steady states of symptomatic humans against different values of R0 ranging from 0 to 3. Parameter values are the
same as those in Figure 3.5
in a malaria endemic region. Figure 3.5a, b shows the relationship between the basic repro-
duction number and the disease profile as it affects both mosquito and human populations.
The disease establishes itself for values of R0 > 1 and dies out if R0 < 1. The values of R0
were obtained by varying β and R0 = 1 corresponds to β = 1.87. Figure 3.6 is a bifurcation
diagram showing a switch from a disease free state to an endemic state. The result is obtained
by drawing the steady states of symptomatic humans against different values of R0.
Each curve in Figure 3.7a represents the effect of θ on S for a given γ. The red curve in
particular shows that for a certain level of symptomatic treatment, γ = 60 it requires a post
disease treatment, θ = 21 to drive the disease to extinction. Treatment of both symptomatic
and asymptomatic humans can easily lead to a disease free state. Figure 3.7b gives the
variation of the amount of symptomatic humans as γ gradually increases from zero in the
absence of post disease treatment.
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In order to demonstrate the impact of the basic reproduction number on the dynamics
of the system, we plot the steady states of the various human and mosquito compartments
against the basic reproduction number (R0). Figures 3.5a,b show the disease free state when
R0 is less than unity and for R0 > 1 the disease invades both the human and mosquito
populations. The plot shows a transcritical bifurcation in the vicinity of R0 = 1, as is
expected from the analysis. Although some uncertainty still surrounds our quest on whether
or not the disease invades at R0 = 1 the disease free state is stable for values of R0 < 1, but
becomes unstable when R0 > 1 whereas, the endemic state becomes stable as expected.
The disease free state assumes that the entire mosquito and human populations are free
from the disease. Any simulation leading to S = 0, by varying the model parameters will not
be valid if it does not target C = 1 and X = 1. Hence we also demonstrate the effect of θ
and γ on C and X in Figure 3.8. The results show that as S → 0, there is the indication
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Figure 3.7: Plot of symptomatic humans against drug strength showing impact of clinical and post disease treatment on
malaria control. In Figure 3.7b, θ = 0, Whilst each curve in Figure 3.7a represents a plot of symptomatic humans with a given
level of treatment against different values of θ. Initial conditions and parameter values are the same as those in Figure 3.3
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that with various combinations of symptomatic and asymptomatic treatment, humans and
mosquitoes will likely become free from the disease.
3.9. Discussion
Our model describes a typical situation of an endemic malaria. This is supported by the value
of R0 for θ = 0, given as 33.4, obtained from data using (3.5.2). There is a high proportion
of latent asymptomatic humans since they require a longer time to loose infection before
experiencing disease symptoms. The numerical solution (Figure 3.3) shows that about 90%
of the entire population will be engulfed by the disease within a period of one year out of
which about 8% will be sick and would require medical attention in the hospital resulting
in loss of man-hours. Although those mostly affected by the disease are usually children
and pregnant women [83], the economic cost of the disease to households and government is
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Figure 3.8: Plot of susceptible humans and mosquitoes against drug strength. Parameter values and initial conditions are
the same as those in Figure 3.7. The disease dies out for different combined values of γ and θ.
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enormous. The results also show that about 38% of the population would be carrying a greater
number of gametocytes without showing symptoms of the disease within the period whilst
approximately 32% of the population is asymptomatic and equally harbouring some levels of
asexual parasites due to their being infected from infectious mosquitoes despite their partial
immunity. We assume an equal transmission rate ηh into the symptomatic compartment for
both latent and latent asymptomatic classes but the latter keeps on building up instead of
flowing into the symptomatic class. Although, the asymptotic analysis shows approximately
90% of humans in the Latent asymptomatic class, this does not in any way show that the
results are not correct. The reason for this disparity is that the analysis is based on the
assumption that  1 and we have presented a simulation in this regard in section 3.7.6 that
agrees well with the results of the analysis.
The model prediction seems plausible since immunity to malaria has always been asso-
ciated with continuous exposure to infection. In particular, [91] has shown that the rate of
development of clinical immunity to malaria correlates with the length of infection and that
asymptomatic status is reached sooner when the infections are longer. Although we expect
this behaviour since latent asymptomatic individuals have partial immunity and are not ex-
pected to show disease symptoms until they loose immunity, it rather portends a dangerous
scenario which could pose serious threats to the control of the disease especially if there hap-
pens to be a sudden upsurge of the disease in the population if more of these individuals loose
immunity within a short interval of time. This is expected since, asymptomatic carriage may
represent a mode of entry to symptomatic malaria especially in young children [101] and in
regions of high malaria transmission, every member of the community might be chronically
infected and as such there could be a high prevalence of sub-clinical malaria [109]
A good mathematical model of epidemiology(apart from being mathematically tractable)
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can be assessed on its application to disease control. We consider γ as a treatment parameter
due to the results of our time scale analysis. The non-dimensional parameter, γ is the ratio
of rh and la where rh is the recovery rate of symptomatic humans due to treatment and la
is the loss of asymptomatic infection or simply, the recovery rate of asymptomatic humans.
The duration of untreated or inadequately treated P. falciparum infection ranges from 197
to 480 days [36] and due to epidemiological observation of populations under treatment, the
average duration of infection reduces from 270 days to 14 days [38]. From results obtained by
Tumwiine et al. [111], early, prompt and proper treatment of symptomatic humans reduces
the duration of infection to as low as 3 days.
In order to determine the effect of γ we consider an ideal situation where the duration of
infection can be reduced to zero through effective administration of treatment to symptomatic
infectious human on the first day of the observation of the disease symptoms such that the
gametocytes are destroyed or made inactive to the extent that they would not infect suscepti-
ble mosquitoes, i.e, rh ∈ [0,∞). We deduce that increasing the duration of partial immunity
increases R0. Acquisition of partial immunity is beneficial to the individual who has it but
could be detrimental to the entire population because it increases the reservoir of infection. A
strict suggestion by [22] demands that in order to bring a disease under control in a population
of varying size, we need to reduce the reservoir of infection to zero with increasing time. We
note that a faster way of reducing R0 is by reducing β, η or f . The only way of reducing η is
by increasing la, the rate of immunity loss or the duration of asymptomatic infection. We de-
duce that reducing the duration of asymptomatic infection reduces R0, which agrees with the
findings of [22]. We also introduce a post disease parameter θ ∈ [0,∞) aimed at reducing the
time partially immune humans spend in the asymptomatic and latent asymptomatic classes.
An asymptotic analysis on the model with the treatment parameters shows that for θ = 0,
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the model can only predict a disease free state when γ is of O(−3). In order to assess
treatment success we consider the distinguished limit case
γ =
γ0

, → 0, γ →∞ (3.9.1)
with an assumption that for successful treatment to take place, S ∼ O(small), C ∼ 1 +
O(small) and X ∼ 1+O(small). The results suggest that treatment of symptomatic humans
alone cannot lead to the eradication of malaria but could only help in the management and
control of the disease. We deduce from our analysis that at leading order
R0 =
1
γ0
βˆfˆ ρˆdˆ
qˆ(fˆ + qˆ)
, (3.9.2)
where γ0 = O(
2) compares well with the one obtained using the next generation matrix. We
also consider the cases γ = 0 with treatment of asymptomatic humans and treatment of both
sick and partially immune individuals. The results show that there is the possibility of erad-
icating the disease by treating both symptomatic and asymptomatic infectious humans. The
key information we derive from the treatment analysis is that if for instance, a particular drug
of reasonable efficacy administered on sick people requires O(−3) to bring the disease under
control, then less effort of O(−1) is required to achieve the same objective when combined
with asymptomatic treatment effort of O(−1).
Malaria transmission is a cyclic process of parasite transfer between human and mosquito
populations. While there is the likelihood of humans avoiding the irritating bites from
mosquitos, there seems to be a natural or ecological demand from the female anopheles
mosquito to feed on humans in order to reproduce. Although the origin of the parasite is
yet to be known, considering the process in one direction, it seems the mosquito deposits
young parasites during blood meal and later comes back to ingest the matured form of the
parasite and provide a conducive environment for its reproduction, since it lacks the ability
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to reproduce sexually in the human host. The parasite spends a longer time in the human
host than in the vector and its within-host occupation apart from causing disease pathology
and mortality, also sets the pace for transmission to another host. If the host has a hash
environment inimical to the survival of the parasite then disease morbidity, mortality and
transmission will be greatly reduced. The immune system plays a great role in defending
the host’s system against foreign pathogens. In the next chapter we will study the human
immune system and its mechanism in relation to malaria pathogenesis.
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CHAPTER 4
PATHOGENESIS OF MALARIA
4.1. In-host pathogenesis
In a single bite an estimated average of 15 sporozoites are injected into the human body by
a feeding mosquito infected with plasmodium falciparum [97]. A sporozoite travels in the
blood stream to the liver where it invades hepatic cells, matures into schizonts and produces
30000 to 40000 merozoites within 6 days [87]. Each merozoite tries to invade a red blood cell
where it reproduces asexually, and after approximately 48 hours the erythrocyte ruptures,
releasing a number of merozoites to renew the cycle. Some merozoites differentiate into
gametocytes which are later picked up by a female anopheles mosquito during her blood
meal. The interaction between merozoites and red blood cells is well represented in the
malaria parasite life cycle diagram (bottom-right) in section 1.2.
Malaria infection in humans by Plasmodium species is associated with a reduction in
haemoglobin levels, frequently leading to anaemia [72]. This happens especially when the
destruction of red blood cells is followed by a decreased production of red blood cells from
the bone marrow. During the pre-antibiotic era for treating neurosyphilis, patients were
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treated with malariotherapy, in which they were inoculated with the asexual form of the
malaria parasite in order to raise their body temperature. Data from such patients will help
to explain the interaction between merozoites and red blood cells during a malaria episode.
Patient data
Here, we present data of two previously uninfected neurosyphilis patients undergoing malaria
therapy inoculated with two different strains of P. falciparum malaria parasites, namely El
Limon and McLendon strains. These data were extracted from Jakeman et al. [54] and
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Figure 4.1: Malaria data of neurosiphilis patients inoculated with El Limon and McLendon strains of Plasmodium falciprum
malaria parasite marked as patient S1301 and S1288 respectively in [54].
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are part of the data set obtained from the South Carolina and Milledgeville State hospitals.
Haemoglobin values were converted to red blood cell counts using 5× 106 erythrocytes/µl in
a person with 15g/dl haemoglobin. The data demonstrate how red blood cell count drops
and peaks in both patients during the period of the disease. Since these individuals had no
previous malaria at the time of inoculation, we assume they did not have malaria specific
immune cells prior to inoculation apart from the normal level of innate immune cells.
The evolution of malaria parasites like any other pathogen can instigate an immune re-
sponse in the host and depending on the effectiveness of the immune system the parasites
are either eliminated with little or no trace of disease symptoms or the parasites establish
themselves with life threatening symptoms if left untreated.
4.2. The immune system
Malaria is caused by the interaction between the plasmodium parasite and red blood cells in
the human host. The immune system is known to be the defender of the body against antigenic
substances. It exhibits a complex system of specialised network of cells, organs and tissues in
which their molecular and cellular interactions generate protection against foreign invaders.
The entire process of immunity consists of the innate and adaptive immune responses. The
former is nonspecific as to the type of infection and is ready to be mobilised as a first line
of action against the invading organism without recourse to previous infection, whereas the
latter, which takes some time to develop displays some immunological memory by reacting
more rapidly on subsequent exposure to the same pathogen.
All cells of the immune system are produced in the bone marrow and they include myeloid
(neutrophils, basophils, eosinpophils, macrophages and dendritic cells) and lymphoid (B lym-
phocyte, T lymphocyte and Natural Killer) cells [69]. The significance of these two varieties
of immune cells is that myeloid induces red blood cells and platelets in addition to controlling
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the innate immune mechanism. Whilst lymphoid, comprising T cells, B cells and natural
killer(NK) cells plays a crucial role in adaptive immune response. T cells produced in the
bone marrow undergo a process of maturation in the thymus differentiating into naive CD8+
cells and CD4+ T helper cells(Th1 and Th2). These helper cells later prime CD8+ cells to
kill pathogens directly by cytotoxicity and indirectly by inducing B cells to produce antigen
specific antibodies.
The immune response to malaria is greatly determined by the activities of antigen pre-
senting cells (APCs), namely dendritic cells(DCs), macrophages and B lymphocytes. APCs
capture and process antigens for presentation to T cells (CD4+ and CD8+ T cells). During
phagocytosis, bacteria are usually altered through a process called opsonization, such that
they are more readily and more efficiently engulfed. Although macrophages contribute im-
mensely to opsonisation and phagocytosis of malaria pathogens it is still unclear as to how
tissue macrophages interact with blood stage merozoites. Due to the inherent connectivity of
the organs of the immune system with one another and with other organs and tissues by the
network of lymphatic vessels, it becomes possible for lymphocytes to travel through blood
vessels and cells through the lymphatic vessels thereby, creating an exchange of fluid and
cells through blood and lymphatic vessels, enabling the lymphatic system to track evading
pathogens. There are likely two possibilities in which tissue macrophages can encounter blood
stage merozoites. The lymph node could be a meeting point since antibodies are known to
mill around a lymph node waiting for a macrophage to bring an antigen [79], or a macrophage
stationed in the tissue might catch a merozoite or infected erythrocyte since these could be
found in the blood transported to the tissues. Furthermore, given that the erythrocyte stages
of plasmodium circulates in the blood and do not enter tissues, the most likely location for
such innate mechanism to take place is the spleen [104]. Figure 4.2 illustrates the working of
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the immune system starting from antigen presentation by the innate immune cells to the de-
velopment of specific immune response. With the aid of toll-like receptors (TLRs) expressed
on their membrane, dendritic cells recognise and capture malaria parasites and infected red
blood cells most likely at the Marginal Zone for presentation to CD4+ and CD8+ T cells.
Initial preparations involves coating the pathogens with antigens especially in association with
MHC class II and other costimulatory molecules for proper recognition by the T cells. This
initiates differentiation of CD4+ T cells into helper cells, namely T helper 1(Th1) and T helper
2 (Th2) cells and Regulatory T cells (Treg). Mature dendritic cells produce IL-12 inducing
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Figure 4.2: Pathway diagram of immune response in relation to malaria infection. Dendritic cells capture parasites and
present antigens to naive CD4+ T cells. These cells differentiates into regulatory cells and Th1 and Th2 helper cells. The Th2
cells help B cells to produce IgG malaria specific antibodies. The Th2 cells produce Interferon gamma which activates CD8+ T
cells to kill parasites. Natural killer cells and macrophages also produce interferon gamma directly or indirectly. In a situation
of severe pathology, the partway diagram illustrates inhibition of interferon gamma and other stimulatory molecules to reduce
disease severity.
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Th1 cell to produce inflammatory cytokine Interferon gamma (IFN -γ), which makes CD8+
T cells to become cytotoxic, hence having the capacity to phagocytose. Th2 cells help B cells
to differentiate into plasma cells and secret antibodies. IL-12 activates natural Killer (NK)
cells, which further enhances the production of (IFN -γ). Macrophages activated by (IFN -γ)
produce inflammatory cytokines such as Tumour Necrosis Factor−α (TNF -α), IL-1, IL-6.
In the majority of patients with severe and uncomplicated malaria, TNF -α and IL-1 regulate
intercellular adhesion molecule 1 (ICAM -1) [88], which in addition to CD36, bind infected
erythrocytes [88, 13]. We note that binding of uninfected red blood cells is also possible. The
binding of uninfected and parasite infected erythrocytes to endothelial cells through CD36
has been examined in vitro by [75] with the binding of parasite infected erythrocytes being
significantly higher than that of uninfected erythrocytes, which may have been bound inadver-
tently since uninfected erythrocyte binding is independent of IFN -γ. Through phagocytosis,
macrophages and dendritic cells become heavily loaded with indigestive particles, haemozoin
due to uptake of haemoglobin, retarding their functional capacity as antigen-presenting cells
and resulting in a situation where large amounts of pro-inflammatory cytokines, precisely
(IFN -γ) and (TNF -α).
The pathogenic manifestations of malaria are mainly due to these pro-inflammatory cy-
tokines released by macrophages in response to malaria parasites and their products [102].
However, these unpleasant inflammatory responses do not continue indefinitely as they are
often regulated by some immunosuppressive anti-inflammatory cytokines. For instance, the
immunomodulatory cytokines IL-10 and Transforming growth factor β (TGF -β) play a key
role in limiting the pathology of malaria [86]. High ratios of IFN -γ, TNF -α and IL-12 to
TGF -β, or IL-10 are associated with decreased risk of malaria infection but increased risk of
clinical disease in those who do become infected [33]. TGF -α particularly plays an important
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role in controlling the transition between proinflammatory and anti-inflammatory responses
during the acute and resolving phases of the disease by mediating through a dose-depended
effect, the activation of macrophages, inhibiting both IFN -γ and TNF -α production, while
at the same time upregulating IL-10 and downregulating the expression of adhesion molecules
[78]. The immune system plays a key role in disease pathogenesis in the human host. Many
epidemiological modellers have used mathematical models to describe in-host interaction of
blood stage malaria parasites with red blood cells and the immune system. We present a brief
review of some of these models in the next section.
4.2.1. Review of within host models
We learnt from the life history of the malaria parasite that the female anopheles mosquito
deposits sporozoites, the assexual form of the parasite into the human system and later
picks up gametocyte, the sexual form of the parasite from the human blood. Out of the
three phases of the malaria parasite development, it is only the sporozoite formation phase
that takes place inside the mosquito. The other two phases namely, the merozoite and the
gametocyte formation stages occur in the human host. The blood stage merozoite replication
process is the main cause of malaria morbidity and mortality. Like most, all other infectious
diseases, malaria infection triggers both the innate and adaptive immune responses [11]. Thus,
understanding the dynamics of the parasite in the human host is crucial to the quest for
malaria elimination and eradication.
The first model describing malaria parasite interaction with the human host seems to
be that of Anderson et al. [4] where they used several mathematical models to examine
nonlinear dynamical phenomena in host parasite interaction. One of these models was used
to investigate the effects of immunological responses that target different stages in a parasite
life cycle. In a more detailed consideration, they made particular reference to the malaria
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parasite life cycle in which their findings suggest that the effectiveness of a given immunological
response is inversely proportional to the life expectancy of the target stage of the parasite
development cycle.
In a related work, a single strain mathematical model was proposed by Hetzel and An-
derson [51] to investigate blood-stage malaria infection. The model is a slight modification
of that of Anderson et al. [4] in which an additional loss term was included based on the
assumption that merozoites are equally likely to be absorbed into already infected erythro-
cytes. In analysing the model they consider the parasite and host red blood cell population
dynamics in the absence of immunity. They find that certain conditions determined by the
model parameters will favour persistent invasion of red blood cells by parasites, leading to the
identification of some important parameters like the rates of merozoite production and death
and those of erythrocyte production, death and invasion. Numerical results show oscillatory
behaviour in which they aver that the basic force behind the rise and fall in parasitaemia
in the model without immunity is the density of susceptible erythrocytes, suggesting that
availability of red blood cells is crucial in the determination of the initial pattern of infection
during malaria. On analysing the model with simple immune response, they find that the
destruction of infected red blood cells by immune cells is much more effective in controlling
parasite density than the destruction of merozoites by immune cells.
Considering antigenic variation and multiple strain biology, Anderson [6] presented a math-
ematical framework to interpret the interaction between parasite population growth and the
host immune system with special attention to the effect of antigenic variation and parasite
evolution in response to immunological attack through the use of a chemotherapeutic agents.
The concept of multiple strain presence in the parasite population was integrated in a simple
mathematical model and the results show a build-up of non-specific immunological responses
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leading to reduction of total parasite abundance. Prior to this reduction, the periods of the
oscillations in the abundances of each strain are set by the proliferation rate of each parasite
strain and the magnitude of the specific immunological responses induced death rate of the
parasites.
Since 1988, when the first work on within-host modelling was initiated, a considerable
work has been done in this area and a review of some of them is given by Molineaux and
Dietz [74]. Most of the works range from modelling the dynamics of the densities of healthy
erythrocytes, infected erythrocites and free merozoites without the immune system to those
involving immune effectors. Prominent in the characteristics of the results is the periodicity
and synchronisation of events during parasite invasion of red blood cells. For instance, Hoshen
et al. [53] used an in-host mathematical model with and without immune response to study
the blood stage development of P. falciparum asexual parasite and they find that synchronicity
of the infection followed by periodic symptoms seems to be an inherent feature of infection,
irrespective of the duration of merozoite released from the liver. It will, therefore, cause
fever and other uncomfortable symptoms as known in malaria patients. They also simulate
the effects of an induced host immune response and show how the level of immunity affects
the development of the disease. Using an age-structured model, Rouzine and McKenzie
[98] also show that Periodic fever experienced by the host during malaria attack is due to
synchronisation between the replication cycles of parasites in red blood cells initiated by innate
immune responses. Although the mechanism of synchronisation is yet to be well understood,
periodic oscillations characterising intra-host models with immunity has been widely reported.
During malaria infection interaction between red blood cells, merozoites and the immune
effectors lead to erythrocyte destruction. Thus anaemia appears to be an inevitable conse-
quence of malaria infection. Gravenor et al. [46], proposed an in-host model with immune
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response aimed at regulating malaria parasitemia. They fitted their model to data from
Kitchen [57] representing percentage of uninfected erythrocytes over 4 weeks of an artificially
induced infection in a malaria therapy patient. In a concluding remark they state that the
interaction between parasites and erythrocytes when combined with immune mechanisms in-
dicates that in the long term, parasite replication at low parasite densities can contribute
significantly to the high degree of anaemia observed in natural infection. However, Jakeman
et al. [54] contend that it is the destruction of uninfected red blood cells that primarily results
in anaemia in non-immune patients. They fitted their discrete model result to parasitemia
and anaemia data from neurosiphilis patients undergoing malaria therapy and find that for
each red blood cell that is observed to become parasitised, an additional 8.5 red blood cells
are destroyed through phagocytosis of erythrocytes bound to merozoites.
However in a new treatment model of within host dynamics proposed by Chiyaka et al.
[23], non-oscillatory solutions are observed. Their model is aimed at correcting two key areas
they identified as lacking in previous models. That is, inability to show the effect of immune
effectors on merozoite invasion of red blood cells including suppression of parasite production
by antibodies and the inability to account for the accelerated supply rate of red blood cell
from the bone marrow during a malaria infection and the loss of infected erythrocytes. The
model is a system of five ordinary differential equations in which the contributions of red
blood cells, infected red blood cells, merozoites, B cells and antibodies are well represented.
In analysing the model, they derived the basic reproduction number for parasite invasion
in the presence or absence of immune response and a critical drug efficacy that is required
for parasite clearance in case the immune system fails to clear the parasites. The numerical
results show that without treatment, the most effective role the immune system plays to clear
parasite is its ability in inhibiting parasite growth in erythrocytes. Increasing the death rate
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of infected red blood cells is more effective than the death rate of merozoites by immune cells.
This model appears to improve on previous models by integrating some of the known
biology. However, it does not account for the natural death rate of infected red blood cells
that may occur within the period of schizogony, but rather considers the bursting rate as the
death rate, a trend that has followed other previous in-host models. This gives an incorrect
expression for the basic reproduction number as expressed in their work. Although, their basic
reproduction number contains the infected red blood cell death rate constant, it can be shown
through the same method they have used that this constant will vanish when determining the
largest eigenvalue of the matrix describing the secondary infections arising from the initial
infection. A later work by Tuwiine et. al [112] improved on this limitation, but omitted
some important aspect of the biology since other parts of the model replicate the structure
of previous in-host models. Another in-host model with immune response describing the
dynamics of malaria infection was proposed by Li et al. [61] in which they generalise the
ideas in some known models including those in Anderson [6] and Chiyaka et al. [23]. A more
general class of within host malaria model has been given by Tewa et al. [107] in which they
carry out local and global stability analysis on the disease free equilibrium.
4.2.2. Summary from the survey
In-host malaria models describe the interaction of host red blood cells with blood stage
parasites. Throughout our survey, we find that none of the in-host models show explicitly the
effect of innate immune response on the pathology of the disease or account for the natural
death rate of infected red blood cells during the period of schizogony.
In the next chapter, we present the derivation, and analysis of an in-host model. We
will model the post-liver stage of malaria development and immune response with time delay
between first contact of innate immune cells and antigen presenting cells, and the emergence
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of trained adaptive immune cells aimed at describing the interaction between red blood cells
in a naive human host after a single infectious mosquito bite. Some of the features of the
model proposed in Chiyaka et al. [23] will be adopted and we show explicitly, the activities
of innate immune cells in respect of antigen presentation, describing their role in activating
specific immune response. For mathematical tractability we will be making considerable
simplifications, however the separate and common role of innate and adaptive response will
be preserved.
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CHAPTER 5
DESCRIPTION AND ANALYSIS OF
WITHIN-HOST MATHEMATICAL MODELS
5.1. Model development
In the previous chapter, the human pathogenesis and immune response was discussed. In
this chapter we derive and study a mathematical model that describes the infiltration of red
blood cells by merozoites and the immune activity that aims to interfere and destroy the
infection. The health of the infected individual is dependent on the red blood cell count of
the host, denoted as density X. We assume that a population of merozoites, of density M ,
are introduced at t = 0 say, representing release from the liver. Red blood cells infected by
merozoites react with healthy cells to move to an infected state, (density Y ). The maturation
of infected red blood cells results in the production of subsequent generations of merozoites
with some differentiating into gametocytes being the asexual form of the parasites. We use
G to represent the concentration of gametocytes.
The working of the immune system in response to the plasmodium parasite ensures sev-
eral immune cells working in unison to protect the host against severe pathology. Due to
75
mathematical tractability and simplicity, coupled with a reasonable consideration of biologi-
cal relevance, we use one variable P to represent the blood-borne phagocytic innate immune
cell density (NK cells, macrophages and dendritic cells) that also serve as antigen presenting
cells. Antibodies are produced in large amount by B cells induced through T cells activation
in response to signals from P , and since antibody-mediated immunity is more effective than
cell-mediated immunity [28], we denote the activities of antibodies, trained T cells and B cells
by the variable A designating it as concentration of adaptive immune cells. Although It is
quite unusual, but for the purpose of this work we will also be referring to A as concentration
of antibodies. Cytokine output by adaptive immune cells is assumed to be rapid, and in
quasi-equilibrium with immune cell density. The state variables and their descriptions are
summarised in Table 5.1
State variable Description
X Concentration of red blood cells
Y Concentration of infected red blood cells
M Concentration of merozoites
G Concentration of gametocytes
P Concentration of innate immune cells
A Concentration of antibodies
Table 5.1: The state variables in the model .
Merozoites infect red blood cells on contact but the presence of antibodies restricts this
process. Adopting a single mass action kinetic form for the interaction between merozoites
and blood cells, we assume infection rate is given by βxXM/(1 + c0A), where βx and c0
are constants. The factor 1/(1 + c0A) is the role of antibodies in blocking invasion and c0,
the efficiency of antibodies in reducing erythrocytic invasion. Since red blood cells develop
continuously from stem cells in the bone marrow through reticuloctyes to mature in about
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7 days and live a total of about 120 days [93], we assume a rate of recruitment, λx, of
fresh erythrocytes from the bone marrow and a natural death rate, µxX. Combining these
assumptions, we have for infected red blood cells
dX
dt
= λx − βxXM
1 + c0A
− µxX. (5.1.1)
The removal of Infected red blood cells through phagocytosis by the innate immune cells
occurs on contact, and is enhanced by the presence of antibodies [123]. A single expression to
describe this process is kyPY (1+kaA), where ky and ka are constants. We assume that during
the 2−day period of parasitised erythrocyte schizogony, which occurs in 5 stages, first and
subsequent generation infected red blood cells die at rates µnY [14], or survive to experience
a per capita death rate µy due to parasite induced rupture. Combining these assumptions
gives
dY
dt
=
βxXM
1 + c0A
− (µy + µn)Y − kyPY (1 + kaA) , (5.1.2)
where the source term assumes that there is no loss of blood cells on infection.
The rupturing of an infected red blood cell produces an average of r merozoites such that
the net rate of merozoites production is rµyY (1 − θ)/(1 + c1A), where θ is the fraction of
merozoites committed to gametocytogenesis, r is the the number of merozoites per bursting
schizont and c1 is the efficiency of antibodies in blocking the release of new merozoites. Ga-
metocytes and merozoites die naturally at rates µgG and µmM or are killed by innate and
adaptive immune cells. Merozoites last only about 30 minutes if they fail to infect red blood
cells [70]. Whilst the lifespan of gametocyte is about 16 days [49]. As with infected red
blood cells, the immune system will attack merozoites directly on encounter, this too being
enhanced by antibodies presence. Unlike [23] that considers antibodies that block invasion
only, we assume that antibodies assist phagocytic cells in killing merozoites [67] and also
inhibit gametocyte development in the human host by binding to young gametocytes during
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their developmental stages [108]. An antibody binding to the surface of a merozoite, could
neutralise parasites, or lead to Fc-dependent mechanisms of parasite killing by macrophages
[67, 100]. The rate of merozoites and gametocytes killing through binding are expressed as
kmkbPAM and kgkcPAG in (5.1.3) and (5.1.4) respectively with rate constants km and kg.
Hence,
dM
dt
=
rµy (1− θ)Y
1 + c1A
− βxMX
1 + c0A
− µmM − kmPM (1 + kbA) , (5.1.3)
dG
dt
=
rµyθY
1 + c1A
− µgG− kgPG (1 + kcA) . (5.1.4)
It is assumed that immune cells are partly supplied from stem cells in the bone marrow at
a constant net rate bm and partly stimulated by the presence of infected red blood cells and
merozoites [23] at a constant per capita rate. We assume that immune cells die at a rate µpP .
The induced rate of innate immune cell production by parasites presence is represented by
η1(Y + φM) where φ is some constant indicating the phagocyte growth differences between
merozoites and infected red blood cells. The production of malaria specific antibodies is most
likely associated with the presence of sporozoites or merozoites and their ability to infect
host cells triggering immune response. Antibodies A are recruited at rates proportional to
merozoites and parasites presence at a rate η2{Y (t− d1) + g2M(t− d1)} with a constant, g2,
representing adaptive immune cell production difference between merozoites and parasitized
red blood cells, and a time delay, d1, being the lag between the time of contact of parasites
and antigen presenting cells and the time when adaptive cells are produced. The terms
P (kyY + kmM) and A(η3Y + η4M) describe the deterioration rates of innate immune cells
and antibodies, respectively, due to their interaction with the parasites. We assume that
antibodies die at a rate µt(A0−A), where, A0 is some non-zero starting density and assuming
the number of memory cells does not change much over the course of a single malaria cycle,
then the number of memory cells decline as the merozoites are removed. Combining these
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assumptions we have for the innate immune cells and antibodies
dP
dt
= bm + η1 (Y + φM)− µpP − P (kdY + knM) , (5.1.5)
dA
dt
= η2{Y (t− d1) + g2M(t− d1)}+ µa (A0 − A)− A (η3Y + η4M) . (5.1.6)
5.1.1. Initial and history conditions
Our primary aim is to study infection in a previously uninfected human caused by a single
mosquito infectious bite. Thus the initial condition forX is the concentration of red blood cells
describing the healthy state of the individual. This is represented by the healthy steady state
rate, λx/µx. Similarly, we will use the immune cell steady state bm/µp as the initial density
of innate immune cells in the individual. We recall from 4.1 that a successful infectious bite
of a mosquito can produce an average of 525000 merozoites giving the initial concentration
of merozoites released into the blood stream as 0.105 cells/µl. The concentration of infected
red blood cells as well as that of gametocytes is zero at the release of hepatic merozoite
since it is the blood stage merozoites that penetrate red blood cells and eventually convert to
gametocytes.
As mentioned in the equation describing the concentration of antibodies we want to em-
phasize that the choice of A0 as a non-zero initial density of antibodies is important in that
instead of restricting the model to only a single contact it makes provision for subsequent
contacts which will lead to accumulated immunity from previous infections. For first contact,
A0 = 0 and since the number of memory cells does not change much over the course of a
single infection, then A → 0 as the parasites are cleared. However, if a second infection is
initiated before antibodies completely decline to zero, after the first set of parasites have been
removed, then A → A0 indicates some additional amount of immunity after one infection.
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Hence, we will study the system subject to the initial conditions
X(0) = λx/µx, Y (0) = 0, M(0) = 0.105, G(0) = 0, P (0) = βm/µp, A(0) = 0
In a delay differential equation, the time derivative at the current time depends on the solution
and possibly its derivative at previous times. The derivative in (5.1.6) depends on the solution
at the previous time t− d1, it is necessary to provide an initial history function to specify the
value of the solution before time t = 0. Hence we state the following history condition.
X(t) = λx/µx, Y (t) = 0, M(t) = 0, G(t) = 0, P (t) = βm/µp, A(0) = 0, ∀t < 0.
The model has lots of parameters and we need to determine their values in order to carry
out a proper study of the dynamics. However, we will first derive the dimensionless form of
the model in the next section as this will provide a basis for determining the dimensional
parameter values.
5.2. Nondimensionalisation
The dynamics in this system works on a number of time scales, e.g. natural red blood cell
turnover (∼ 120 days), blood infiltrated merozoite maturation in blood cells (∼ 2 days), non-
infiltrated merozoite survival (∼ 30 minutes), adaptive immune response (∼ 2 days), etc. We
scale time with the maturation of merozoites and write
t =
tˆ
µy
,
where, more precisely,
1
µy
is the duration of schizogony leading to cell induced death of infected
red blood cells and subsequent release of new generation merozoites. The dimensionless time,
tˆ = 1 represents a time scale of about 2 days, which is a relatively longer time compared
with the longevity of merozoites and their invasion capacity. The choice of this scaling will
enable us to study the system in relation to the replication rate of blood stage parasites. We
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normalise the red blood cell variable using the healthy steady state rate, λx/µx. We also
rescale the infected red blood cell, merozoite and gametocyte using the same parameter, so,
it is easier to ascertain directly the ratio between blood cells and merozoites. We rescale the
innate immune density with the healthy state bm/µp and antibodies with activation level 1/c0.
We thus make the following scalings,
X =
λx
µx
Xˆ, Y =
λx
µx
Yˆ , M =
λx
µx
Mˆ, G =
λx
µx
Gˆ, P =
bm
µp
Pˆ , A =
1
c0
Aˆ.
We define the following non-dimensional parameters
σ =
µx
µy
, β =
βxλx
µxµy
, µ =
µn
µy
, d =
µm
µy
, k1 =
ka
c0
, k2 =
kb
c0
, k3 =
kc
c0
, k =
kybm
µpµy
,
e =
µg
µy
, b =
µp
µy
, α =
kmbm
µpµy
, f =
kgbm
µpµy
, ω =
λxµpη1
bmµxµy
, h1 =
η3λx
µxµy
, h2 =
η4λx
µxµy
,
φ0 = c0A0, g1 =
η2c0λx
µxµy
, g3 =
µa
µy
, k4 =
kdλx
µxµy
, k5 =
knλx
µxµy
, τ = d1µy, k6 =
c1
c0
.
which leads to the dimensionless form of the system
dX
dt
= σ (1−X)− βXM
1 + A
, (5.2.1)
dY
dt
=
βXM
1 + A
− (1 + µ)Y − kPY (1 + k1A), (5.2.2)
dM
dt
=
r (1− θ)Y
1 + k6A
− βMX
1 + A
− dM − αPM (1 + k2A) , (5.2.3)
dG
dt
=
rθY
1 + k6A
− eG− fPG(1 + k3A). (5.2.4)
dP
dt
= b(1− P ) + ω (Y + φM)− P (k4Y + k5M) , (5.2.5)
dA
dt
= g1{Y (t− τ) + g2M (t− τ)}+ g3 (φ0 − A)− A (h1Y + h2M) . (5.2.6)
subject to the following history and initial conditions
(X(t), Y (t),M(t), G(t), P (t), A(t)) =
(1, 0, 0, 0, 1, 0) for t < 0,(1, 0, 1.05× 10−7, 0, 1, 0) for t = 0. (5.2.7)
We note that (5.2.4) is redundant since it is decoupled from the other equations. However,
we include it in order to determine the concentration of gametocytes in a single malaria cycle.
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We solve the system using the dimensionless parameter values shown in Table 5.2, where
parameter values are expressed in terms of a small parameter,  to enable the application of
asymptotic analysis in describing timescales of events in the human host as parasites interact
with red blood cells. We define  as the ratio of µn and µm so that   1 describes a
situation where the death rate of merozoites is large compared to the death rate of infected
red blood cells making merozoite survival a direct consequence of parasite replication and
disease pathology. Following our remarks in the last part of section 5.1.1, we will now discuss
the estimation of the model parameter values in the next section.
5.3. Parameter values
The definitions of the various dimensionless and dimensional parameters are given in Table 5.2
and Table 5.3 respectively. The values of the parameters used for the simulations are derived
from different sources including experimental data, estimates from other mathematical models
and estimates from our model. Parameter values obtained from experimental sources or other
mathematical models are indicated in Table 5.3 using asterisk or bullet with a description
provided at the bottom. The choices of the remaining parameter values are made based on
fitting the model to the malaria data of neurosiphilis patients in section 4.1.
Firstly we determine the dimensionless parameter values in the third column of Table 5.2
by fitting the model equations (5.2.1)−(5.2.6) to the malaria data of the patient infected with
the El Limon strain. The solution is obtained using dde23, a MATLAB routine solver, with
the initial and history conditions stated in (5.2.7). We show results in Figure 5.1 whilst details
of the solver will be provided in section 5.8. The choice of parameter values is motivated by the
qualitative behaviour of the solution. We note that there is evidence of secondary outbreak of
the disease as shown in Figure 5.2. However, we have used a continuum approximation such
that we ignore the concentration of merozoites when it is reasonably small, i.e. if M < Mmin,
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then M ≡ 0, Y ≡ 0 so, dX/dt = σ(1−X). We consider sensible time scales for these processes,
which will be discussed later in section 5.7, and we will only focus on the case where M < Mmin
in section 5.7.6. Secondly we determine the values of the remaining dimensional parameters
in Table 5.3 using the combinations of parameters expressed in the first column of Table 5.2
Dimensional form Nondimensional parameter Value Value in terms of 
µx
µy
σ 0.02 
βxλx
µxµy
β 49 O(1

)
µn
µy
µ 0.11 O(1)
µm
µy
d 96 O(1

)
ka
c0
k1 2.3 O(1)
kb
c0
k2 20 O(1)
kc
c0
k3 2.1 O(1)
c1
c0
k6 15.2 O(1)
kybm
µpµy
k 0.23 O(1)
µg
µy
e 0.034 O()
µp
µy
b 0.6 O(1)
kmbm
µpµy
α 30 O(1

)
kgbm
µpµy
f 0.35 O(1)
λxµpη1
bmµxµy
ω 10 O(1)
η3λx
µxµy
h1 0.45 O(1)
η4λx
µxµy
h2 0.34 O(1)
η2c0λx
µxµy
g1 1.8 O(1)
µa
µy
g3 0.6 O(1)
kdλx
µxµy
k4 0.028 O()
knλx
µxµy
k5 0.031 O()
r r 16 O(1)
θ θ 0.0064 O()
φ φ 2 O(1)
g2 g2 1.86 O(1)
m0 m0 0.000000105 O(
2)
Table 5.2: Dimensionless parameter values of Inhost model defined in terms
of the small parameter  = µn
µm
≈ 0.001, this being relevant for section 5.7.
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Figure 5.1: Results showing pathogenesis of malaria in the human host in which initially introduced merozoites invade red
blood cells to reproduce and in the process form sexual parasites. Innate immune cells proliferate as they respond to pathogens.
This culminates in the production of specific immune response that leads to parasite clearance. We note that t = 1, represents 2
days in real time corresponding to the the period of each erythrocytic schizogony. The initial conditions used are as stated above
whereas the parameter values are σ = 0.02, β = 49, µ = 0.11, d = 96, k1 = 2.3, k2 = 20, k3 = 2.1, k6 = 15.2, k = 0.23, e = 0.034,
b = 0.6, α = 30, f = 0.35, ω = 10, h1 = 0.45, h2 = 0.34, g1 = 1.8, g3 = 0.6, k4 = 0.028, k5 = 0.031, r = 16, θ = 0.0064, φ = 2,
φ0 = 0, g2 = 1.86. The data represent those of a malaria patient infected with El Limon strain marked as patient S1301 in [54]
In Figure 5.1, the concentration of infected red blood cells drops to its minimum level
due to invasion by merozoites and starts growing at the time of recovery when the immune
system gains control. The minimum level of X, 0.55 occurs around t = 5.4. At the begin-
ning of infection, the red blood cells seem to maintain their normal level until perhaps the
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Figure 5.2: Results showing secondary outbreak of the disease. The concentration of red blood cells drops after the initial
attack and recovery is initiated as immune response gains control. However, the immune cells relax after the concentration of
merozoites drops creationg room for merozoites growth and re-invasion of the red blood cells. The initial conditions and the
parameter values are the same as those in Figure 5.1
concentration of merozoites is large enough to offset the erythropoietic
function of red blood cells. In Figure 5.1b, c, d, the concentrations of infected red blood
cells, merozoites and gametocytes peak, round about the same period when X drops to its
minimum with M and Y having similar shapes an indication of some form of proportionality.
This is an expected behaviour since a merozoite convert to an infected red blood cell on
successfully penetrating a red blood cell. Although the peak value of M is less than that of
Y , it may not be unconnected with the high death rate of merozoites.
Figure 5.1e describes how innate immune cells respond to the presence of malaria pathogens
by proliferating to a peak value and finally tail off. At the initial stage of infection, P main-
tained its normal level and shortly after concentrations of parasites attain their maximum
levels by dragging the concentration of red blood cells to its minimum, P grows to its peak.
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This facilitates rapid production of specific immune cells as shown in Figure 5.1f. Although
not very clear from the graph, quite a negligible amount of A emerge after the time lag t = 1
during which innate immune cells initiates the training of naive T cells and B cells. The peak
of innate immune cells marks a massive destruction of gametocytes, merozoites and infected
red blood cells and as M and Y die out there is no more feed back from Y to G. Hence,
the concentration of gametocytes decays and since there is no more infection to boost the
production of antibodies, A dies out whilst P returns to its normal level.
In Figure 5.3 we show the effect of φ0 on the dynamics of the disease. Up to now we have
shown only the first contact case of φ0 = 0. After each contact the value of φ0 in the context
of the model will increment upwards a small amount, ∆φ0 say, though we have assumed
that ∆φ0  1 in the analysis. The graph shows increasing φ0, and hence the readiness of the
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Figure 5.3: Results showing the effect of changing φ0 on minimum level of red blood cells. The initial conditions and
parameter values used are the same as those in Figure 5.1 except that φ0 = 0 was varied from 0 to 0.08 at interval of 0.001
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innate immune response to respond, the amount of damage caused to red blood cells decreases
until φ0 ≥ 0.071 when the immune system is completely effective and interestingly, φ0 = 0.71
corresponds to R0 = 1.
5.4. Existence and uniqueness of solution
The rescaling means that the uninfected state has X = 1, P = 1 and all other variables being
zero. We note that since ω > k4 and ωφ > k5 then P ≥ 1. The scaling on Y and M being
the same as that of X means that the RHSs are continuous. The solution of (5.2.1)−(5.2.6)
belongs to the set Ω, where Ω is defined on the set
Ω = {X, Y,M,G, P,A : 0 ≤ X ≤ 1, 0 ≤ Y ≤ 1, 0 ≤M ≤ 1, 0 ≤ G ≤ 1, P ≥ 1, A ≥ 0}.
It is straightforward to deduce positivity, as in each case dZ/dt ≥ 0 when Z = 0, where
Z ∈ S = {X, Y,M,G, P,A} and all variables in S/Z are non-negative. We can easily show
from (5.2.1) that 0 ≤ X ≤ 1. Assuming there are times t1 and t2 such that X(t1) < 0 and
X(t2) > 1. If we start with initial conditions, X(0) > 0, M(0) > 0 and A(0) > 0, then
the trajectories of X(t) for 0 < t < t1, t2 will either tend towards 0, 1 or oscillate between 0
and 1. Suppose X(t) = 0, then dX/dt > 0 meaning X(t) is increasing and cannot cross the
line X = 0. Similarly, X(t) = 1 implies dX/dt < 0 and X(t) cannot cross the line X = 1.
Both cases contradict our initial assumptions X(t1) < 0 and X(t2) > 1 and we conclude that
0 ≤ X(t) ≤ 1. Theorem A in (Driver, 1977, P259) states that a system
dX
dt
= F (t,X,X (t− τ1) , ...,X (t− τj)) , (5.4.1)
subject to the history condition
X(t) = X0(t), for − max
i=1,..,j
(τi) ≤ t ≤ 0,
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where F and X0 are Lipschitz continuous and the positivity condition
∂Fi
∂Xi
≥ 0, when Xi = 0 and Xk ≥ 0 for k 6= i, holds, (5.4.2)
then there exists a solution and it is unique. Although the theorem is hinged on “local
Lipschitz” conditions, it suffices for uniqueness and F is locally Lipschitzian if it has first
partial derivatives with respect to all the X ′is [32]. In our case, j = 1, the history condition
in 5.2.7 is continuous and F is the right hand side of system (5.2.1)−(5.2.6). Certainly F
is continuous, and so too are the partial derivatives. The system meets the criteria of this
theorem, hence there exists a solution and it is unique.
5.5. The basic reproduction number
Using the same next generation matrix as in our previous analysis in Chapter 3, we consider
the system
R′h = FhRh − VhRh, (5.5.1)
where,
Fh =

0 q6 0
0 0 0
0 0 0
 , Vh =

q1 0 0
−q2 q3 0
−q4 0 q5
 , Rh =

Y
M
G
 .
It can be shown that the linearisation of (5.2.1)−(5.2.6) at the disease-free equilibrium is a
two dimensional system without delay, which justifies the use of the next generation matrix
approach. We note that whenever a merozoite penetrates a healthy red blood cell, a new
infection or precisely, a new infected red blood cell emerges. The matrix FhRh describes
the emergence of these new infections. Every surviving infected red blood cell undergoes a
process of schizogony or transition back to the merozoite compartment or differentiates into
gametocytes. These pathogenic processes together with the immune response is represented
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by VhRh where Rh denotes the erythrocytic stages of the plasmodium life cycle. The constants
q′is are expressed in terms of the model parameters as follows:
q1 = 1 + µ+ k(1 + k1φ0), q2 =
r(1− θ)
1 + k6φ0
, q3 =
β
1 + φ0
+ d+ α(1 + k2φ0),
q4 =
rθ
1 + k6φ0
, q5 = e+ f(1 + k3φ0), q6 =
β
1 + φ0
.
The non-negative matrix Gh = FhV
−1
h is expressed in the form
Gh =

q7 q8 0
0 0 0
0 0 0
 , (5.5.2)
where,
q7 =
q2q6
q1q3
, q8 =
q6
q3
.
The square of the largest eigenvalue of Gh gives the inhost basic reproduction number
R01 =
βr(1− θ)
(1 + k6φ0)(kk1φ0 + 1 + µ+ k)(αk2φ20 + αk2φ0 + αφ0 + dφ0 + β + d+ α)
, (5.5.3)
which approximates the number of secondary red blood cell infections due to one hepatic
merozoite released into the blood stream of a disease free human. Although the largest
eigenvalue of Gh is R0
1/2
1 the square root arises on the ground that it takes two generations
for infected hosts to produce new infected hosts [31]. But in practise, the square root is left
off the reproduction number.
We recall that one of the objectives of this work is to investigate whether or not a naive
individual who contacts malaria through a single infectious bite will survive without treat-
ment. The innate immune response and the development of adaptive immunity to contain
the disease is imperative. Thus we will present three forms (R01, R02 and R03) of the ba-
sic reproduction number. The form presented in (5.5.3) contains φ0, an initial amount of
antibodies. This represents a situation in which an individual has a second or subsequent
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contact after going through the first malaria episode and the time interval between contacts
is short enough to guarantee the existence of some antibodies before the next contact. For
first malaria infection, φ0 = 0 and the basic reproduction number will be
R02 =
βr(1− θ)
(1 + µ+ k)(β + d+ α)
. (5.5.4)
A mere view of R02 suggests that the contribution of immunity to the control of infection is
dominated by the innate immunity parameters k and α since the adaptive immunity profile
parameters k1, k2, k6 and φ0 are absent. However, we note that φ0 = 0 is only an initial state
of the level of specific immune cells in an individual without malaria antibodies at the time of
infectious contact with a mosquito and as we can see clearly from (5.5.3), φ0 = 0 nullifies the
specific contributions of k1, k2 and k6 to the clearance of parasites but during infection some
amount of antibodies are created and these parameters will become effective. The ability of
innate immune cells in training naive T cells and B cells to create antibodies and complement
the activities of phagocytic and natural killer cells, depends on the efficiencies of k and α.
However, this may vary from human to human but lacking in HIV/AIDS patients. We can
easily show that in the worst scenario where both innate and specific immune responses are
absent, the basic reproduction number is
R03 =
βr(1− θ)
(1 + µ)(β + d)
. (5.5.5)
5.6. Steady state solution and stability analysis
It is worth noting that using the values in Table 5.2, R03 ≈ 3. Since β is significantly
smaller than d, then viable therapeutic strategies targeting merozoite invasion of red blood
cells (reducing β) and enhancing merozoite death (increasing d) could potentially be effective.
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This assumes that the values are reliable.
Our preliminary investigation centres on analysing the model, (5.2.1)−(5.2.6) to ascertain
whether a naive individual without immune response can survive a single infectious mosquito
bite with the aim of determining the total number of gametocytes produced at the end of
the infection or at death. The disease-free equilibrium point of system (5.2.1)−(5.2.6) is
(X, Y,M,G, P,A) = (1, 0, 0, 0, 1, φ0). We commence the stability analysis by assuming a little
perturbation away from the disease-free state. For instance, if we let for t ≥ 0
X = 1 + ερ1e
λt, Y = ερ2e
λt, M = ερ3e
λt,
G = ερ4e
λt, P = 1 + ερ5e
λt, A = φ0 + ερ6e
λt,
where the pis are constants and ε is a small parameter given the size of the perturbation, and
(X, Y,M,G, P,A) = (1, 0, 0, 0, 1, 0) for t < 0. The task is to find the eigenvalues, λ = λi, i =
1, ..., 6, such that (ρ1, ρ2, ρ3, ρ4, ρ5, ρ6) 6= (0, 0, 0, 0, 0, 0).
By substituting the perturbations of X, Y , M , G, P and A in system (5.2.1)−(5.2.6),
which after rearranging and ignoring terms of O(ε2) leads to
r1 0 β 0 0 0
0 r2 −β 0 0 0
0 −r4 r3 0 0 0
0 −r6 0 r5 0 0
0 r7 r8 0 r9 0
0 r10 r11 0 0 r12


ρ1
ρ2
ρ3
ρ4
ρ5
ρ6

=

0
0
0
0
0
0

where the ris are expressed as
r1 = (φ0 + 1)(λ+ σ), r2 = (φ0 + 1)(kk1φ0 + k + λ+ µ+ 1),
r3 = αk2φ
2
0 + αk2φ0 + αφ0 + dφ0 + λφ0 + β + d+ α + λ,
r4 = r(1− θ)(φ0 + 1), r5 = (k6φ0 + 1)(fk3φ0 + e+ f + λ), (5.6.1)
92
r6 = rθ, r7 = k4 − ω, r8 = k5 − ωφ, r9 = b+ λ,
r10 = e
λτh1φ0 − g1, r11 = eλτh2φ0 − g1g2, r12 = eλτ (g3 + λ).
Since (ρ1, ρ2, ρ3, ρ4, ρ5, ρ6) 6= (0, 0, 0, 0, 0, 0), the determinant of the coefficient matrix must be
zero. Thus the eigenvalues satisfy the characteristic equation
r1r12r9r5 (r2r3 − βr4) = 0. (5.6.2)
We observe that four of the eigenvalues are trivially negative and the remaining two are
expressed in the following equation.
λ2 +
(
r13 +
r14
φ0 + 1
)
λ+
r13r14
φ0 + 1
(
1− βr(1− θ)
(k6φ0 + 1)r13r14
)
= 0. (5.6.3)
where, r13, r14 are defined as
r13 = kk1φ0 + k + µ+ 1, r14 = αk2φ
2
0 + αk2φ0 + αφ0 + dφ0 + β + d+ α,
and the ratio in the second bracket is an expression for R01 in 5.5.3.
Sum of roots = −
(
r13 +
r14
φ0 + 1
)
and Product of roots =
r13r14
φ0 + 1
(1−R01) .
Since all the parameters are positive, there will be at most one positive root if R01 > 1. Thus
the disease free state is locally asymptotically stable if R01 < 1 and unstable for R01 > 1. We
note that the delay term in (5.2.6) for dA/dt makes no contribution to this analysis.
5.7. Asymptotic analysis of in-host model
In this section, we will present the timescale analysis of the in-host model, which we have
used to describe the progression of the disease from the release of merozoites from a rupturing
hepatic schizont into the blood stream to the time of parasite clearance assuming a single
infectious mosquito bite. The analysis shows that following a single infectious bite of a
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mosquito, blood stage parasites proliferate causing a reduction in red blood cell level and
depending on the intervention and efficiency of the immune response, parasites will be cleared.
We have assumed that   1 and all parameters are equal to the fractional powers of  as
given in Table 5.2. It is a common practice in timescale analysis to use different notations in
describing variables in different timescales but due to the numerous time scales involved in
this analysis and for the sake of brevity, we have resorted to using an “over-bar” for each time
scale noting that the solutions and discussions only apply to the particular time scale being
considered. There are 7 major timescales as predicted by our model describing the trend of
events on malaria pathogenesis in the human host. These include:
t = O() : Initial concentration of merozoites decays as meroziotes infect red blood cells
initiating the processes involved in the training of T cells and B cells with no significant
effect on the order of X and P . Due to short term viability, meroziotes that could not
penetrate red blood cells die out.
t = 
b0
ln
(
1

)
+ O()(b0 = βˆ + dˆ+ αˆ) : In this timescale, the fast decaying density of mero-
zoites drops by an order of magnitude due to infiltration into red blood cells.
t = O (1) : A non-negligible amount of infected red blood cells convert to merozoites causing
M and Y to equilibriate. Immature gametocytes emerge in low concentration as infected
red blood cells mature to release subsequent generation merozoites some of which are
committed to gametocytogenesis
t = τ + O() : This timescale marks the emergence of an initially negligible concentration
of specific immune response in the form of trained T cells, B cells and antibodies after
the initial lag time of antigen presentation.
t = τ + O(1) : increased density of parasites and infected red blood cells in this timescale
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stimulates more production of trained T cells and B cells. Break down in this timescale
occurs when the concentration of infected red blood cells become O(1), a period pre-
ceding the development of innate immune response capable of reducing the level of
infection.
t = τ + 2
R
ln(1

) + O(1)
(
R = βˆrˆ
βˆ+dˆ+αˆ
− (1 + µˆ+ kˆ)
)
: This is the major timescale that
describes the in-host dynamics. Infected red blood cell density, X decreases to its
minimum. The immune system gains control as parasite levels peak and after reducing
Y , M and G to negligible levels, P and A return to their normal states.
t = O (−1) : In this time scale, red blood cells recover and return to normal level.
In this analysis, we will consider a case of first malaria infection caused by a single mosquito
bite in which we have assumed φ0 = 0, signifying absence of initial concentration of malaria
specific immune cells. Using the size of parameters indicated in Table 5.2 in terms of  we
rescale the parameters as follows.
σ = σˆ, β =
1

βˆ, µ = µˆ, d =
1

dˆ, k1 = kˆ1, k2 = kˆ2, k3 = kˆ3,
k6 = kˆ6, k = kˆ, e = eˆ, b = bˆ, α =
1

αˆ, f = fˆ , ω = ωˆ, (5.7.1)
h1 = hˆ1, h2 = hˆ2, g1 = gˆ1, g3 = gˆ3, k4 = kˆ4, k5 = kˆ5,
r = rˆ, θ = θˆ, φ = φˆ, g2 = gˆ2, m0 = 
2mˆ0,
where the quantities with hats are assumed O(1) in size. These rescalings lead to the following
system

dX
dt
= 2σˆ (1−X)− βˆXM
1 + A
, (5.7.2)

dY
dt
=
βˆXM
1 + A
−  (1 + µˆ)Y − kˆPY (1 + kˆ1A), (5.7.3)

dM
dt
= 
rˆ
(
1− θˆ
)
Y
1 + k6A
− βˆXM
1 + A
− dˆM − αˆPM
(
1 + kˆ2A
)
, (5.7.4)
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dG
dt
= 
rˆθˆY
1 + k6A
− eˆG− fˆPG(1 + kˆ3A). (5.7.5)
dP
dt
= bˆ(1− P ) + ωˆ
(
Y + φˆM
)
− P
(
kˆ4Y + kˆ5M
)
, (5.7.6)
dA
dt
= gˆ1Y (t− τ) + gˆ1gˆ2M (t− τ)− gˆ3A− hˆ1AY − hˆ2AM, (5.7.7)
subject to
t = 0, X = 1, Y = 0, M = 2mˆ0, G = 0, P = 1, A = 0,
t < 0, X = 1, Y = 0, M = 0, G = 0, P = 1, A = 0.
We summarise the analysis for each timescale with full details in Appendix C.1.
5.7.1. t = O()
We scale time using
t = t¯
and relevant scalings for the dependent variables are
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 2M¯, G ∼ 4G¯, P ∼ P¯ , A = 0. (5.7.8)
To leading order we obtain
dX¯
dt¯
∼ 0, dY¯
dt¯
∼ βˆM¯ , dM¯
dt¯
∼ −
(
dˆ+ βˆ + αˆ
)
M¯,
dG¯
dt¯
∼ rθY¯ , dP¯
dt¯
∼ 0, (5.7.9)
describing the initial state of the disease. These are subject to
t¯ = 0, X¯ = 1, Y¯ = 0, M¯ = mˆ0, G¯ = 0, P¯ = 1, A¯ = 0.
Solving this system leads to the leading order solution
X¯ ∼ 1, P¯ ∼ 1, Y¯ ∼ βˆmˆ0
b0
(
1− e−b0 t¯
)
, M¯ ∼ mˆ0e−b0 t¯,
G¯ ∼ rˆθˆβˆmˆ0
b0
t¯− rˆθˆβˆmˆ0
b20
(
1− e−b0 t¯
)
, A¯ = 0, (5.7.10)
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where
b0 = βˆ + dˆ+ αˆ.
We observe that the initial concentration of merozoites released from hepatic schizont is
decaying as meroziotes infect red blood cells. However, this does not have any significant
effect on the order of X and P . The contact between innate immune cells and merozoites
initiates the processes involved in the training of T cells and B cells, and due to the short
term viability of merozoites the parasites that could not penetrate red blood cells die out. A
rebalance of the system occurs when M¯ = O(), i.e. on a time scale of t¯ =
1
b0
ln
(
1

)
+O(1).
5.7.2. t = 
b0
ln(1

) + O()
In order to describe events in this time scale, we write
t =

b0
ln
(
1

)
+ t¯
and rescale the dependent variables as
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 3M¯, G ∼ 4 rˆθˆβˆ
b20
ln
(
1

)
+ 4G¯, P ∼ P¯ , A = 0.
Substituting these into the non dimensional system gives the leading order system
dX¯
dt¯
∼ 0, dY¯
dt¯
∼ 0, dM¯
dt¯
∼ βˆrm0
b0
− b0M¯, dG¯
dt¯
∼ rˆθˆβˆmˆ0
b0
,
dP¯
dt¯
∼ 0, (5.7.11)
subject to, by matching with t = O() timescale solution
X¯ ∼ 1, Y¯ ∼ βˆmˆ0
b0
, M¯ ∼ mˆ0e−b0 t¯, G¯ ∼ rˆθˆβˆmˆ0
b0
t¯, P¯ ∼ 1, (5.7.12)
as t→ −∞, to leading order. The solutions are
X¯ ∼ 1, Y¯ ∼ βˆmˆ0
b0
, M¯ ∼ βˆmˆ0
b20
+ mˆ0e
−b0 t¯, G¯ ∼ rˆθˆβˆmˆ0
b0
t¯− rˆθˆβˆmˆ0
b20
, P¯ ∼ 1, A¯ = 0,
The merozoites that have successfully penetrated red blood cells are undergoing the first
round of erythrocytic schizogony. We note this is an artefact of the continuum assumption
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and the time scale of t =

b0
ln
(
1

)
(about 2 hours) is too short for the likely release of new
merozoites. However, the contribution at this stage is negligible at leading order so we argue
that is sound to this order. Concentrations of red blood cells and innate immune cells still
remain at normal levels whilst gametocytes and adaptive immune cells are yet to emerge.
There is a rebalance in the system in the gametocyte equation at t = O
(
1

)
.
5.7.3. t = O(1), t < τ
In this timescale, we scale time as
t = t¯.
The scalings of the variables are
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 3M¯, G ∼ 3G¯, P ∼ P¯ , A = 0.
Following our usual substitution of the rescalings into (5.7.2)−(5.7.7), we found that other
equations are similar to those in the preceding time scale except
dY¯
dt¯
∼
(
βr
b0
− (1 + µ+ k)
)
Y¯ , M¯ ∼ rˆY¯
b0
,
dG¯
dt¯
∼ rˆθˆY¯ − fˆ G¯, dP¯
dt¯
∼ bˆ(1− P¯ ),
subject to, by matching,
Y¯ =
βˆmˆ0
b0
, M¯ =
βˆrˆmˆ0
b20
, P¯ = 1, G¯ = 0, at t¯ = 0.
Solving the system yields
X¯ ∼ 1, P¯ ∼ 1, Y¯ ∼ βˆm0
b0
e+Rt¯, M¯ ∼ rˆβˆm0
b20
e+Rt¯, A¯ = 0,
G¯ =
rˆθˆβˆm0(
fˆ +R
)
b0
e+Rt¯, R = a0 (Rc − 1) ,
where
R = a0(Rc − 1),
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and where a0 = 1 + µˆ+ kˆ, and in particular,
Rc =
βˆrˆ
a0b0
=
βˆrˆ
(1 + µˆ+ kˆ)(βˆ + dˆ+ αˆ)
,
is the leading order basic reproduction number approximating that of the system for θ  1, is
a necessary and sufficient condition for the disease to die out. We observe that Rc < 1 means
R < 0 so that merozoites and infected red blood cells decay to zero, such that Y never exceeds
O(2); this is to be expected on (M¯, Y¯ ) = (0, 0) as a steady state when Rc < 1. However, if
Rc > 1, M¯ and Y¯ grow exponentially indicating the disease is beginning to establish itself as
the first set of merozoites start producing subsequent merozoites and immature gametocytes.
The results suggest that chemotherapy may yield optimum result if implemented in this time
scale to keep the basic reproduction number less than unity as it would help to eliminate
second generation merozoites during their release. In the case of Rc < 1 the disease will die
off without impacting significantly on red blood cells (presumably there will be no symptoms),
we will then not discuss this case further and concentrate on Rc > 1. The adaptive immune
system begins to activate at t = τ , indicating the next time scale.
5.7.4. t = τ + O(), Rc > 1
This time scale corresponds to the initial t = O() time scale of merozoite emergence from the
liver, and the initial phase of merozoite presentation to naive T and B cells by dendritic cells.
After a delay of t = τ , the adaptive immune response and, consequently, antibody production
is starting. For this timescale we write
t = τ + t¯.
Due to this being a rapid time scale the variables X, Y , M , G and P are “frozen” at leading
order, namely
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 2M¯, G ∼ 4G¯, P ∼ P¯ . (5.7.13)
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Since Y (t− τ) = O(2) and M(t− τ) = O(2) then
A = 3A¯.
and substituting the t = O() solution for Y and M yields
dA¯
dt¯
= gˆ1
βˆmˆ0
b0
(
1− e−b0 tˆ
)
+ gˆ1gˆ2m0e
−b0 t¯,
subject to A¯(0) = 0, which has the solution
A¯ =
gˆ1βˆmˆ0
b0
{t¯+ gˆ2− 1 + (1− gˆ1)e−b0 t¯}.
We observe that in large time A will grow linearly. As indicated by the first two timescales,
the output of antibodies/T cells is through infected red blood cell stimulation as merozoites
momentarily decline at

b0
ln
(
1

)
+ O() timescale. The next balance shift at leading order
occurs at t¯ = O
(
1

)
, i.e. A¯ = O
(
1

)
.
5.7.5. t = τ + O(1), Rc > 1
In this timescale we scale time as
t = τ + t¯.
The scalings of other variables are given as
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 3M¯, G ∼ 3G¯, P ∼ P¯ , A ∼ 2A¯.
Substituting these rescalings into (5.7.2)−(5.7.7) yields a system in which X and P still
maintain their normal levels. Other variables are expressed by the following equations
dY¯
dt¯
= βˆM¯ −
(
1 + µˆ+ kˆ
)
Y¯ , M¯ =
rˆY¯(
dˆ+ βˆ + αˆ
) ,
dG¯
dt¯
= rˆθˆY¯ − fˆ G¯, dP¯
dt¯
= bˆ(1− P¯ ), dA¯
dt¯
= gˆ1Y¯ (t− τ)− gˆ3A¯,
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subject to
Y¯ (0) ∼ βˆmˆ0
b0
, G¯(0) ∼ 0, P¯ (0) = 1, A¯(0) ∼ 0, by matching.
The solutions are
Y¯ ∼ βˆmˆ0
b0
eRt¯, A¯ ∼ gˆ1βˆmˆ0
b0(g3 +R)
eR(t−τ), G¯ ∼ rˆθˆβˆmˆ0
b0(fˆ +R)
eRt¯, M¯ ∼ βˆmˆ0e
Rt¯
b20
, P ∼ 1.
The solution indicates that densities of the various parasite stages are growing exponentially
and there is possibility of full blown malaria with consequences of anaemia. There is also
rapid production of antibodies, however their contribution to controlling the disease is still
negligible. There is a shift in balance in the system at leading order when the infected cells
Y¯ = O(1), corresponding to a time scale
2
R
ln
(
1

)
+O(1)
5.7.6. t = τ + 2
R
ln(1

) + O(1), R > 0
This is a significant timescale in which the effect of malaria reaches its peak and the adaptive
immune response begins to take effect. We translate in time from the previous time scale and
write
t = τ +
2
R
ln(
1

) + t¯,
though we note here that formerly the τ term is superfluous, however, since the large term is
logarithmic, in practise τ will not be that much smaller. The variable rescalings in this time
scale are
X ∼ X¯, Y ∼ Y¯ , M ∼ M¯, G ∼ G¯, P ∼ P¯ , A ∼ A¯,
subject to
X¯ ∼ 1, Y¯ ∼ βˆm0
b0
eRt¯, M¯ ∼ βˆm0e
Rt¯
b20
, G¯ ∼ rˆθˆβˆm0
b0(fˆ +R)
eRt¯, P¯ ∼ 1, A¯ ∼ gˆ1βˆm0
b0(gˆ3 +R)
e−RτeRt¯,
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as t¯→∞, from matching. On substitution of these variables into (5.7.2)−(5.7.7) followed by
appropriate balancing of terms we have the following leading order system,
dX¯
dt¯
= − βˆX¯M¯
1 + A¯
, (5.7.14)
dY¯
dt¯
=
βˆX¯M¯
1 + A¯
− (1 + µˆ) Y¯ − kˆP¯ Y¯
(
1 + kˆ1Aˆ)
)
, (5.7.15)
M¯ =
rˆY¯
βˆX¯ +
(
αˆP¯ + dˆ
) (
1 + k6A¯
)
+ αˆkˆ2P¯ A¯
(
1 + A¯
) , (5.7.16)
dG¯
dt¯
=
rˆθˆY¯
1 + k6A¯
− fˆ P¯ G¯− fˆ kˆ3P¯ G¯A¯, (5.7.17)
dP¯
dt¯
= bˆ(1− P¯ ) + ωˆY¯ , (5.7.18)
dA¯
dt¯
= gˆ1Y¯ (t− τ)− hˆ1A¯Y¯ − gˆ3A¯. (5.7.19)
This system is considerably more difficult than those in the previous timescales, and full
solutions cannot be found. A key observation of the equation is that
dX¯
dt¯
< 0, so there will be
a noticeable decline in red blood cells. Furthermore,
dP¯
dt¯
> 0 so innate cells are increasing and
inflammatory response is expected. We thus expect, it is this timescale in which the malaria
symptoms will be experienced.
Numerical simulations suggest that Y¯ → 0 as t¯→∞ and X¯ → X∞ > 0. We derive lower
and upper bounds for X∞ in the following section, and in particular, X∞ = O(1). We present
a numerical solution to demonstrate this behaviour.
5.7.6.1. Numerical simulations
The numerical simulations describing events in this timescale are presented in Figure 5.4a,
b,c,d and Figure 5.5a, b. The results suggest rapid exponential decay in Y and M after
attaining their maximum levels whilst Red blood cell density, X decays to its minimum level.
Gametocytes, innate immune cells and antibodies are also decaying after an initial peak.
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5.7.6.2. Lower bound
The leading order system appears not to have a closed form solution but considering a worse
scenario characterising absence of adaptive immune response with the following assumptions
ω  1, b ω, g1  1, h1  1, A¯ = O
(
max(gˆ1, hˆ1)
)
,
dP¯
dt¯
= O (ω) ,
then P¯ ∼ 1 and we obtain the first two equations of the SIR model
dX¯
dt¯
= − βˆrˆX¯Y¯
βˆX¯ + αˆ + dˆ
,
dY¯
dt¯
=
(
βˆrˆX¯
βˆX¯ + αˆ + dˆ
− a0
)
Y¯ ,
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Figure 5.4: Result showing the behaviour of X, Y , M and G. The variable X decays while Y , M and G initially grow
but later decay. The initial conditions are X = 1, Y = Rt + ln(βˆm0/b0), G = rˆθˆβˆm0 exp(Rt¯)/
(
fˆ b0 +Rb0
)
, P = 1, A =
g1βm0 exp
(
R(t− τ))/(gˆ3b0 + Rb0), with the parameter values σˆ = 20, βˆ = 0.049, µˆ = 0.11, dˆ = 0.096, rˆ = 16, θˆ = 6.4, eˆ = 34,
fˆ = 0.35, φˆ = 2, αˆ = 0.03, kˆ = 0.28, kˆ1 = 2.3, kˆ2 = 0.038, kˆ3 = 2.1, kˆ4 = 28, kˆ5 = 31, kˆ6 = 15.2, bˆ = 0.6, ωˆ = 10, φˆ0 = 0,
gˆ1 = 1.8, gˆ2 = 1.86, gˆ3 = 0.6, hˆ1 = 0.45, hˆ2 = 0.34, mˆ0 = 0.0105.
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Figure 5.5: Result showing the behaviour of P and A. The variables P and A decay after an initial growth. Parameter
values and initial conditions are the same as those in Figure 5.4.
.
This is a special form of the classic SIR model where the infection rate is bounded by healthy
red blood cells. The term a0Y¯ describes the rate at which infected red blood cells are removed
through natural deaths and immune response. The first approximation to the system in this
time scale is obtained by analysing the the ordinary differential equation
dY¯
dX¯
= −
(
1− a0
rˆ
)
+
a0
(
αˆ + dˆ
)
βˆrˆX¯
,
describing the rate of change of concentration of infected red blood cells with respect to the
concentration of healthy red blood cells. The solution of the equation is given by
Y¯ − Y¯0 =
(
1− a0
rˆ
) (
1− X¯)+ a0
(
αˆ + dˆ
)
βˆrˆ
ln
(
X¯
)
,
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since Y¯ → 0 and X¯ → 1 as t¯ → −∞. As with SIR model, Y¯0 → 0 as t¯ → −∞, then we can
deduce X¯ → X∞, where
(
1− a0
rˆ
)
(1−X∞) +
a0
(
αˆ + dˆ
)
βˆrˆ
ln (X∞) ≈ 0. (5.7.20)
This is the first approximation to X, a long term behaviour of the concentration of red blood
cells guaranteeing possible recovery from the disease, a case where Rc < 1. By definition, a
requirement for primary invasion is that the basic reproduction number must exceed unity
[51]. Considering the case of a large Rc > 1, then X∞  1 and (5.7.20) reduces to
a0
(
αˆ + dˆ
)
βˆrˆ
ln (X∞) ≈ −
(
1− a0
rˆ
)
,
with solution
XSIR∞ ≈ exp
(
− βˆ(rˆ − a0)
a0(αˆ + dˆ)
)
.
An improved approximation to X∞ may be obtained by considering the contribution of innate
immune cells (P ), to the dynamics of the disease. Assuming, g1  1, b 1 and A 1, then
we analyse the system
dX¯
dt¯
= − βˆrˆX¯Y¯
βˆX¯ + αˆP¯ + dˆ
, (5.7.21)
dY¯
dt¯
=
(
βˆrˆX¯
βˆX¯ + αˆP¯ + dˆ
− (1 + µˆ+ kˆP¯ )
)
Y¯ , (5.7.22)
dP¯
dt¯
= ωˆY¯ . (5.7.23)
We consider as a first case, the equation
dP¯
dX¯
= − ωˆ
rˆ
− αˆωˆ
βˆrˆ
P¯
X¯
− ωˆdˆ
βˆrˆX¯
. (5.7.24)
Multiplying through by X¯
αˆωˆ
βˆrˆ
(
assumming
αˆωˆ
βˆrˆ
6= 1
)
, we get
d
dXˆ
(
P¯ X¯
αˆωˆ
βˆrˆ
)
= − ωˆ
rˆ
X
αˆωˆ
βˆrˆ − ωˆdˆ
βˆrˆ
X¯
αˆωˆ
βˆrˆ
−1
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By integrating and matching the solution with that of the previous timescale (P = 1, X = 1
as t¯→ −∞), we have
P =
(
1 +
ωˆβˆ
αˆωˆ + βˆrˆ
+
dˆ
αˆ
)
X¯
− αˆωˆ
βˆrˆ − ωˆβˆ
αˆωˆ + βˆrˆ
X¯ − dˆ
αˆ
(5.7.25)
describing P in terms of X. Also, by considering the second case we integrate the equation
dY¯
dtˆ
= −dX¯
dtˆ
− (1 + µˆ)
ωˆ
dP¯
dtˆ
− kˆ
2ωˆ
dP¯ 2
dtˆ
to get
Y¯ = 1− X¯ + (1 + µˆ)
ωˆ
(1− P¯ ) + kˆ
2ωˆ
(1− P 2).
We have as t¯→∞,
0 = 1− X¯∞ + (1 + µˆ)
ωˆ
(1− P¯∞) + kˆ
2ωˆ
(1− P 2∞), (5.7.26)
and by substituting (5.7.25) in (5.7.26) we have
f(X¯∞) = 0,
where
f(X¯) = 1− X¯ + (1 + µˆ)
ωˆ
(1− P¯ (X¯) + kˆ
2ωˆ
(1− P (X¯)2), (5.7.27)
and as ωˆ →∞, f(X¯)→ 1− X¯. By considering real solution for P∞ in (5.7.26) we obtain the
expression,
X¯XY P∞ ≤
(1 + µˆ)2
2ωˆkˆ
+
(1 + µˆ)
ωˆ
+
kˆ
2ωˆ
+ 1. (5.7.28)
We expect XXY P∞ > X
SIR
∞ , signifying a reduction of red blood cell invasion by merozoites due
to innate immune cell activation. Thus
exp
(
− βˆ(rˆ − a0)
a0(αˆ + dˆ)
)
≤ X¯∞ ≤ (1 + µˆ)
2
2ωˆkˆ
+
(1 + µˆ)
ωˆ
+
kˆ
2ωˆ
+ 1.
We note from section 5.3 that we only consider first outbreak and hence as Y →  we assume
that infection is finished. In Figure 5.4 and Figure 5.5 infected red blood cells, merozoites and
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gametocytes die out whilst innate immune cells and antibodies return to their normal state,
after clearing the infection. The remaining equation describes the recovery of uninfected red
blood cells at time t¯ = O
(
1

)
.
5.7.7. t = O (−1)
In this timescale, red blood cells return to normal level. The scalings are
t =
1

t¯, X ∼ X¯.
On substitution of these into (5.7.2), we obtain the leading order equation
dX¯
dt¯
= σˆ
(
1− X¯) .
The initial condition X¯(0) = X∞ solves the equation to give
X¯ ∼ 1− (1−X∞) e−σˆtˆ,
and as tˆ→∞, X ∼ 1 as expected.
5.7.7.1. Comparing asymptotic solutions with numerical solution
In this section we compare the solution of the full system with the asymptotic approximation.
Figure 5.6a, b, c, d gives approximations for red blood cells, infected red blood cells merozoites
and gametocytes whilst the approximations for innate immune cells and antibodies are given
in Figure 5.7a, b. The minimum of x and the peaks of Y , G, P and A appear reasonable. The
choice of the comparison parameters, σ, b and g3, does not need the implementation of the
continuum approximation assumption. The reduced system is a reasonable approximation of
the biology described by the full system and we note from 5.7.18 and 5.7.19 that what drives
the immune system is mainly infected red blood cells. Parameters for comparison are σˆ, b
and g3. For σˆ = 30, recovery is noticeably moderate t. Also, bˆ = gˆ3 = 0.1, so P and A relax
slowly leading to a negligible bounce back of Y and M in t ∈ [0, 40]
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Figure 5.6: Results showing the numerical solutions of the full system and approximations from the asymptotic analysis.
Solid lines represent the full model whilst dotted lines are used for the approximations. We used the same initial conditions as
those in Figure 5.4 and parameter values are  = 0.001, σˆ = 30, b = 0.1, g3 = 0.1 with every other dimensionless parameter set
to unity.
5.7.8. Conclusion from this analysis
In this section we have used asymptotic analysis to describe the interaction of the malaria
parasite, human erythrocytes and the immune cells. The analysis explains a situation in
which a individual who contacts malaria for the first time through a single infectious bite of
a mosquito progresses with the disease from the initial release of erythrocytic merozoites into
the blood stream. There are seven major time scales predicted by the model in which following
a single infectious mosquito bite, blood stage parasites proliferate causing a reduction in red
blood cell level and depending on the effectiveness of the immune system, both sexual and
asexual parasites are eliminated. We note the following concluding remarks from the analysis
about the progression of the disease in the human host:
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Figure 5.7: Results comparing numerical solutions and asymptotic approximations of P and A. Initial conditions and
parameter values are the same as those in Figure 5.6
• Upon release from the liver, initial population of merozoites decline rapidly as they
invade red blood cells. However it has negligible impact on the red blood cells and
innate immune system, as X and P remained at their normal concentrations from the
first time scale until the sixth time scale, i.e. approximately 5 days; a period within
which the concentration of merozoites is not large enough to cause a significant reduction
in red blood cell level.
• Although the activities of antigen presentation and phagocytosis leading to the training
of naive B cells and T cells were initiated in the early time scales, it was not until the
time scale, t > τ that specific immune response emerged into the system. It appears the
initial stimulation comes from immune cell interaction with merozoites only. However
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this stimulation has an additional boost as shown in the analysis when innate immune
cells started interacting with infected red blood cells generated by subsequent generation
merozoites leading to substantial increase in A.
• Throughout the analysis, we have demonstrated that the development of specific immu-
nity depends on the presence of malaria parasites. The concentration of red blood cells
drops to its minimum as evident in time scale
t = τ +
2
R
ln
(1

)
+O(1). (5.7.29)
Events in this timescale demonstrate that it is infected red blood cells that contribute
most to the development of adaptive immune response. It is during this timescale when
the adaptive and innate immune response takes control of the infection and eventually
drives down merozoite level as infected red blood cells are being removed.
• One important result from our analysis in t = O(1) time scale is that the parasite
will invade if the leading order basic reproduction number is greater than unity, which
suggest that chemotherapy may yield optimum result if implemented in this time scale to
keep the basic reproduction number less than unity as it would help to eliminate second
generation merozoites during their release. We expect perpetual presence of parasite in
the human host as in the case of the endemic state of the transmission model but it is
quite interesting from our findings that emergence of the immune profile, which may be
individual specific, will lead to parasite clearance.
• We note that if we allowed secondary outbreak in section 5.7.6, then after first outbreak
as Y → O(), P and A relax to pre-illness levels which can then allow Y → O(1) and
cause a secondary outbreak ultimately leading to a steady state where 1 −X = O(1).
Other factors absent in the model may become important in these circumstances.
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5.8. Numerical simulations of in-host model
In this section we present more numerical simulations of our model to corroborate the findings
in the asymptotic analysis. We will also make reference to some of the simulations presented
in section 5.3. The system under consideration is that of delay differential equations in which
there is a single constant delay, τ in the A equation that expresses the time lag before the
emergence of adaptive immune response. The numerical routine solver, MATLAB dde23,
which we have used here, deals with the solution of delay differential equations with con-
stant delays. Note in some cases some of the variables are presented in a logged axis. The
dimensionless parameters used for the simulations are defined in Table 5.2 and the initial
conditions are X = 1, Y = 0, M = 0.000000105, G = 0, P = 1, A = 0. These conditions
describe a situation where a naive human, i.e. A(0) = φ0, where φ0 = 0, is exposed to
malaria infection for the first time in which hepatic merozoites from a single infectious bite
of a mosquito are released into the blood stream to undergo the first phase of erythrocytic
schizogony. An individual having normal concentration of red blood cells (X = 1) and nor-
mal concentration of innate immune cells(P = 1) is infected with an initial concentration
of merozoites (M = 0.000000105 representing 35000 merozoites [87]). The program was run
in MATLAB using a relative and absolute tolerance of 10−7 with a delay of two days. The
history conditions are the same as the initial conditions for t ≥ 0, but if t < 0, except that
we set M to zero.
In Figure 5.8, merozoites invade red blood cells and immune cells respond by attacking
and eliminating pathogens, leading to red blood cell recovery and subsequent drop down of
immune cells. Although different sets of parameter values are used, the form of the solution
is similar to the one in Figure 5.1. However, the minimum red blood cell levels and the times
it takes to reach such levels in both cases are different. This is expected because different
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Figure 5.8: Results showing model fitting to data. The blue dots are data of the McLendon strain malaria infected patient
in Figure 4.1b with t = 1, representing 2 days in real time corresponding to the the period of each erythrocytic schizogony. The
initial and history conditions used are stated in section 5.2.7 and our choice of parameter values are the same as those in Figure
5.1 except k2 = 28, k6 = 4.2, k = 0.13, e = 0.0012, α = 35, f = 0.25, ω = 9, h1 = 0.45, h2 = 0.34, g1 = 0.8, g2 = 1.26.
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Figure 5.9: Results showing the effect of immune response on the pathogenesis of malaria. The red curve represents
concentration of red blood cells when the individual has both innate and adaptive immune response. The curves with the cyan
and blue colours indicate red blood cell concentrations due to innate immunity only and adaptive immunity only, respectively.
The initial conditions and parameter values used are the same as those in Figure 5.1. Death is assumed to occur at red blood cell
levels below the dotted horizontal line and red blood cell level reduces to as low as the magenta curve in the absence of immunity.
individuals respond differently to disease pathology and may have different immune response
statuses due to several individual specific factors. For instance, a good feeding habit of an
individual can promote a strong immune system that can even reduce the infection rate of
red blood cells.
The blue dots in Figure 5.8a represent data on the concentration of red blood cells of a
malaria patient infected with a different (McLendon) strain from that of Figure 5.1a. These
data were extracted from Jakeman [54] and are part of the data set obtained from the South
Carolina and Milledgeville State hospitals in which previously uninfected neurosyphilis pa-
tients were inoculated with P. falciparum malaria parasites as a means of malaria therapy for
neurosyphilis. In Figure 5.9 we demonstrate the effect of different immune profiles on disease
pathology using a death threshold defined by a third of the normal red blood cell level. The
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Figure 5.10: Results showing total concentration of gametocyte at any point in time as the disease progresses until death
at t = 6.2. The initial conditions and parameter values used are the same as those in Figure 5.9.
results suggest with both innate and adaptive immune response the minimum level of red
blood cell tend to be above the threshold level. But in the absence of one or both of the im-
mune types the minimum blood level will be below the threshold. As the disease progresses,
gametocytes are produced from infected red blood cells. The rate of production is higher in
the absence of immunity. Figure 5.10 shows the total amount of gametocyte produced at any
point in time from the start of the disease until death.
5.8.1. Discussion
We formulated a mathematical model for the in-host dynamics of malaria parasites focusing
on the erythrocytic blood-stage asexual parasite and gametocyte formation. This is of im-
portance as it is this stage in which clinical symptoms and mortality is relevant, as well as
the stage by which humans can transmit the disease to the mosquito vector. At the begin-
ning of first contact with the malaria parasite, innate immune cells first swing into action
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through antigen presentation mechanism leading to the training of naive T cells and B cells
and subsequent production of antibodies. This informed us of the inclusion of the delay pa-
rameter τ that provides for the time lag between contact and emergence of specific immune
response. Throughout our simulations we assumed a delay of 2 days, which seems realistic as
it is within the range of specific immune cells development for other infectious diseases. In
our numerical simulations we have been able to demonstrate some of the dynamic processes,
describing in-host interaction of the malaria parasite with red blood cells and host immunity.
A major feature in this interaction is the depletion or reduction of the concentration of red
blood cells eventually resulting to anaemia. Although several factors may seem to influence
the development of anaemia, the primary influence appears to be parasite density especially,
maintenance of high or moderately high density [57].
After the release of merozoites into the blood stream from the liver, there is rapid invasion
by parasites but this does not immediately cause the concentration of red blood cells to fall.
This could be partly due to recruitment of red blood cells and the intervention of innate
immune cells providing a first line of defence to thwart the growth of parasites. During
malaria infection like in many other infections, the innate immune system plays a dual role.
On one hand it acts as a first line of defence to limit rapid parasite growth and to initiate an
adaptive immune response and avoid re-infections [62], and on the other hand, its excessive
activation can drive over-production of pro-inflamatory cytokines leading to inflammation and
pathology [105]. Another reason could be that since there are only 1.05 × 10−7 of them at
t = 0, immune response is low key until M and Y have reached sufficient levels.
We note that our model is a continuum model and does not guarantee complete clearance
of parasites. It is constructed in such a way that the presence of malaria pathogens stimulates
the innate immune response to activate the adaptive immune responses. Thus a rise in parasite
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level will be followed by a corresponding rise in the concentration of both humoral and T cell
and B cell mediated immune response. We observed that the parasite invades red blood cells,
causing a fall in the concentration of uninfected red blood cells and a corresponding rise in
the concentrations of infected red blood cells, merozoites and gametocytes. Consequently,
the concentrations of both the innate and adaptive immune cells rise to force down the
concentrations of merozoites, infected red blood cells and gametocytes to a negligible level
incapable of invading, leading to red blood cell recovery and eventual return of the immune
cells to their normal levels.
Considering the case of the patient infected with McLendon strain, we determine from
the numerical solution an estimate of the total amount of gametocytes at death as 6.9 ×
104cells/µl. For survival purposes, it is not in the interest for malaria plasmodium to kill the
human host, as this would deny a mosquito’s access to gametocytes; in order to maximise
mosquito uptake of gametocyte it is best for the host to survive the disease, producing ga-
metocytes for as long as possible. Our primary aim of this model is to investigate whether
or not parasites deposited in the human host through a single infectious bite could lead to
death. It is actually a difficult thing to determine at what stage death would occur during
malaria attack, but since red blood cell concentration is crucial in the survival of the human
host, we assume that death occurs when the concentration of red blood cells has dropped
to its fatal level, specifically, around third of the normal blood level. Using this definition,
our results show that a non-immune deficiency human, though depending on the values of
the model parameters which are individual specific may likely survive a single bite malaria
infection. This is illustrated in Figure 5.1a and Figure 5.8a where we have fitted the model
to neurosyphilis data extracted from [54], part of the data set obtained from the South Car-
olina and Milledgeville State hospitals in which previously uninfected neurosyphilis patients
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were inoculated with P. falciparum malaria parasites as a means of malaria therapy for neu-
rosyphilis. In both cases the minimum level of red blood cells is a little above the estimated
fatal level.
The behaviour of the solution follows the pattern described in Kitchen, [57], in which he
avers that in the naturally evolving disease, the greatest loss of erythrocyte occurs during that
period subsequent to attainment of the maximum parasite density and prior to the appearance
of definite evidence that the host defence mechanism has gained control over the situation.
In a related development, he asserts that if a moderate parasite density is maintained for a
period of three or four weeks in P. falciparum or P. vivax attack then this might reduce the
initial normal level of red blood cells to 1.5 × 106cells/µl or less. Although our numerical
result in Figure 5.1a shows that it takes 14 days after the realease of merozoites into the
blood stream for the blood level to drop to its minimum of 2.7×106cells/µl, we note that the
likely time duration from the period of infectious bite to attainment of minimum blood level is
about 3 weeks since it takes about 6 days from the time of bite to the release of merozoites. In
dimensional terms, the concentration of merozoites reached its maximum of 5.5×105cells/µl,
two days prior to the attainment of the minimum level of red blood cells, whilst maximum
concentration of adaptive immune cells or evidence of sufficient immune defence was attained
three days after.
We seek an understanding of the effect of immune response on the control of parasitemia
and also the role innate immune response play in protecting the individual against malaria
in first infection. By switching off the specific immune response mechanism we find that
an individual without adaptive immunity is likely to die after 18 days of infectious bite.
This is shown in Figure 5.9 in which the the horizontal line intersects with the red blood
cell curve at (6.2, 0.3) where we have assumed death to occur when the individual attains
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a fatal haemoglobin or red blood cell level. We find from the simulations that the initial
level of adaptive immune cells or antibodies, φ0, plays a crucial role in the elimination of
parasites. This explains how continuous malaria contacts especially in endemic areas can lead
to acquisition of partial immunity. Increasing φ0 reduces the rate at which red blood cells
are invaded thus improving the minimum level. Figure 5.3 shows a plot of φ0 against various
minimum levels of red blood cells. An important aspect of this result is that given a particular
concentration of antibodies, we can determine the strength of parasite invasion of red blood
cells noting that the strength of invasion is determined by the extent to which the parasite
can reduce the red blood cell level.
An optimum concentration of antibodies is one that will be capable of protecting the
individual from invasion. We find from the simulations that by boosting the specific immune
response up to a concentration of 0.071 in dimensionless form will prevent the parasite from
invading, thus ensuring parasite/disease free situation. A mathematical model structured to
create a good understanding of the immune effector mechanisms of parasite regulation, control
and elimination will facilitate the production of a malaria vaccine of relatively high efficacy.
The global effort in malaria control especially, the contributions of the World Health
Organisation is commendable in many areas including that of vaccine production. Following
the emergence of RTS, S, the only malaria vaccine that has entered the phase 3 trial, there
are indications of some rising hope that a malaria vaccine will soon be in use. It is a pre-
erythrocytic vaccine aimed at stopping the release of merozoites from the liver into the blood
stream. Although some successes have been recorded in terms of severe disease reduction
in young children within the age group of 6-12 weeks and older children of the age range
5-17 months, the drug is still within an efficacy level of about 36.6%-50% [99] including the
tendency of the individual becoming reinfected. Thus, more work is required to identify the
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optimum vaccination age and dosing schedule for RTS, S, more immediate issues are to define
an acceptable level of protection and determine the true rate at which vaccine efficacy declines
below this level, as this will help determine the optimal boosting strategy [94].
The significance of φ0 in our model as it relates to subsequent contacts seems to provide
an insight into a boosting strategy in which the immune system can be conditioned to a level
that the individual will be capable of avoiding reinfection.
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CHAPTER 6
CONCLUSION
6.1. Concluding remarks
Malaria is an infectious disease with a dangerous global burden in which the quest for regional
elimination and entire global eradication cannot be over emphasized. In this work we have
constructed and analysed two mathematical models describing two major areas involving the
transmission of the disease between human and mosquito populations, and its dynamics as the
parasites within the human host interact with red blood cells and the immune system. Our
transmission model describes human-mosquito interaction on malaria epidemiology. Suscep-
tible and asymptomatic humans get infected when they are bitten by an infectious mosquito.
They then progress through the latent, symptomatic and asymptomatic classes, before re-
entering the susceptible class. Susceptible mosquitoes can become infected when they bite
symptomatic, asymptomatic or latent asymptomatic humans, and once infected they move
through the latent and infectious mosquito classes. We used both numerical simulations and
analytical methods to obtain solutions to the system. The numerical results show the model
can predict an endemic malaria situation but for some values of the model parameters a
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disease free state can be realised.
Single dose malaria drugs do not completely clear parasites but temporarily create asymp-
tomatic malaria and this has not been considered in previous models. Another area of novelty
is the second class of incubating humans resulting from the reinfection of asymptomatic hu-
mans. We have proposed and analysed a new transmission model incorporating these ideas.
The methods of analysis employed in previous malaria models have mainly focused on stabil-
ity analysis. In our case we have used in addition, asymptotic analysis to track the dynamics
of disease transmission starting from an initial introduction of a small amount of infected
mosquitos into a malaria free human population. Through our asymptotic analysis we have
provided insight into the transmission of the disease as shown by the numerical simulations.
There are important remarks about the transmission of the disease, which we have highlighted.
The noticeable build-up of latent asymptomatic humans at steady state confirms previous
experimental results that asymptomatic status is maintained through continuous infection.
This is a clear characteristic of the dynamics of malaria in an endemic region. It portends a
dangerous scenario and creates adverse effect on public policies aimed at control or eradication
of the disease. Although Ross [96] posits that to remove malaria in a region, the number of
mosquitos needs to be reduced below a particular threshold, Ngwa et al. [82] contend that this
approach would only be a temporary measure, especially in a malaria endemic region claiming
that the disease will resurface as the mosquito population recovers. However, our findings
suggest that Ngwa’s claim may hold in a situation of high proportion of asymptomatic carriers.
But if they are treated then the disease will not resurface despite recovery of the mosquito
population. If the attainment of asymptomatic status is an advantage then it appears adults
are gaining at the expense of children and women (who may likely loose immunity during
pregnancy). This gain may not be sustained for a long time as the analysis demonstrates that
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asymptomatic individuals will rapidly become latent when the epidemic takes hold.
During the treatment analysis we considered options of transmitting treated latent asymp-
tomatic humans to either the susceptible or latent class but the basic reproduction number
remains unchanged in both cases. This suggests that partially immune individuals may be
treated by gametocyte destroying drugs only, or by drugs that act on both asexual para-
sites and gametocytes. We recall from our previous discussion in chapter 2 that the basic
reproduction number R0 plays a crucial role in disease dynamics. It is a threshold value
that determines whether or not a disease will fully establish itself. Comparing the R0 of our
transmission model with that obtained in [29], we found that there are additional parameters
in our R0, namely η, α, ρ, f , h, d, which is due to the additional classes found in our model.
When the putative drug parameter, θ 6= 0, the term 1 + λ + θ replaces 1 + λ and taking the
limit as θ →∞ does not drive R0 to 0 but only reduces it to less than unity depending on the
values of the model parameters. This suggest that treating only asymptomatic individuals,
apart from being a mere epidemiological paradox would not guarantee disease eradication
except it is done with some form of vector control keeping the parameter β at a reasonable
level.
Our result is a deterministic approach to the hypothesis given in [85]. Past and present
policies of the WHO for the elimination and eradication of malaria have been geared towards
vector control and treatment of symptomatic humans and despite the huge amount of money
spent there are still reports of greater part of the world population affected by the disease.
The recent Global Malaria Programme’s new initiative, T3, urges malaria-endemic countries
to ensure that every suspected malaria case is tested, that every confirmed case is treated
with a quality-assured antimalarial medicine, and that the disease is tracked through timely
and accurate surveillance systems to guide policy and operational decisions [118].
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Our results suggest that testing, treating and tracking of suspected symptomatic cases
without considering the asymptomatic group that forms a greater part of the reservoir of
infection will thwart the global effort on the elimination and eradication of malaria. Although
the issue of treating asymptomatic humans may be difficult to control in that it would take a
lot of sensitisation and enlightenment campaigns to be able to persuade people who are not
having the symptoms of a disease to take treatment. However, we suggest that ‘Check Your
Malaria Status’ (CYMS) be introduced along side T3.
In this work, we have also proposed and analysed a within-host malaria model in which
the interaction between parasites, red blood cells and the immune system are well represented
based on a simplified form of the known biology. The novelty in the model comprises inclusion
of terms describing the mechanism of antigen presentation of innate immune cells at the start
of infection in preparation to triggerring adaptive immune response after a time delay and
an Fc-dependent mechanism of parasite killing. We used the model to study the dynamics of
disease pathology, parasite evolution from the young asexual erythrocyte stage to the mature
sexual exo-erythrocytic stage in a naive host. Both numerical simulations and asymptotic
analysis were employed in our study and the numerical results show that a naive human that
cannot develop specific immunity to malaria may not be able to survive a single mosquito
bite but in the presence of adaptive immunity there is possibility of parasite clearance even
though some levels of anaemia could be experienced.
6.1.1. Limitations of the models
Models are generally simplifications of reality and therefore subject to limitations. For in-
stance in an attempt to construct models to curb the shortcomings of previous models, we
end up having models with other limitations. Our in-host model does not account for the
accelerated production of red blood cells during malaria infection and the additional killing
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of erythrocytes by phagocytosis of nonviable merozoites attached to them. This is considered
in the model of Chiyaka et al. [23] by including additional two terms. The exclusion in our
model is based on the assumption that the two terms might cancel out. But in a situation
where the net contributions of these terms is large it may affect the results. The issue of
parasite clearance is another limitation. Another factor we have not considered in our model
is the inhibition of immune cell growth. Inhibitory cytokines reduce the secretion of IL-10, a
major cytokine that induces B cell proliferation and immunoglobulin production [67], thereby
reducing the production of antibodies. Our model is a continuum model and we find out
from the simulations that the immune system drives the concentration of parasite to a very
low level which we assumed to be negligible in terms of number of parasites present in the
blood stream. Similarly, during the asymptotic analysis, gametocytes are seen to emerge in
the third time scale, less than two days after infection and before the end of the first cycle of
schizogony, which may not be a good representation of reality. However, since  = 0.001, the
density of gametocytes, being O(4) is assumed to be zero. It was not until the sixth time
scale when a non negligible amount of O() was produced.
6.1.2. Suggestion for future work.
The two models we have developed in this study are aimed at describing the dynamics of
malaria transmission and pathogenesis with the aim of assessing possible elimination strate-
gies. The models can be relevant in areas where malaria has been persistently prevalent and
regions that have achieved malaria elimination. However, the models are mere simplifications
of reality and some modifications are required for improvement, which will provide directions
for further studies. The following areas are included for consideration.
• Numerical simulations of the transmission model suggest that combined treatment of
both symptomatic and asymptomatic individuals will lead to malaria elimination. We
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propose pilot studies in malaria endemic regions using this model as a theoretical frame-
work.
• Environmental factors favourable to mosquito breeding also contribute to the pattern
of disease transmission. These factors may vary seasonally within a region or between
regions. We propose a model modification that will incorporate temperature and rainfall
so as to ensure regional specific results.
• An asymptotic expansion of R0 shows that the putative drug, θ, used for the treatment
of asymptomatic humans is not as effective as γ, the full treatment parameter. Whilst in
the numerical simulations, θ appears to be much more effective in killing off the disease.
The mechanism for this behaviour is not yet known, and hence the need for further
investigation.
• Antibodies production: Though it is assumed that the production of antibodies comes
from activation of naive T cells and B cells through interaction between innate immune
cells and pathogens, it is not fully represented in the in-host model. The delay term ap-
pears to cover this limitation but in strict sense we do not expect antibodies production
whenever innate immune cells are absent. Thus we propose a modification in which the
antibodies equation is multiplied by P − 1.
• Subsequent contact: The in-host model is studied by assuming only a first contact in
the analysis whereas results from our simulations indicate a good prospect of reducing
disease pathology on consideration of boosting the immune response, and hence we
propose inclusion of subsequent contact in future work on the model.
• During malaria infection certain mechanisms operate to inhibit the production of an-
tibodies especially when the effect of proinflamatory activities is high and phagocytic
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cells become heavily laden with haemozoin particles. Regulatory T cells produce in-
hibitory cytokines to reduce the secretion of IL-10, a major cytokine that induces B
cell proliferation and immunoglobulin production[67]. Consideration of this may create
a major extension of the model as it will require two additional equations for T cells
and B cells.
• Through the asymptotic analysis of the in-host model we found that the immune system
is mostly driven by infected red blood cells. Further investigation is recommended
to ascertain the validity of this result. The genetic constituent of red blood cells as
different from that of merozoite should be determined. This may create an insight into
manufacturing a vaccine that will boost the immune system to the extent of stopping
merozoite invasion of red blood cells.
This list is not exhaustive and it has not in any way invalidated the results of our work but we
hope that these suggestions will help to extend the frontier of knowledge and create a better
direction in the quest for malaria eradication.
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APPENDIX A
APPENDIX
A.1. Expressions for important constants in the stability analysis of transition model
b4 = a1a2a3a4a5, C1 = a1a2a4a5, C2 = a1 + a2 + a3 + a4 + a5,
C3 = a1a
2
5{a5(4a22 + 5a2a4) + 4a32 + 8a22a4 + 8a2a24},
C4 = a1{a5(5a32a4 + 8a22a24 + 5a2a34) + 4a32a24 + 4a22a34 + a2a44},
C5 = a1a5{a35(a2 + a4) + 4a24a25 + 4a34a5 + a44 + 2a32a25 + 4a5(a42 + 5a22a34)},
C6 = a2a4(a
2
2a4 + a
2
2a5 + 2a2a
2
4 + 5a2a4a5 + a
3
4 + 5a
2
4a5),
C7 = a1a
3
5{a5(a22 + a2a4 + a24) + 5a22a4 + 5a2a24 + 2a34},
C8 = a1a
2
5(8a
2
2a
2
4 + 5a2a
3
4 + a
4
4) + a1a2a
4
4a5 + a
4
2a4
2a5,
C9 = a
3
5{a5(a22a4 + a2a24) + 2a32a4 + 4a22a24 + 2a2a34},
C10 = a5{a5(a42a4 + 4a32a24 + 4a22a34 + a2a44) + 2a32a34 + a22a44},
D1 = a3 + 2(a1 + a2 + a4 + a5), D2 = a1(a1 + 3a2 + 2a3 + 3a4 + 3a5) + 3a
2
2 + 4a2a3,
D3 = a1(6a2a4 + 6a2a5 + 4a3a4 + 4a3a5 + 3a
2
4), D4 = 6a1a4a5 + 3a1a
2
5 + a
3
2 + 2a
2
2a3 + 3a
2
2a4,
D5 = a4(a
2
4 + 3a2a4 + 3a4a5 + 2a3a4 + 3a
2
5 + 4a3a5 + 6a2a5,
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D6 = 4a2a3a4 + a
3
5 + 2a3a
2
5 + 3a2a
2
5 + 3a
2
2a5 + 4a2a3a5,
D7 = C
2
1(a2a4 + a
4
5)(a2 + a4) + C
2
1a5(a
2
2 + a2a4 + a
2
4) + C8,
D8 = 2C1a2a4a
4
5(a2 + a4) + C1a2a4a
3
5(5a2a4 + 4a
2
2 + 4a
2
4) + C3,
D9 = a
2
2a
2
4(a4 + a2)
2 + a1a
2
4a5(8a
2
2 + 5a2a4 + a
2
4) + C4 + C5,
D10 = a
2
2C1 + C6C7, D11 = a2a4a5(a
3
4 + 2a
2
4a5 + a4a
2
5 + 4a2a4a5 + a2a
2
5),
E1 = βηfρd, E2 = βηfb.
A.2. Demonstrating the effect of inequalities obtained in 3.6.7 on R0
R0 =
βηf{b (1 + λ+ θ) + ρd}
(η + λ) (α + γ + ρ+ λ) (1 + λ+ θ) (f + q) (h+ q)
. (A.2.1)
ηβ
η + λ
≤ q, (A.2.2)
fb
f + q
≤ γ + λ, (A.2.3)
fd
f + q
≤ λ(η + θ + λ)
η + λ
. (A.2.4)
We show that if (A.2.2)−(A.2.4) hold, then R0 ≤ 1.
Numerator of (A.2.1) = βηf{b (1 + λ+ θ) + ρd}.
Numerator of (A.2.1) = βη{fb (1 + λ+ θ) + fρd}. (A.2.5)
Denominator of (A.2.1) = (η + λ) (h+ q) {(λ+ γ) (f + q) (1 + λ+ θ)
+ (α + ρ) (1 + λ+ θ) (f + q)},
Denominator of (A.2.1) = (η + λ) (h+ q)
{
(λ+ γ) (1 + λ+ θ) (f + q) (A.2.6)
+{ρ (1 + λ+ θ) (f + q) + α (1 + λ+ θ) (f + q)}}
Comparing (A.2.5) and (A.2.6) we observe from (A.2.2) that
βη ≤ (η + λ)q ≤ (η + λ)(h+ q), (A.2.7)
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and from (A.2.3) that
fb ≤ (γ + λ)(f + q), (A.2.8)
and hence
fb(1 + θ + λ) ≤ (γ + λ)(f + q)(1 + θ + λ). (A.2.9)
Also, from (A.2.4),
fd ≤ (f + q)λ(η + λ+ θ)
η + λ
⇒ fd ≤ (f+q)(1+λ+θ), since 1+θ+λ > λ(η + λ+ θ)
η + λ
. (A.2.10)
Thus, the numerator of (A.2.1) is less than the denominator, meaning, R0 < 1.
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APPENDIX B
APPENDIX
B.1. Time-scale analysis (transition model)
By letting θ = 0, we present the time scale analysis of the dimensionless system
2
dC
dt
= 4λˆ+ γˆS + 2A− βˆZC − 4λˆC + 4αˆCS, (B.1.1)
2
dL
dt
= βˆZC − ηˆL− 4λˆL+ 4αˆLS, (B.1.2)
2
dLA
dt
= βˆZA− ηˆLA − 4λˆLA + 4αˆLAS, (B.1.3)
2
dS
dt
= ηˆL+ ηˆLA −
(
ρˆ+ γˆ + 4αˆ + 4λˆ
)
S + 4αˆS2, (B.1.4)
2
dA
dt
= ρˆS −
(
2 + 4λˆ
)
A− βˆZA+ 4αˆAS, (B.1.5)

dX
dt
= qˆ (1−X)− bˆSX − dˆAX − dˆLAX + hˆXZ, (B.1.6)

dY
dt
= bˆSX + dˆAX + dˆLAX −
(
fˆ + qˆ
)
Y + hˆY Z, (B.1.7)

dZ
dt
= fˆY −
(
hˆ+ qˆ
)
Z + hˆZ2, (B.1.8)
subject to
C(0) = 1, L(0) = 0, LA(0) = 0, S(0) = 0, A(0) = 0,
Y (0) = y0, X(0) = 1− y0, Z(0) = 0,  1, y0  ,
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in which all parameters are expressed in terms of their size as a power of  indicated in table
3.3, namely
β =
1
2
βˆ, η =
1

ηˆ, µ = 2µˆ, λ = 2λˆ, α = 2αˆ, γ =
1

γˆ, ρ =
1
2
ρˆ, (B.1.9)
b =
1

bˆ, d =
1

dˆ, f =
1

fˆ , g =
1

gˆ, h = hˆ, q =
1

qˆ.
We analyse this system for the case of newly introduced infected mosquitoes to a previously
uninfected region.
B.1.1. Time scale 1: t = O(2)
• Scalings: t = 2tˆ,
C ∼ 1 + y0Cˆ1, L ∼ y0Lˆ0, LA ∼ 3y20LˆA0 , S ∼ 2y0Sˆ0,
A ∼ 2y0Aˆ0, X ∼ 1− y0 + y0Xˆ1, Y ∼ y0 + y0Yˆ1, Z ∼ y0Zˆ0.
Substituting these scalings into the dimensionless system leads to the following
• Equations
dCˆ1
dtˆ
= −βˆZˆ0(1 + y0Cˆ1) + 2(γˆSˆ0 + Aˆ0)− 4λˆCˆ1 + 5αˆ(1 + y0Cˆ1)Sˆ0,
dLˆ0
dtˆ
= βˆZˆ0(1 + y0Cˆ1)− ηˆLˆ0 − 4λˆLˆ0 + 6y0αˆLˆ0Sˆ0,
dLˆA0
dtˆ
= βˆAˆ0Zˆ0 − ηˆLˆA0 − 4λˆLˆA0 + 6y0αˆLˆA0Sˆ0,
dSˆ0
dtˆ
= ηˆL0 − ρˆSˆ0 + 2y0ηˆLˆA0 − (γˆ + 4αˆ + 4λˆ)Sˆ0 + 6y0αˆSˆ20 ,
dAˆ0
dtˆ
= ρˆS0 − (2 + 4λˆ)Aˆ0 − y0βˆZˆ0Aˆ0 + 6y0αˆAˆ0Sˆ0,
dXˆ1
dtˆ
= qˆ(1− Xˆ1)− 2bˆSˆ0(1− y0 + y0X1)− 2dˆAˆ0(1− y0 + y0Xˆ1)
+ 2hˆ(1− y0 + y0Xˆ1)Zˆ0)− 3y0dˆLˆA0(1− y0 + y0Xˆ1),
dY¯1
dtˆ
= −
(
fˆ + qˆ
)
(1 + Yˆ1) + 
2bˆSˆ0(1− y0 + y0X1) + 2dˆAˆ0(1− y0 + y0X1)
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+ 2hˆ(1− y0 + y0Yˆ1)Zˆ0) + 3y0dˆLˆA0(1− y0 + y0Xˆ1),
dZˆ0
dtˆ
= fˆ(1 + Y1)− (qˆ + hˆ)Zˆ0 + 3y0hˆZˆ20 ,
— The system changes balance at tˆ = O(−2/3). This happens in the Y equation as
the lower order term 2dˆAˆ0 catches up with the O(1) term fˆ + qˆ. We observe from the
solution in this timescale that Aˆ0 = O(t
3). Thus 2tˆ3 = O(1) implies tˆ = O(−
2
3 ). We
note that y0   and tˆ = O(− 23 ) is the smallest time in which the asymptotic expansion
will no longer be valid.
B.1.2. Time scale 2: t = O(4/3)
• Scalings: t = 4/3t¯,
C ∼ 1 + −1/3y0C¯1, L ∼ −1/3y0L¯0, LA ∼ −1/3y20L¯A0 ,
S ∼ 2/3y0S¯0, A ∼ y0A¯0, X ∼ 1− y0 + 1/3y0X¯1,
Y ∼ y0 + 1/3y0Y¯1, Z ∼ 1/3y0Z¯0.
On substitution of these scalings into the dimensionless system we have
• Equations
dC¯1
dt¯
= −βˆZ¯0(1 + − 13y0C¯1) +  43 (γˆS¯0 +  13 A¯0)− 4λˆC¯1) +  133 αˆ(1 + − 13y0C¯1)S¯0,
dL¯0
dt¯
= βˆZ¯0(1 + 
− 1
3y0C¯1)−  13 ηˆL¯0 −  103 λˆL¯0 + 4y0αˆL¯0S¯0,
dL¯A0
dt¯
= βˆA¯0Z¯0 −  13 ηˆL¯A0 − 
10
3 λˆL¯A0 + 
4y0αˆL¯A0S¯0,

2
3
dS¯0
dt¯
= ηˆL¯0 − ρˆS¯0 + y0ηˆL¯A0 − (γˆ + 4αˆ + 4λˆ)S¯0 + −
14
3 y0αˆS¯
2
0 ,
dA¯0
dt¯
= ρˆS¯0 − y0

1
3
βˆZ¯0A¯0 − ( 43 +  103 λˆ)A¯0 + 4y0αˆA¯0S¯0,
dX¯1
dt¯
= qˆ(1−  13 X¯1)− dˆA¯0(1− y0 +  13y0X¯1)−  23 bˆS¯0(1− y0 +  13y0X¯1)
− y0

1
3
dˆL¯A0(1− y0 + 
1
3y0X1) + 
4
3 hˆ(¯1− y0 +  13y0X¯1)Z¯0,
132
dY¯1
dt¯
= −
(
fˆ + qˆ
)
(1 + 
1
3 Y¯1) + dˆA¯0(1− y0 +  13y0X¯1) +  23 bˆS¯0(1− y0 +  13y0X¯1)
+
y0

1
3
dˆL¯A0(1− y0 + 
1
3y0X¯1) + 
4
3y0hˆ(1 + 
1
3 Y¯1)Z¯0,
dZ¯0
dt¯
= fˆ(1 + 
1
3 Y¯1)−  13 (hˆ+ qˆ)Z¯0 +  53y0hˆZ¯20 ,
— Solutions in this timescale suggest that X1 = O(t¯
4) and the approximations
become poor when the second term 
1
3 t¯4 becomes O(1), i.e. t¯4 = O(−
1
3 ). This leads to
a break down in the X equation when t¯ = O(−1/12).
B.1.3. Time scale 3: t = O(5/4)
• Scalings: t = 5/4t˜,
C ∼ 1 + −1/2y0C˜1, L ∼ −1/2y0L˜0, LA ∼ −3/4y20L˜A0 ,
S ∼ 1/2y0S˜0, A ∼ −1/4y0A˜0, X ∼ 1 + y0X˜1,
Y ∼ y0Y˜1, Z ∼ 1/4y0Z˜0.
By substituting the scalings into the dimensionless system and carrying out some simplifica-
tions we get the following
• Equations
dC˜1
dt˜
= −βˆZ˜0(1 + − 12y0C˜1) +  32 (A˜0 +  14 γˆS˜0)−  134 λˆC˜1 +  92 αˆ(1 + − 12y0C˜1)S˜0,
dL˜0
dt˜
= βˆZ˜0(1 + 
− 1
2y0C˜1)−  12 ηˆL˜0 −  104 λˆL˜0 +  154 y0αˆL˜0S˜0,
dL˜A0
dt˜
= βˆA˜0Z˜0 −  14 ηˆL˜A0 − 
13
4 λˆL˜A0 + 
15
4 y0αˆL˜A0S˜0,

1
2
dS˜0
dt˜
= ηˆL˜0 − ρˆS˜0 + y0

1
4
ηˆL˜A0 − (γˆ + 4αˆ + 4λˆ)S˜0 + 4y0αˆS˜20 ,
dA˜0
dt˜
= ρˆS˜0 − y0

1
3
βˆZ˜0A˜0 − ( 54 +  134 λˆ)A˜0 +  154 y0αˆA˜0S˜0,
dX˜1
dt˜
= −dˆA˜0(1 + y0X˜1)−  14 qˆX˜1 −  34 bˆS˜0(1 + y0X˜1)−  12y0dˆL˜A0(1 + y0X˜1)
+ 
3
2 hˆ(1 + y0X˜1)Z˜0,
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dY˜1
dt˜
= dˆA˜0(1 + y0X˜1)−  14 (fˆ + qˆ)Y˜1 +  34 bˆS˜0(1 + y0X˜1) +  12y0dˆL˜A0(1 + y0X˜1)
+ 
3
2y0hˆY˜1Z˜0,
dZ˜0
dt˜
= fˆ Y˜1 −  14 (qˆ + hˆ)Z˜0 +  32y0hˆZ˜20 ,
— The governing equation of the system is
d4Z˜0
dt˜4
= KZ˜0, obtained by successive
differentiation of
dZ˜0
dt˜
, where K = βˆηˆfˆ dˆ and For K0 = K
1
4 , change in balance occurs in
the C solution when t˜ = ln(1/2/y0)/K0.
B.1.4. Time scale 4: t = 
5
4 ln(1/2/y0)/K + O(
5
4 )
• Scalings: t =  54 ln(1/2/y0)/K +  54 tˇ,
C ∼ Cˇ0, L ∼ Lˇ0, LA ∼ 1/4LˇA0 , S ∼ Sˇ0, A ∼ 1/4Aˇ0,
X ∼ 1 + 1/2Xˇ1, Y ∼ 1/2Yˇ1, Z ∼ 3/4Zˇ0.
• Equations
dCˇ0
dtˇ
= −βˆCˇ0Zˇ0 +  32 (Aˇ0 +  14 γˆSˇ0)−  134 λˆ(1− Cˇ0) +  174 αˆCˇ0Sˇ0,
dLˇ0
dtˇ
= βˆCˇ0Z˜0 −  14 ηˆLˇ−  134 λˆLˇ0 +  174 αˆLˇ0Sˇ0,
dLˇA0
dtˇ
= βˆAˇ0Zˇ0 −  14 ηˆLˇA0 − 
13
4 λˆLˇA0 + 
17
4 y0αˆLˇA0Sˇ0,

3
4
dSˇ0
dtˇ
= ηˆLˇ0 − ρˆSˇ0 +  14 ηˆLˇA0 − (γˆ + 4αˆ + 4λˆ)Sˇ0 + 5αˆSˇ20 ,
dAˇ0
dtˇ
= ρˆSˇ0 − βˆZˇ0Aˇ0 − ( 54 +  134 λˆ)Aˇ0 +  174 αˆAˇ0Sˇ0,
dXˇ1
dtˇ
= −dˆAˇ0(1 +  12 Xˇ1)− dˆLˇA0(1 + 
1
2 Xˇ1)−  12 qˆXˇ1 −  34 bˆSˇ0(1 +  12 Xˇ1)
+ 
3
2 hˆ(1 + 
1
2 Xˇ1)Zˇ0,
dYˇ1
dtˇ
= dˆAˇ0(1 + 
1
2 Xˇ1) + dˆLˇA0(1 + 
1
2 Xˇ1) + 
3
4 bˆSˇ0(1 + 
1
2 Xˇ1)−  12 (fˆ + qˆ)Yˇ1
+ 2hˆYˇ1Zˇ0,
dZˇ0
dtˇ
= fˆ Yˇ1 −  14 (qˆ + hˆ)Zˇ0 + 2hˆZˇ20 .
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— Some simplification leads to the following fourth order nonlinear ordinary dif-
ferential equation that determines the dynamics of the system
d4Fˇ
dtˇ4
= −K
(
1− eFˇ
)
,
Fˇ = ln(Cˇ0).
— Major break down of the solutions occur in the X equation where the X1 term
becomes O(1), i.e when tˇ = O
(
−1/4
)
.
B.1.5. Time scale 5: t = O()
• Scalings: t = t?,
C ∼ 2C?0 , L ∼ L?0, LA ∼ L?A0 , S ∼ S?0 ,
A ∼ A?0, X ∼ X?0 , Y ∼ Y ?0 , Z ∼ Z?0 .
Substituting these scalings into the dimensionless system leads to
• Equations

dC?0
dt?
= −βˆC?0Z?0 + γˆS?0 + A?0 − 2λˆ(1− 2C?0) + 4αˆC?0S?0 ,
dL?0
dt?
= −ηˆL?0 + βˆZ?0C?0 − 3λˆL?0 + 4αˆL?0S?0 ,
dL?A0
dt?
= βˆZ?0A
?
0 − ηˆL?A0 − 3λˆL?A0 + 4αˆL?A0S?0 ,

dS?0
dt?
= ηˆ(L?0 + LA0
?)− ρˆS?0 − (γˆ + 4αˆ + 4λˆ)S?0 + 5αˆS20?,

dA?0
dt?
= ρˆS?0 − βˆZ?0A?0 − (2 + 4λˆ)A?0 + 4αˆA?0S?0 ,
dX?0
dt?
= qˆ(1−X?0 )− dˆL?A0X?0 − (bˆS?0X?0 + dˆA?0X?0 − hˆX?0Z?0),
dY ?0
dt?
= +dˆL?A0X
?
0 − (fˆ + qˆ)Y ?0 + (bˆS?0X?0 + dˆA?0X?0 − hˆY ?0 Z?0),
dZ?0
dt?
= fˆY ?0 − qˆZ?0 − hˆ(1− Z?0 2).
— Approximation to L will no longer be O(1) when t = ln (1/) /η.
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B.1.6. Time scale 6: t =  ln(1/)/η + O()
• Scalings:  ln(1/)/η + t´,
C ∼ 2C´0, L ∼ L´0, LA ∼ 1, S ∼ S´0,
A ∼ A´0, X ∼ X´0, Y ∼ Y´0, Z ∼ Z´0.
On substitution of these into the dimensionless system we obtain the following
• Equations

dC´0
dt´
= −βˆC´0Z´0 + γˆS´0 + A´0 − 2λˆ(1− 2C´0) + 4αˆC´0S´0,
dL´0
dt´
= −ηˆL´0 + βˆZ´0C´0 − 3λˆL´0 + 4αˆL´0S´0,
dL´A0
dt´
= βˆZ´0A´0 − ηˆL´A0 − 3λˆL´A0 + 4αˆL´A0S´0,

dS´0
dt´
= ηˆL´A0 − ρˆS´0 + ηˆL´0 − (γˆ + 4αˆ + 4λˆ)S´0 + 5αˆS´20 ,

dA´0
dt´
= ρˆS´0 − βˆZ´0A´0 − (2 + 4λˆ)A´0 + 4αˆA´0S´0,
dX´0
dt´
= qˆ(1− X´0)− dˆL´A0X´0 − (bˆS´0X´0 + dˆA´X´0 − hˆX´0Z´0),
dY´0
dt´
= dˆL´A0X´0 − (fˆ + qˆ)Y´0 + (bˆS´0X´0 + dˆA´0X´0 − hˆY´0Z´0),
dZ´0
dt´
= fˆ Y´0 − qˆZ´0 − hˆ(1− Z´20).
— Other variables maintain their steady status and LA0 ∼ 1,
— and the only remaining equation is
dL´0
dt´
=
γˆηˆ
ρˆ
− ηˆL´0.
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APPENDIX C
APPENDIX
C.1. Asymptotic analysis (in-host model)
For the Inhost dynamics we seek asymptotic analysis of The dimensionless system

dX
dt
= 2σˆ (1−X)− βˆXM
1 + A
, (C.1.1)

dY
dt
=
βˆXM
1 + A
−  (1 + µˆ)Y − kˆPY (1 + kˆ1A), (C.1.2)

dM
dt
= 
rˆ
(
1− θˆ
)
Y
1 + k6A
− βˆXM
1 + A
− dˆM − αˆPM
(
1 + kˆ2A
)
, (C.1.3)
dG
dt
= 
rˆθˆY
1 + k6A
− eˆG− fˆPG(1 + kˆ3A). (C.1.4)
dP
dt
= bˆ(1− P ) + ωˆ
(
Y + φˆM
)
− P
(
kˆ4Y + kˆ5M
)
, (C.1.5)
dA
dt
= gˆ1Y (t− τ) + gˆ1gˆ2M (t− τ)− gˆ3A− hˆ1AY − hˆ2AM, (C.1.6)
subject to
t = 0, X = 1, Y = 0, M = 2mˆ0, G = 0, P = 1, A = 0,
t < 0, X = 1, Y = 0, M = 0, G = 0, P = 1, A = 0.
We want our readers to note that for the purpose of brevity, we have used an “over-bar”
to identify the rescaled variables in each time scale instead of the usual practice of different
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variables for different timescales.
C.1.1. Time scale 1: t = O()
• Scalings: t = t¯,
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 2M¯, G ∼ 4G¯, P ∼ P¯ , A = 0
Substituting these into the dimensionless system leads to
• Equations
dX¯
dt¯
= 2σˆ
(
1− X¯)− 2βˆX¯M¯ ,
dY¯
dt¯
= βˆX¯M¯ −  (1 + µˆ) Y¯ − kˆP¯ Y¯ ,
dM¯
dt¯
=
(
dˆ+ βˆ + αˆP¯
)
M¯ + rˆY¯ − 2rθˆY¯ ,
dG¯
dt¯
= rˆθˆY¯ − fˆ P¯ G¯− 2eˆG¯,
dP¯
dt¯
= bˆ
(
1− P¯)+ 3ωˆ (Y¯ + φˆM¯)− 3kˆ4P¯ Y¯ − 3kˆ5P¯ M¯ ,
• There is a change in balance when M¯ = O(). i.e at t¯ = 1
b0
ln(1

) +O(1)
C.1.2. Time scale 2: t = 
b0
ln(1

) + O()
• Scalings: t = 
b0
ln(
1

) + t¯,
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 3M¯, G ∼ 4 rˆθˆβˆ
b20
ln
(
1

)
+ 4G¯, P ∼ P¯ , A = 0
On substitution of these into (C.1.1)-(C.1.6) we have the following
• Equations
dX¯
dt¯
= 2σˆ
(
1− X¯)− 3βˆX¯M¯ ,
dY¯
dt¯
= βˆX¯M¯ −  (1 + µˆ) Y¯ − kˆP¯ Y¯ ,
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dM¯
dt¯
= rˆY¯ +
(
dˆ+ βˆ + αˆP¯
)
M¯ − rθˆY¯ ,
dG¯
dt¯
= rˆθˆY¯ − fˆ P¯ G¯− 2eˆG¯,
dP¯
dt¯
= bˆ
(
1− P¯)+ 3ωˆY + 4 (ωˆφˆM − kˆ4P¯ Y¯ )− 5kˆ5P¯ Y¯ ,
• The Solution breaks down at t¯ = O(1/)
C.1.3. Time scale 3: t = O(1), t < τ
• Scalings: t = t¯,
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 3M¯, G ∼ 3G¯, P ∼ P¯ , A = 0
Substituting these scalings into the dimensionless system yeilds
• Equations
dX¯
dt¯
= σˆ
(
1− Xˆ
)
− 2βˆX¯M¯ ,
dY¯
dt¯
= βˆX¯M¯ − (1 + µˆ) Y¯ − kˆP¯ Y¯ ,

dM¯
dt¯
= rˆY¯ −
(
dˆ+ βˆ + αˆP¯
)
M¯ − rθˆY¯ ,
dGˆ
dtˆ
= rˆθˆY − fˆ P¯ G¯− eˆG¯,
dP¯
dt¯
= bˆ
(
1− P¯)+ 2 (ωˆ − kˆ4P¯) Y¯ + 3 (ωˆφˆ− kˆ5P¯) M¯,
C.1.4. Time scale 4: t = τ + O(), Rc > 1
• Scalings: t = τ + t¯,
— In this time scale, all other variables become frozen but
A ∼ 3A¯
By substituting this together with the scalings of Y and M for the first time scale into (C.1.6)
we have the
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• Equation
dA¯
dt¯
= gˆ1Y¯ (t− τ) + gˆ1gˆ2M¯ (t− τ)− gˆ3A− 3hˆ1A¯Y¯ − 3hˆ2A¯M¯ .
• The solution to this equation breaks down at tˆ = ln( 1 )
b0
+O(1)
C.1.5. Time scale 5: t = τ + O(1), Rc > 1
• Scalings: t = τ + t¯,
X ∼ X¯, Y ∼ 2Y¯ , M ∼ 3M¯,
G ∼ 3G¯, P ∼ P¯ , A ∼ 2A¯,
Substituting these scalings into the dimensionless system leads to the following
• Equations
dX¯
dt¯
= σˆ
(
1− Xˆ
)
− 2βˆX¯M¯ ,
dY¯
dt¯
= βˆX¯M¯ − (1 + µˆ) Y¯ − kˆP¯ Y¯ ,

dM¯
dt¯
= rˆY¯ +
(
dˆ+ βˆ + αˆP¯
)
M¯ − rθˆY¯ ,
dGˆ
dtˆ
= rˆθˆY − fˆ PˆG− eˆGˆ,
dPˆ
dtˆ
= bˆ
(
1− P¯)+ 2 (ωˆ − kˆ4P¯) Y¯ + 3 (ωˆφˆ− kˆ5P¯) M¯,
dA¯
dt¯
= gˆ1Y¯ (t− τ)− g3A¯+ gˆ1gˆ2M¯ (t− τ)− 2hˆ1A¯Y¯ − 3hˆ2A¯M¯ ..
• The approximations will become poor in the P equation, when Y = O(1/2), i.e. t =
2
R
ln( 1

)
b0
+O(1).
C.1.6. Time scale 6: t = τ + 2
R
ln(1

) + O(1), R > 0
• Scalings: t = τ + 2
R
ln(1

) + t¯,
X ∼ X¯, Y ∼ Y¯ , M ∼ M¯,
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G ∼ G¯, P ∼ P¯ , A ∼ A¯,
• Equations
dX¯
dt¯
= − βˆX¯M¯
1 + A¯
− σˆ(1− X¯), (C.1.7)
dY¯
dt¯
=
βˆX¯M¯
1 + A¯
− (1 + µˆ) Y¯ − kˆP¯ Y¯
(
1 + kˆ1A¯)
)
, (C.1.8)

dM
dt
=
rˆY¯
1 + k6A¯
− βˆX¯M¯
1 + A¯
− dˆM¯ − αˆP¯ M¯(1 + kˆ2A¯)− θˆY
1 + k6A
, (C.1.9)
dG¯
dt¯
=
rˆθˆY¯
1 + k6A¯
− fˆ P¯ G¯(1 + kˆ3A¯)− eˆG¯, (C.1.10)
.
dP¯
dt¯
= bˆ(1− P¯ ) + ωˆY¯ + (ωˆφˆM¯ − kˆ4P¯ Y¯ )− 2kˆ5P¯ M¯ , (C.1.11)
dA¯
dt¯
= gˆ1Y¯ (t− τ)− hˆ1A¯Y¯ − g3A¯+ (gˆ1gˆ2M¯(t− τ)− hˆ2A¯M¯).. (C.1.12)
• The system does not seem to have a closed form solution but we have made some
important approximations for the variables in this time scale in which details are given
in section 5.7.6 of the main text. Numerical solution in this timescale shows that Y , M ,
G and A are exponentially small and P ∼ 1.
• The X equation changes balance at the commencement of recovery when t = O(1/)
C.1.7. Time scale 7: t = O (−1)
• Scalings: t = 1

tˆ,
X ∼ X¯,
Substituting these into (C.1.1) we get,
• Equation
dX¯
dt¯
= σˆ
(
1− X¯) ,
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